No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d4q1sY_, 1.0000, 0.00, 1.000, 211, 211, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2, d4q1sK_, 0.9992, 0.15, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3, d4j70Y_, 0.9990, 0.16, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4, d5bxlY_, 0.9989, 0.18, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-G170A MUTANT
5, d5bxlK_, 0.9989, 0.18, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-G170A MUTANT
6, d5bouY_, 0.9989, 0.17, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
7, d5bouK_, 0.9989, 0.17, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
8, d4ya4Y_, 0.9989, 0.18, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H114D MUTANT
9, d4ya4K_, 0.9989, 0.18, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H114D MUTANT
10, d4j70K_, 0.9989, 0.17, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
11, d5d0wY_, 0.9988, 0.19, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1S MUTANT
12, d5d0wK_, 0.9988, 0.19, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1S MUTANT
13, d5czaY_, 0.9988, 0.18, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-D166N MUTANT
14, d5czaK_, 0.9988, 0.18, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-D166N MUTANT
15, d5cgfY_, 0.9988, 0.18, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-G48C MUTANT
16, d5cgfK_, 0.9988, 0.18, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-G48C MUTANT
17, d4z1lY_, 0.9988, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
18, d4ya1Y_, 0.9988, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116N MUTANT
19, d4ya1K_, 0.9988, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116N MUTANT
20, d4y9yY_, 0.9988, 0.18, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116E MUTANT
21, d4y9yK_, 0.9988, 0.18, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116E MUTANT
22, d4y8rY_, 0.9988, 0.18, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116D MUTANT
23, d4y8rK_, 0.9988, 0.18, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-H116D MUTANT
24, d5fg9Y_, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
25, d5fg9K_, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
26, d5fg7Y_, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-T1A MUTANT
27, d5fg7K_, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-T1A MUTANT
28, d4z1lK_, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
29, d4y8mY_, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
30, d4y8mK_, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
31, d4rurY_, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
32, d4rurK_, 0.9987, 0.19, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
33, d4qv7Y_, 0.9987, 0.19, 0.995, 212, 211, YCP BETA5-A50V MUTANT
34, d4qv7K_, 0.9987, 0.19, 0.995, 212, 211, YCP BETA5-A50V MUTANT
35, d4qv4Y_, 0.9987, 0.19, 0.995, 212, 211, YCP BETA5-M45T MUTANT
36, d4qv4K_, 0.9987, 0.19, 0.995, 212, 211, YCP BETA5-M45T MUTANT
37, d4quyY_, 0.9987, 0.19, 0.995, 212, 211, YCP BETA5-A49S-MUTANT
38, d4quyK_, 0.9987, 0.19, 0.995, 212, 211, YCP BETA5-A49S-MUTANT
39, d4quxY_, 0.9987, 0.19, 0.995, 212, 211, YCP BETA5-A49T-MUTANT
40, d4quxK_, 0.9987, 0.19, 0.995, 212, 211, YCP BETA5-A49T-MUTANT
41, d3tddY_, 0.9987, 0.19, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
42, d3tddK_, 0.9987, 0.19, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
43, d5fgaY_, 0.9986, 0.20, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
44, d5fgaK_, 0.9986, 0.20, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
45, d5cz7Y_, 0.9986, 0.20, 0.991, 217, 211, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
46, d5cz7K_, 0.9986, 0.20, 0.991, 217, 211, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
47, d4qv5Y_, 0.9986, 0.20, 0.995, 212, 211, YCP BETA5-M45I MUTANT
48, d4qv5K_, 0.9986, 0.20, 0.995, 212, 211, YCP BETA5-M45I MUTANT
49, d4qv1Y_, 0.9986, 0.20, 0.995, 212, 211, YCP BETA5-M45A MUTANT
50, d4qv1K_, 0.9986, 0.20, 0.995, 212, 211, YCP BETA5-M45A MUTANT
51, d4lqiY_, 0.9986, 0.20, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
52, d4lqiK_, 0.9986, 0.20, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
53, d5cz6Y_, 0.9985, 0.20, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
54, d5cz6K_, 0.9985, 0.20, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
55, d4qv9Y_, 0.9985, 0.20, 0.995, 212, 211, YCP BETA5-C63F MUTANT
56, d4qv9K_, 0.9985, 0.21, 0.995, 212, 211, YCP BETA5-C63F MUTANT
57, d4qv3Y_, 0.9985, 0.20, 0.995, 212, 211, YCP BETA5-M45V MUTANT
58, d4qv3K_, 0.9985, 0.20, 0.995, 212, 211, YCP BETA5-M45V MUTANT
59, d4eu2Z_, 0.9985, 0.21, 0.995, 212, 211, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
60, d5fgfY_, 0.9984, 0.21, 0.991, 214, 211, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
61, d5fgfK_, 0.9984, 0.21, 0.991, 214, 211, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
62, d5cz4Y_, 0.9984, 0.21, 1.000, 212, 211, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
63, d5cz4K_, 0.9984, 0.21, 1.000, 212, 211, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
64, d1rypZ_, 0.9984, 0.21, 0.995, 212, 211, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
65, d4qv8Y_, 0.9983, 0.22, 0.995, 212, 211, YCP BETA5-C52F MUTANT
66, d4qv8K_, 0.9983, 0.22, 0.995, 212, 211, YCP BETA5-C52F MUTANT
67, d2gplY_, 0.9983, 0.22, 1.000, 212, 211, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
68, d2gplK_, 0.9983, 0.22, 1.000, 212, 211, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
69, d1rypL_, 0.9983, 0.22, 0.995, 212, 211, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
70, d5lajY_, 0.9982, 0.23, 1.000, 212, 211, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
71, d5lajK_, 0.9982, 0.23, 1.000, 212, 211, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
72, d5fgeY_, 0.9982, 0.22, 0.995, 218, 211, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
73, d5fgeK_, 0.9982, 0.22, 0.995, 218, 211, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
74, d5fgdY_, 0.9982, 0.23, 0.995, 216, 211, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
75, d5fgdK_, 0.9982, 0.23, 0.995, 215, 211, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
76, d4qzzY_, 0.9982, 0.23, 1.000, 212, 211, YCP IN COMPLEX WITH OMURALIDE
77, d4qzzK_, 0.9982, 0.23, 1.000, 212, 211, YCP IN COMPLEX WITH OMURALIDE
78, d4eu2L_, 0.9982, 0.22, 0.995, 212, 211, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
79, d2fnyY_, 0.9981, 0.24, 1.000, 212, 211,  
80, d3e47Y_, 0.9980, 0.24, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
81, d3e47K_, 0.9980, 0.24, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
82, d2fnyK_, 0.9980, 0.24, 1.000, 212, 211,  
83, d1g0uY_, 0.9978, 0.25, 1.000, 212, 211, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
84, d5d0vY_, 0.9977, 0.26, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
85, d5d0vK_, 0.9977, 0.26, 0.995, 218, 211, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
86, d3wxrZ_, 0.9977, 0.26, 1.000, 212, 211, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
87, d1g0uK_, 0.9977, 0.26, 1.000, 212, 211, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
88, d4r00Y_, 0.9976, 0.26, 0.995, 212, 211, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
89, d4r00K_, 0.9976, 0.26, 0.995, 212, 211, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
90, d4qzwY_, 0.9975, 0.27, 0.995, 212, 211, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
91, d4qzwK_, 0.9974, 0.27, 0.995, 212, 211, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
92, d3wxrL_, 0.9974, 0.27, 1.000, 212, 211, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
93, d3hyeY_, 0.9974, 0.28, 1.000, 212, 211, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
94, d3hyeK_, 0.9974, 0.28, 1.000, 212, 211, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
95, d3dy3Y_, 0.9974, 0.28, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
96, d3dy3K_, 0.9974, 0.28, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
97, d4qv6Y_, 0.9973, 0.28, 0.995, 212, 211, YCP BETA5-A49V MUTANT
98, d4qv6K_, 0.9973, 0.28, 0.995, 212, 211, YCP BETA5-A49V MUTANT
99, d3gptY_, 0.9973, 0.28, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
100, d3gptK_, 0.9973, 0.28, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
101, d3gpwY_, 0.9971, 0.29, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
102, d3gpwK_, 0.9971, 0.29, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
103, d2fakY_, 0.9971, 0.29, 1.000, 212, 211, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
104, d2fakK_, 0.9971, 0.29, 1.000, 212, 211, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
105, d3dy4Y_, 0.9970, 0.29, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
106, d3dy4K_, 0.9970, 0.29, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
107, d4qv0K_, 0.9964, 0.34, 0.991, 212, 211, YCP BETA5-A49T-A50V-DOUBLE MUTANT
108, d3shjY_, 0.9964, 0.32, 1.000, 212, 211, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
109, d3shjK_, 0.9964, 0.32, 1.000, 212, 211, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
110, d3l5qP_, 0.9962, 0.33, 0.995, 212, 211,  
111, d3l5q2_, 0.9962, 0.33, 0.995, 212, 211,  
112, d1vsyZ_, 0.9962, 0.33, 0.995, 212, 211,  
113, d1vsyL_, 0.9962, 0.33, 0.995, 212, 211,  
114, d4qv0Y_, 0.9961, 0.36, 0.991, 212, 211, YCP BETA5-A49T-A50V-DOUBLE MUTANT
115, d3un8Y_, 0.9961, 0.34, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
116, d3un8K_, 0.9961, 0.33, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
117, d5fhsY_, 0.9958, 0.35, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
118, d4qw0Y_, 0.9958, 0.35, 0.991, 212, 211, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
119, d4qw0K_, 0.9958, 0.35, 0.991, 212, 211, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
120, d4fzgY_, 0.9957, 0.35, 1.000, 212, 211, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
121, d4fzgK_, 0.9957, 0.35, 1.000, 212, 211, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
122, d5fhsK_, 0.9956, 0.36, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
123, d4qvyY_, 0.9956, 0.36, 0.995, 212, 211, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
124, d4qvyK_, 0.9956, 0.36, 0.995, 212, 211, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
125, d4fzcY_, 0.9956, 0.36, 1.000, 212, 211, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
126, d4fzcK_, 0.9956, 0.36, 1.000, 212, 211, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
127, d4r17Y_, 0.9941, 0.18, 1.000, 211, 210, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
128, d4r17K_, 0.9941, 0.18, 1.000, 211, 210, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
129, d5laiY_, 0.9939, 0.19, 1.000, 211, 210, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
130, d5laiK_, 0.9939, 0.19, 1.000, 211, 210, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
131, d4r18Y_, 0.9937, 0.21, 1.000, 211, 210, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
132, d4r18K_, 0.9937, 0.21, 1.000, 211, 210, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
133, d4qvvY_, 0.9935, 0.44, 0.995, 212, 211, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
134, d4qvvK_, 0.9935, 0.44, 0.995, 212, 211, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
135, d4qvwY_, 0.9933, 0.44, 0.995, 212, 211, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
136, d4qvwK_, 0.9933, 0.45, 0.995, 212, 211, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
137, d4qw1Y_, 0.9922, 0.48, 0.995, 212, 211, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
138, d4qw1K_, 0.9922, 0.48, 0.995, 212, 211, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
139, d4qvlY_, 0.9920, 0.49, 1.000, 212, 211, YCP IN COMPLEX WITH BORTEZOMIB
140, d4qvlK_, 0.9920, 0.49, 1.000, 212, 211, YCP IN COMPLEX WITH BORTEZOMIB
141, d5d0xY_, 0.9914, 0.51, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
142, d5d0xK_, 0.9914, 0.51, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
143, d4r02Y_, 0.9911, 0.51, 1.000, 212, 211, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
144, d4jt0Y_, 0.9911, 0.51, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
145, d4qw3Y_, 0.9910, 0.52, 0.995, 212, 211, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
146, d4qw3K_, 0.9910, 0.52, 0.995, 212, 211, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
147, d4jt0K_, 0.9910, 0.51, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
148, d4qvmY_, 0.9909, 0.52, 0.995, 212, 211, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
149, d4qvmK_, 0.9909, 0.52, 0.995, 212, 211, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
150, d5l5aK_, 0.9908, 0.36, 0.776, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
151, d5l5aY_, 0.9907, 0.37, 0.776, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
152, d5bxnY_, 0.9906, 0.53, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
153, d5bxnK_, 0.9906, 0.53, 1.000, 212, 211, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
154, d5l5bY_, 0.9905, 0.38, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
155, d5l5bK_, 0.9905, 0.38, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
156, d4qvpY_, 0.9904, 0.53, 0.995, 212, 211, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
157, d4qvpK_, 0.9904, 0.53, 0.995, 212, 211, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
158, d5jhrY_, 0.9902, 0.54, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
159, d5jhrK_, 0.9901, 0.54, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
160, d3mg4Y_, 0.9901, 0.54, 1.000, 212, 211, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
161, d5l5rY_, 0.9899, 0.40, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
162, d5l5rK_, 0.9899, 0.40, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
163, d3bdmY_, 0.9897, 0.55, 1.000, 212, 211, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
164, d1jd2R_, 0.9897, 0.55, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
165, d4qvnY_, 0.9896, 0.56, 0.995, 212, 211, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
166, d3bdmK_, 0.9896, 0.55, 1.000, 212, 211, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
167, d1jd2K_, 0.9896, 0.56, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
168, d5l5eY_, 0.9895, 0.42, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
169, d4r02K_, 0.9895, 0.56, 1.000, 212, 211, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
170, d4qvnK_, 0.9895, 0.56, 0.995, 212, 211, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
171, d3nzjY_, 0.9895, 0.56, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
172, d5l5eK_, 0.9894, 0.42, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
173, d3nzjK_, 0.9894, 0.56, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
174, d5l5wY_, 0.9893, 0.42, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
175, d5l5wK_, 0.9893, 0.42, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
176, d5m2bY_, 0.9890, 0.43, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
177, d5m2bK_, 0.9890, 0.43, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
178, d4qvqY_, 0.9885, 0.59, 0.995, 212, 211, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
179, d4qvqK_, 0.9885, 0.59, 0.995, 212, 211, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
180, d3mg4K_, 0.9885, 0.59, 1.000, 212, 211, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
181, d3mg0K_, 0.9883, 0.59, 1.000, 212, 211, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
182, d4inuY_, 0.9882, 0.59, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
183, d4inrY_, 0.9881, 0.59, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
184, d3mg0Y_, 0.9880, 0.60, 1.000, 212, 211, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
185, d4inrK_, 0.9879, 0.60, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
186, d3gpjY_, 0.9879, 0.60, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
187, d3gpjK_, 0.9879, 0.60, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
188, d5dkiY_, 0.9878, 0.60, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
189, d5dkiK_, 0.9878, 0.60, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
190, d4no1Y_, 0.9877, 0.61, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
191, d4no1K_, 0.9877, 0.61, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
192, d4inuK_, 0.9877, 0.60, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
193, d2f16Y_, 0.9877, 0.61, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
194, d2f16K_, 0.9876, 0.61, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
195, d4jsqY_, 0.9871, 0.62, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
196, d5l64Y_, 0.9870, 0.50, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
197, d5dkjY_, 0.9870, 0.62, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
198, d5dkjK_, 0.9870, 0.62, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
199, d4jsqK_, 0.9870, 0.62, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
200, d5l64K_, 0.9869, 0.50, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
201, d5l5zY_, 0.9869, 0.50, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
202, d5l5zK_, 0.9869, 0.50, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
203, d4jsuY_, 0.9869, 0.63, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
204, d3oevY_, 0.9869, 0.63, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
205, d4qwuK_, 0.9868, 0.70, 0.995, 212, 211, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
206, d4jsuK_, 0.9868, 0.63, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
207, p3un4K_, 0.9868, 0.63, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
208, d4intY_, 0.9867, 0.63, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
209, p3un4Y_, 0.9867, 0.63, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
210, d4qwuY_, 0.9866, 0.71, 0.995, 212, 211, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
211, d4intK_, 0.9864, 0.64, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
212, d5l5fY_, 0.9863, 0.52, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
213, d5l5fK_, 0.9863, 0.52, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
214, p3jcpUA_, 0.9863, 0.64, 1.000, 212, 211, 
215, p3jcpG_, 0.9863, 0.64, 1.000, 212, 211, 
216, d5l5dY_, 0.9860, 0.53, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
217, d5l5dK_, 0.9859, 0.53, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
218, d5l63Y_, 0.9856, 0.54, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
219, d5l63K_, 0.9856, 0.54, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
220, d5l60Y_, 0.9854, 0.54, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
221, d5l60K_, 0.9854, 0.54, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
222, d5l62Y_, 0.9852, 0.55, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
223, d5l62K_, 0.9852, 0.55, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
224, d5l5iY_, 0.9851, 0.55, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
225, d5l5iK_, 0.9851, 0.55, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
226, d5l61Y_, 0.9850, 0.56, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
227, d5d0tY_, 0.9850, 0.67, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
228, d5l61K_, 0.9849, 0.56, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
229, d5d0tK_, 0.9849, 0.67, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
230, d3oevK_, 0.9848, 0.68, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
231, d5l6bK_, 0.9846, 0.57, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
232, d5l6cY_, 0.9845, 0.57, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
233, d5l6cK_, 0.9845, 0.57, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
234, d5l6bY_, 0.9845, 0.57, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
235, d2zcyY_, 0.9845, 0.68, 1.000, 212, 211, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
236, d2zcyK_, 0.9844, 0.68, 1.000, 212, 211, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
237, d5l67Y_, 0.9843, 0.58, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
238, d5l65Y_, 0.9843, 0.57, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
239, d5l65K_, 0.9843, 0.57, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
240, d5l5xY_, 0.9843, 0.57, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
241, d5l5xK_, 0.9843, 0.57, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
242, d5l5oY_, 0.9843, 0.58, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
243, d5l5jY_, 0.9843, 0.58, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
244, d5l5jK_, 0.9843, 0.58, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
245, d5l67K_, 0.9842, 0.58, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
246, d5l5oK_, 0.9842, 0.58, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
247, d5l5uY_, 0.9841, 0.58, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
248, d5l5uK_, 0.9841, 0.58, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
249, d5l5tY_, 0.9841, 0.58, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
250, d5l5tK_, 0.9841, 0.58, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
251, d5l68Y_, 0.9840, 0.58, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
252, d5l68K_, 0.9840, 0.58, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
253, d5l5pK_, 0.9840, 0.58, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
254, d5l5vY_, 0.9839, 0.59, 0.767, 211, 210,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
255, d5l5vK_, 0.9839, 0.59, 0.767, 211, 210,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
256, d5l5pY_, 0.9839, 0.58, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
257, d5l5yY_, 0.9838, 0.59, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
258, d5l5yK_, 0.9838, 0.59, 0.829, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
259, d5l6aY_, 0.9837, 0.59, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
260, d5l6aK_, 0.9837, 0.59, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
261, d5l66Y_, 0.9837, 0.59, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
262, d5l66K_, 0.9837, 0.59, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
263, d4qwrY_, 0.9835, 0.71, 0.995, 212, 211, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
264, d5lttY_, 0.9834, 0.60, 0.776, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
265, d4qwrK_, 0.9834, 0.71, 0.995, 212, 211, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
266, d4ltcY_, 0.9834, 0.71, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
267, d5lttK_, 0.9833, 0.60, 0.776, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
268, d3nzxY_, 0.9833, 0.71, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
269, d3nzxK_, 0.9832, 0.71, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
270, d5l5sY_, 0.9831, 0.61, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
271, d5l5sK_, 0.9831, 0.61, 0.767, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
272, d5l5hY_, 0.9830, 0.61, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
273, d5l5hK_, 0.9830, 0.61, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
274, d5fggY_, 0.9830, 0.72, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
275, d5fggK_, 0.9830, 0.72, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
276, d5l5qK_, 0.9829, 0.61, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
277, d5l5qY_, 0.9828, 0.61, 0.771, 211, 210, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
278, d4qwjY_, 0.9827, 0.72, 0.995, 212, 211, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
279, d4qwjK_, 0.9827, 0.72, 0.995, 212, 211, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
280, d4ltcK_, 0.9827, 0.72, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
281, d4no8Y_, 0.9821, 0.74, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
282, d4no8K_, 0.9821, 0.74, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
283, d4qwkY_, 0.9820, 0.74, 0.991, 212, 211, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
284, d5l69Y_, 0.9819, 0.63, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
285, d5l69K_, 0.9819, 0.64, 0.781, 211, 210, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
286, d4qwkK_, 0.9819, 0.74, 0.991, 212, 211, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
287, d4qz6Y_, 0.9818, 0.74, 0.991, 212, 211, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
288, d4qz6K_, 0.9818, 0.74, 0.991, 212, 211, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
289, d5cz9Y_, 0.9816, 0.75, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
290, d5cz9K_, 0.9816, 0.75, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
291, d4no6Y_, 0.9814, 0.75, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
292, d4no6K_, 0.9813, 0.75, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
293, d4qwiY_, 0.9803, 0.77, 0.995, 212, 211, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
294, d4qwiK_, 0.9803, 0.77, 0.995, 212, 211, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
295, d4hnpK_, 0.9802, 0.78, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
296, d4qw7Y_, 0.9801, 0.78, 0.995, 212, 211, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
297, d4qw7K_, 0.9801, 0.78, 0.995, 212, 211, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
298, d4qwlY_, 0.9800, 0.78, 0.995, 212, 211, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
299, d4qwlK_, 0.9800, 0.78, 0.995, 212, 211, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
300, d4hnpY_, 0.9800, 0.78, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
301, d4qwgK_, 0.9799, 0.78, 0.995, 212, 211, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
302, d4qwgY_, 0.9798, 0.78, 0.995, 212, 211, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
303, d3nzwY_, 0.9798, 0.78, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
304, p3jcoUA_, 0.9798, 0.78, 1.000, 212, 211, 
305, p3jcoG_, 0.9798, 0.78, 1.000, 212, 211, 
306, d4nnnY_, 0.9797, 0.78, 1.000, 212, 211, YCP IN COMPLEX WITH MG132
307, d4nnnK_, 0.9797, 0.78, 1.000, 212, 211, YCP IN COMPLEX WITH MG132
308, d3nzwK_, 0.9797, 0.78, 1.000, 212, 211, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
309, d1g65K_, 0.9797, 0.78, 1.000, 212, 211, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
310, d4qw6Y_, 0.9795, 0.79, 0.995, 212, 211, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
311, d4qw6K_, 0.9795, 0.79, 0.995, 212, 211, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
312, d4hrcY_, 0.9795, 0.79, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
313, d5d0sY_, 0.9794, 0.79, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
314, d5d0sK_, 0.9794, 0.79, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
315, d4no9Y_, 0.9794, 0.79, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
316, d4no9K_, 0.9794, 0.79, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
317, d1g65Y_, 0.9794, 0.79, 1.000, 212, 211, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
318, d5cz5Y_, 0.9793, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
319, d5cz5K_, 0.9793, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
320, d4qz5Y_, 0.9793, 0.79, 0.995, 212, 211, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
321, d4qz5K_, 0.9793, 0.79, 0.995, 212, 211, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
322, d4qwfY_, 0.9793, 0.79, 0.995, 212, 211, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
323, d4qwfK_, 0.9793, 0.79, 0.995, 212, 211, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
324, d5jhsY_, 0.9792, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
325, d5jhsK_, 0.9792, 0.79, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
326, d5d0zY_, 0.9792, 0.79, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
327, d5d0zK_, 0.9792, 0.79, 0.995, 212, 211, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
328, d4qw5Y_, 0.9792, 0.79, 0.995, 212, 211, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
329, d4qw5K_, 0.9792, 0.79, 0.995, 212, 211, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
330, d3oeuY_, 0.9792, 0.80, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
331, d4qwsY_, 0.9791, 0.80, 0.995, 212, 211, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
332, d4qwsK_, 0.9791, 0.80, 0.995, 212, 211, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
333, d4hrcK_, 0.9790, 0.80, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
334, d5fgiY_, 0.9788, 0.80, 1.000, 212, 211, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
335, d5fgiK_, 0.9788, 0.80, 1.000, 212, 211, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
336, d4qw4Y_, 0.9788, 0.80, 1.000, 212, 211, YCP IN COMPLEX WITH CARFILZOMIB
337, d4qw4K_, 0.9788, 0.80, 1.000, 212, 211, YCP IN COMPLEX WITH CARFILZOMIB
338, d3okjY_, 0.9788, 0.80, 1.000, 212, 211, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
339, d3okjK_, 0.9788, 0.80, 1.000, 212, 211, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
340, d5cz8Y_, 0.9786, 0.81, 0.995, 221, 211, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
341, d5ahjK_, 0.9786, 0.81, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
342, d5cz8K_, 0.9785, 0.81, 0.995, 220, 211, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
343, d5ahjY_, 0.9785, 0.81, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
344, d4qz3Y_, 0.9783, 0.81, 0.995, 212, 211, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
345, d4qz3K_, 0.9783, 0.81, 0.995, 212, 211, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
346, d3oeuK_, 0.9783, 0.82, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
347, d4hrdK_, 0.9782, 0.82, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
348, d3mg7Y_, 0.9782, 0.82, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
349, d4qz7Y_, 0.9781, 0.82, 0.995, 212, 211, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
350, d4qz7K_, 0.9781, 0.82, 0.995, 212, 211, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
351, d5l54Y_, 0.9780, 0.82, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
352, d5l54K_, 0.9780, 0.82, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
353, d4hrdY_, 0.9780, 0.82, 1.000, 212, 211, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
354, d3mg7K_, 0.9780, 0.82, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
355, d3d29Y_, 0.9780, 0.81, 1.000, 212, 211, PROTEASOME INHIBITION BY FELLUTAMIDE B
356, d3d29K_, 0.9780, 0.82, 1.000, 212, 211, PROTEASOME INHIBITION BY FELLUTAMIDE B
357, d3sdiY_, 0.9779, 0.83, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
358, d3sdiK_, 0.9778, 0.83, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
359, d5l55Y_, 0.9777, 0.82, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
360, d5l55K_, 0.9777, 0.82, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
361, d4qltY_, 0.9777, 0.82, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
362, d4qltK_, 0.9777, 0.82, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
363, d3mg6K_, 0.9777, 0.83, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
364, d3mg6Y_, 0.9776, 0.83, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
365, d3sdkY_, 0.9775, 0.83, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
366, d5l52Y_, 0.9774, 0.83, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
367, d5l52K_, 0.9774, 0.83, 1.000, 212, 211, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
368, p5mpcL_, 0.9772, 0.84, 1.000, 212, 211, 
369, d4nnwY_, 0.9772, 0.83, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
370, d4qz4Y_, 0.9771, 0.84, 0.995, 212, 211, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
371, d4qwxK_, 0.9771, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
372, d4nnwK_, 0.9771, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
373, d3sdkK_, 0.9771, 0.84, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
374, d3mg8Y_, 0.9771, 0.84, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
375, d4qz4K_, 0.9770, 0.84, 0.995, 212, 211, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
376, d4qxjY_, 0.9770, 0.84, 0.995, 212, 211, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
377, d4qxjK_, 0.9770, 0.84, 0.995, 212, 211, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
378, d4qluY_, 0.9770, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
379, d4qluK_, 0.9770, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
380, d4qzxK_, 0.9769, 0.84, 0.995, 212, 211, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
381, d4qlvY_, 0.9769, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
382, d4qlvK_, 0.9769, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
383, d4qlsY_, 0.9769, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
384, d4qlsK_, 0.9769, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
385, d4g4sL_, 0.9769, 0.84, 1.000, 212, 211, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
386, d4qzxY_, 0.9768, 0.84, 0.995, 212, 211, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
387, d4qz1K_, 0.9768, 0.84, 0.995, 212, 211, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
388, d4qz0Y_, 0.9768, 0.84, 0.995, 212, 211, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
389, d4qz0K_, 0.9768, 0.84, 0.995, 212, 211, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
390, d4qwxY_, 0.9768, 0.84, 1.000, 212, 211, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
391, d4qz1Y_, 0.9767, 0.84, 0.995, 212, 211, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
392, d3mg8K_, 0.9767, 0.85, 1.000, 212, 211, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
393, d4qz2Y_, 0.9762, 0.85, 0.995, 212, 211, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
394, d4qz2K_, 0.9762, 0.85, 0.995, 212, 211, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
395, d4qlqK_, 0.9748, 0.88, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
396, d4qlqY_, 0.9747, 0.88, 1.000, 212, 211, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
397, p5wviSA_, 0.9444, 1.35, 1.000, 212, 211, 
398, d4r3oZ_, 0.9357, 0.62, 0.665, 201, 200, HUMAN CONSTITUTIVE 20S PROTEASOME
399, d4r3oL_, 0.9357, 0.62, 0.665, 201, 200, HUMAN CONSTITUTIVE 20S PROTEASOME
400, p3uneK_, 0.9343, 0.66, 0.665, 201, 200, MOUSE CONSTITUTIVE 20S PROTEASOME
401, d1iruZ_, 0.9340, 0.67, 0.665, 201, 200, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
402, d1iruL_, 0.9340, 0.67, 0.665, 201, 200, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
403, p5gjqs_, 0.9339, 0.67, 0.665, 201, 200, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
404, p5gjrRA_, 0.9337, 0.67, 0.665, 201, 200, 
405, p5gjrDA_, 0.9336, 0.67, 0.665, 201, 200, 
406, p5gjqe_, 0.9331, 0.69, 0.665, 201, 200, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
407, p3une1_, 0.9331, 0.69, 0.665, 201, 200, MOUSE CONSTITUTIVE 20S PROTEASOME
408, p3uneY_, 0.9330, 0.69, 0.665, 201, 200, MOUSE CONSTITUTIVE 20S PROTEASOME
409, p3unem_, 0.9323, 0.71, 0.665, 201, 200, MOUSE CONSTITUTIVE 20S PROTEASOME
410, d5le5K_, 0.9321, 0.72, 0.665, 201, 200, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
411, p5l4gZ_, 0.9299, 0.76, 0.665, 201, 200, 
412, d5lexK_, 0.9296, 0.66, 0.668, 200, 199, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
413, p5l4gL_, 0.9294, 0.77, 0.665, 201, 200, 
414, d5lf3Y_, 0.9288, 0.79, 0.665, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
415, d4r67L_, 0.9283, 0.79, 0.665, 201, 200, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
416, d4r673_, 0.9283, 0.79, 0.665, 201, 200, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
417, d4r67Z_, 0.9281, 0.79, 0.665, 201, 200, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
418, p4y8tY_, 0.9280, 0.17, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
419, p4y8tK_, 0.9280, 0.17, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
420, p5vfqL_, 0.9279, 0.80, 0.665, 201, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
421, p4r67n_, 0.9279, 0.80, 0.665, 201, 200, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
422, p5vfpL_, 0.9278, 0.80, 0.665, 201, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
423, p4y6vK_, 0.9277, 0.19, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
424, p4x6zZ_, 0.9277, 0.19, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
425, p4y8uY_, 0.9276, 0.20, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
426, p4y8uK_, 0.9276, 0.20, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
427, p4y8nY_, 0.9276, 0.20, 1.000, 197, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
428, p4y8nK_, 0.9276, 0.20, 1.000, 197, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
429, p4y6vY_, 0.9276, 0.20, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
430, p4y69Y_, 0.9276, 0.20, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
431, p4y69K_, 0.9276, 0.20, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
432, p4x6zL_, 0.9276, 0.20, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
433, p4ya5Y_, 0.9275, 0.20, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
434, p4ya5K_, 0.9275, 0.20, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
435, p4y6aY_, 0.9275, 0.21, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
436, p4y6aK_, 0.9275, 0.21, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
437, p5vfuCA_, 0.9274, 0.81, 0.665, 201, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
438, p5vftR_, 0.9274, 0.81, 0.665, 201, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
439, d5lf1Y_, 0.9274, 0.82, 0.665, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
440, p4ya3Y_, 0.9273, 0.22, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
441, p4ya3K_, 0.9273, 0.22, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
442, p4ya0Y_, 0.9273, 0.22, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
443, p4ya0K_, 0.9273, 0.22, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
444, p5lf0Y_, 0.9272, 0.82, 0.665, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
445, p5nifL_, 0.9271, 0.23, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
446, p4zzgL_, 0.9270, 0.25, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
447, p5vfsL_, 0.9269, 0.82, 0.665, 201, 200, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
448, p5vfoR_, 0.9268, 0.82, 0.665, 201, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
449, p5nifZ_, 0.9268, 0.25, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
450, p5vfor_, 0.9267, 0.83, 0.665, 201, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
451, p5vfqKA_, 0.9266, 0.83, 0.665, 201, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
452, p4zzgZ_, 0.9266, 0.27, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
453, d5lf7Y_, 0.9265, 0.83, 0.665, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
454, p5vfpJA_, 0.9264, 0.83, 0.665, 201, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
455, p6gopY_, 0.9261, 0.30, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
456, p6gopK_, 0.9260, 0.30, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
457, d5lf4Y_, 0.9260, 0.84, 0.665, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
458, p5vfrR_, 0.9259, 0.84, 0.660, 201, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
459, p5vfsKA_, 0.9258, 0.85, 0.665, 201, 200, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
460, p4v7oZ_, 0.9258, 0.31, 0.995, 197, 196, 
461, p4v7oL_, 0.9258, 0.31, 0.995, 197, 196, 
462, p4v7oHB_, 0.9258, 0.31, 0.995, 197, 196, 
463, p5t0cJB_, 0.9256, 0.85, 0.660, 201, 200, 
464, p5t0cDA_, 0.9256, 0.85, 0.660, 201, 200, 
465, d5lexY_, 0.9256, 0.64, 0.672, 199, 198, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
466, p1z7qZ_, 0.9255, 0.33, 0.995, 197, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
467, p1z7qL_, 0.9255, 0.32, 0.995, 197, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
468, d5lf3K_, 0.9254, 0.75, 0.668, 200, 199, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
469, p5vfrr_, 0.9253, 0.85, 0.665, 201, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
470, d5le5Y_, 0.9253, 0.65, 0.672, 199, 198, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
471, p5lf0K_, 0.9239, 0.79, 0.668, 200, 199, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
472, d5lf1K_, 0.9238, 0.79, 0.668, 200, 199, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
473, p5t0gR_, 0.9237, 0.88, 0.660, 201, 200, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
474, p5lf6Y_, 0.9237, 0.89, 0.665, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
475, p1fntL_, 0.9234, 0.42, 0.995, 197, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
476, p5vfuQA_, 0.9233, 0.89, 0.665, 201, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
477, p5vftr_, 0.9233, 0.89, 0.665, 201, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
478, p1fntZ_, 0.9233, 0.42, 0.995, 197, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
479, p3unhY_, 0.9232, 0.90, 0.620, 201, 200, MOUSE 20S IMMUNOPROTEASOME
480, p3unhK_, 0.9232, 0.90, 0.620, 201, 200, MOUSE 20S IMMUNOPROTEASOME
481, d3unb1_, 0.9230, 0.90, 0.665, 201, 200, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
482, d5lf7K_, 0.9228, 0.81, 0.668, 200, 199, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
483, p4y7xY_, 0.9227, 0.44, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
484, p4y7xK_, 0.9226, 0.45, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
485, d3unbY_, 0.9225, 0.90, 0.665, 201, 200, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
486, p5lezK_, 0.9224, 0.82, 0.668, 200, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
487, d5lf4K_, 0.9221, 0.82, 0.668, 200, 199, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
488, p5leyK_, 0.9216, 0.84, 0.668, 200, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
489, p5fghY_, 0.9213, 0.49, 0.995, 197, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
490, p5fghK_, 0.9213, 0.50, 0.995, 197, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
491, p4y8kY_, 0.9212, 0.50, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
492, p4v7oTA_, 0.9211, 0.31, 0.995, 196, 195, 
493, p4y8kK_, 0.9210, 0.50, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
494, p4qbyY_, 0.9209, 0.51, 1.000, 197, 196, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
495, p4qbyK_, 0.9208, 0.51, 1.000, 197, 196, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
496, d3unbK_, 0.9206, 0.94, 0.665, 201, 200, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
497, p3unbm_, 0.9205, 0.94, 0.665, 201, 200, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
498, p5lf6K_, 0.9200, 0.87, 0.668, 200, 199, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
499, p4gk7Y_, 0.9199, 0.54, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
500, p4gk7K_, 0.9198, 0.54, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
501, p4y7yK_, 0.9194, 0.55, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
502, p4y7yY_, 0.9193, 0.55, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
503, p4cr45_, 0.9187, 1.66, 0.981, 212, 208, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
504, d3unfK_, 0.9183, 0.98, 0.620, 201, 200, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
505, p5mp9l_, 0.9182, 0.58, 1.000, 197, 196, 26S PROTEASOME IN PRESENCE OF ATP (S1)
506, d3unfY_, 0.9182, 0.98, 0.620, 201, 200, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
507, p5lezY_, 0.9176, 0.82, 0.672, 199, 198, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
508, p5mp95_, 0.9171, 0.62, 1.000, 197, 196, 26S PROTEASOME IN PRESENCE OF ATP (S1)
509, p5leyY_, 0.9169, 0.84, 0.672, 199, 198, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
510, p5mpal_, 0.9163, 0.63, 1.000, 197, 196, 26S PROTEASOME IN PRESENCE OF ATP (S2)
511, p6avoD_, 0.9161, 1.02, 0.600, 201, 200, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
512, p6avoC_, 0.9161, 1.02, 0.600, 201, 200, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
513, p5mpbL_, 0.9160, 0.94, 1.000, 200, 199, 
514, p5m32Y_, 0.9153, 1.04, 0.660, 201, 200, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
515, p5cghY_, 0.9152, 0.67, 0.995, 197, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
516, p5cghK_, 0.9151, 0.67, 0.995, 197, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
517, p5mpa5_, 0.9148, 0.67, 1.000, 197, 196, 26S PROTEASOME IN PRESENCE OF ATP (S2)
518, p4y8sY_, 0.9146, 0.68, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
519, p4y8sK_, 0.9145, 0.68, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
520, p5cggY_, 0.9123, 0.73, 0.995, 197, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
521, p5m32K_, 0.9122, 1.01, 0.663, 200, 199, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
522, p5cggK_, 0.9122, 0.74, 0.995, 197, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
523, p4ya2Y_, 0.9122, 0.74, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
524, p4ya2K_, 0.9122, 0.74, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
525, d4cr25_, 0.9118, 1.96, 0.976, 212, 209, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
526, p4ya7Y_, 0.9117, 0.75, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
527, p4y70Y_, 0.9117, 0.75, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
528, p4y70K_, 0.9117, 0.75, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
529, p5a5b5_, 0.9116, 1.84, 0.976, 212, 209, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
530, p4ya7K_, 0.9116, 0.75, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
531, p4y9zY_, 0.9116, 0.75, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
532, p4cr35_, 0.9116, 1.84, 0.976, 212, 209, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
533, p4y9zK_, 0.9115, 0.75, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
534, p4y7wY_, 0.9115, 0.75, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
535, p4y7wK_, 0.9115, 0.75, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
536, p4y78Y_, 0.9115, 0.75, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
537, p4y8lY_, 0.9113, 0.76, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
538, p4y78K_, 0.9113, 0.76, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
539, p4ya9Y_, 0.9112, 0.76, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
540, p4ya9K_, 0.9112, 0.76, 1.000, 197, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
541, p4y8pY_, 0.9112, 0.76, 1.000, 197, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
542, p4y8pK_, 0.9112, 0.76, 1.000, 197, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
543, p4y8lK_, 0.9112, 0.76, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
544, p4y8hY_, 0.9112, 0.76, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
545, p4y8hK_, 0.9112, 0.76, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
546, p4y80K_, 0.9112, 0.76, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
547, p4y80Y_, 0.9111, 0.76, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
548, p4y8gY_, 0.9110, 0.76, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
549, p4y8qY_, 0.9109, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
550, p4y8qK_, 0.9109, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
551, p4y8gK_, 0.9109, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
552, p4y6zY_, 0.9109, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
553, p4y6zK_, 0.9109, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
554, p4y8jY_, 0.9108, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
555, p4y8jK_, 0.9108, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
556, p4y84Y_, 0.9108, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
557, p4y84K_, 0.9108, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
558, p4y75K_, 0.9107, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
559, p4y74Y_, 0.9107, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
560, p4y8iY_, 0.9106, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
561, p4y77Y_, 0.9106, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
562, p4y77K_, 0.9106, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
563, p4y75Y_, 0.9106, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
564, p4y74K_, 0.9106, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
565, p4y8iK_, 0.9105, 0.77, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
566, p4y82Y_, 0.9104, 0.78, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
567, p4y82K_, 0.9104, 0.78, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
568, p4y81Y_, 0.9103, 0.78, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
569, p4y81K_, 0.9102, 0.78, 1.000, 197, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
570, p4y8oY_, 0.9098, 0.79, 1.000, 197, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
571, p4y8oK_, 0.9098, 0.79, 1.000, 197, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
572, p5cgiK_, 0.9090, 0.81, 0.995, 197, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
573, p5cgiY_, 0.9089, 0.81, 0.995, 197, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
574, p5t0hR_, 0.9074, 1.16, 0.660, 201, 200, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
575, p5mpcZ_, 0.9064, 0.86, 1.000, 197, 196, 
576, p5mpbZ_, 0.9041, 0.91, 1.000, 197, 196, 
577, p5wvkE_, 0.9012, 0.97, 1.000, 197, 196, 
578, p5t0iR_, 0.8965, 1.39, 0.660, 201, 200, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
579, p5t0jR_, 0.8938, 1.38, 0.660, 201, 200, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
580, p5wvkL_, 0.8931, 1.10, 1.000, 197, 196, 
581, p5wviIA_, 0.8796, 1.32, 1.000, 197, 196, 
582, p5gjqo_, 0.8776, 1.78, 0.269, 202, 201, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
583, p5gjrNA_, 0.8771, 1.79, 0.269, 202, 201, 
584, p5gjrZ_, 0.8770, 1.79, 0.269, 202, 201, 
585, d4r3oV_, 0.8770, 1.79, 0.269, 202, 201, HUMAN CONSTITUTIVE 20S PROTEASOME
586, d4r3oH_, 0.8770, 1.80, 0.269, 202, 201, HUMAN CONSTITUTIVE 20S PROTEASOME
587, p5gjqa_, 0.8756, 1.81, 0.269, 202, 201, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
588, p3uneN_, 0.8756, 1.82, 0.264, 202, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
589, p3unep_, 0.8753, 1.82, 0.264, 202, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
590, p3uneb_, 0.8752, 1.81, 0.264, 202, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
591, d5le5N_, 0.8750, 1.80, 0.269, 202, 201, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
592, p3une4_, 0.8746, 1.81, 0.264, 202, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
593, p5le5b_, 0.8744, 1.82, 0.269, 203, 201, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
594, p5a0qZ_, 0.8742, 1.03, 0.681, 192, 191, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
595, p5a0qL_, 0.8742, 1.03, 0.681, 192, 191, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
596, d5lf1N_, 0.8737, 1.83, 0.269, 202, 201, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
597, p4r67x_, 0.8737, 1.83, 0.269, 202, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
598, d4r67H_, 0.8737, 1.83, 0.269, 202, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
599, p5lf1b_, 0.8736, 1.84, 0.269, 203, 201, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
600, d4r67V_, 0.8736, 1.83, 0.269, 202, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
601, p4r67j_, 0.8736, 1.83, 0.269, 202, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
602, p5lf0N_, 0.8734, 1.83, 0.269, 202, 201, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
603, p5l4gM_, 0.8734, 1.62, 0.271, 200, 199, 
604, p5lf0b_, 0.8729, 1.84, 0.269, 203, 201, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
605, p5leyN_, 0.8729, 1.85, 0.269, 202, 201, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
606, p5leyb_, 0.8728, 1.84, 0.269, 203, 201, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
607, d3mi0R1, 0.8724, 2.59, 0.234, 234, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
608, p5lf3b_, 0.8723, 1.86, 0.269, 203, 201, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
609, d1iruH_, 0.8723, 1.86, 0.269, 202, 201, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
610, d1pmaY_, 0.8722, 2.18, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
611, d1iruV_, 0.8722, 1.86, 0.269, 202, 201, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
612, d3mi0V1, 0.8721, 2.60, 0.234, 234, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
613, d5lf7N_, 0.8720, 1.87, 0.269, 202, 201, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
614, p5lexb_, 0.8720, 1.87, 0.269, 203, 201, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
615, d1pma1_, 0.8720, 2.19, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
616, p5lf7b_, 0.8719, 1.86, 0.269, 203, 201, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
617, d5lexN_, 0.8719, 1.87, 0.269, 202, 201, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
618, d1pmaZ_, 0.8719, 2.19, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
619, p5vy3Z_, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
620, p5vy3X_, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
621, p5vy3V_, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
622, p5vy3T_, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
623, p5vy3R_, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
624, p5vy3P_, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
625, p5vy3N_, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
626, p5vy3L_, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
627, p5vy3J_, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
628, p5vy3H_, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
629, p5vy3F_, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
630, p5vy3D_, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
631, p5vy3B_, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
632, p5vy31_, 0.8717, 2.22, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
633, d1ya7M_, 0.8716, 2.24, 0.250, 203, 200, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
634, p5vy4Z_, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
635, p5vy4X_, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
636, p5vy4V_, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
637, p5vy4T_, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
638, p5vy4R_, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
639, p5vy4P_, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
640, p5vy4N_, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
641, p5vy4L_, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
642, p5vy4J_, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
643, p5vy4H_, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
644, p5vy4F_, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
645, p5vy4D_, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
646, p5vy4BA_, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
647, p5vy4B_, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
648, p5vy41_, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
649, d3c92Z1, 0.8715, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
650, d3c92X1, 0.8715, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
651, d3c92W1, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
652, d3c92L1, 0.8715, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
653, d3c92J1, 0.8715, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
654, d3c92I1, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
655, d3c91Z1, 0.8715, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
656, d3c91X1, 0.8715, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
657, d3c91W1, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
658, d3c91L1, 0.8715, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
659, d3c91J1, 0.8715, 2.19, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
660, d3c91I1, 0.8715, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
661, d1pmaS_, 0.8715, 2.19, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
662, d1pmaQ_, 0.8715, 2.19, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
663, d1pmaP_, 0.8715, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
664, p5lf6N_, 0.8714, 1.87, 0.269, 202, 201, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
665, p5lf6b_, 0.8714, 1.86, 0.269, 203, 201, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
666, d3c92V1, 0.8714, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
667, d3c92H1, 0.8714, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
668, d3c91V1, 0.8714, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
669, d3c91H1, 0.8714, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
670, d1pmaW_, 0.8714, 2.19, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
671, d1pmaB_, 0.8714, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
672, d1pma2_, 0.8714, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
673, d3c92N1, 0.8713, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
674, d3c9221, 0.8713, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
675, d3c91N1, 0.8713, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
676, d3c9121, 0.8713, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
677, d1pmaV_, 0.8713, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
678, d1pmaU_, 0.8713, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
679, d1yauM_, 0.8711, 2.25, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
680, d1yarM_, 0.8711, 2.24, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
681, p5m32b_, 0.8710, 1.87, 0.269, 203, 201, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
682, d3jseM_, 0.8710, 2.23, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
683, d3c92Y1, 0.8710, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
684, d3c92M1, 0.8710, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
685, d3c92K1, 0.8710, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
686, d3c9211, 0.8710, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
687, d3c91Y1, 0.8710, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
688, d3c91M1, 0.8710, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
689, d3c91K1, 0.8710, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
690, d3c9111, 0.8710, 2.20, 0.255, 203, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
691, d1pmaT_, 0.8710, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
692, d1pmaR_, 0.8710, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
693, d3jseK_, 0.8709, 2.25, 0.250, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
694, d1pmaX_, 0.8709, 2.20, 0.255, 203, 200, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
695, p5m32N_, 0.8708, 1.89, 0.269, 202, 201, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
696, d3jseL_, 0.8708, 2.25, 0.250, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
697, d3jseJ_, 0.8708, 2.25, 0.250, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
698, d3jseN_, 0.8707, 2.25, 0.250, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
699, d3jseI_, 0.8707, 2.25, 0.250, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
700, d3jseH_, 0.8707, 2.25, 0.250, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
701, p6avoF_, 0.8705, 1.58, 0.293, 199, 198, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
702, p6avoA_, 0.8704, 1.58, 0.293, 199, 198, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
703, d5lf4N_, 0.8704, 1.87, 0.269, 202, 201, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
704, d1ya7L_, 0.8704, 2.24, 0.255, 203, 200, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
705, d1ya7K_, 0.8704, 2.23, 0.255, 203, 200, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
706, d3unb4_, 0.8703, 1.89, 0.264, 202, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
707, p5lf4b_, 0.8702, 1.88, 0.269, 203, 201, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
708, d3unbb_, 0.8702, 1.87, 0.264, 202, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
709, d1yauL_, 0.8702, 2.25, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
710, d1yarJ_, 0.8702, 2.25, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
711, d1ya7J_, 0.8702, 2.23, 0.255, 203, 200, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
712, d1ya7H_, 0.8702, 2.24, 0.255, 203, 200, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
713, d1j2qN_, 0.8702, 2.14, 0.310, 202, 200, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
714, d1j2qL_, 0.8702, 2.14, 0.310, 202, 200, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
715, d1j2qJ_, 0.8702, 2.14, 0.310, 202, 200, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
716, p5lezN_, 0.8701, 1.88, 0.269, 202, 201, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
717, d3unbp_, 0.8701, 1.90, 0.264, 202, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
718, p3jtlM_, 0.8701, 2.24, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
719, p3jtlL_, 0.8701, 2.24, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
720, p3jtlJ_, 0.8701, 2.24, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
721, d1yauJ_, 0.8701, 2.24, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
722, d1ya7I_, 0.8701, 2.26, 0.250, 203, 200, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
723, d1j2qK_, 0.8701, 2.14, 0.310, 202, 200, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
724, d1j2qI_, 0.8701, 2.14, 0.310, 202, 200, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
725, d1j2qH_, 0.8701, 2.14, 0.310, 202, 200, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
726, p3jtlN_, 0.8700, 2.24, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
727, p3jtlK_, 0.8700, 2.24, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
728, p3jtlI_, 0.8700, 2.24, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
729, d3jrmM_, 0.8700, 2.26, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
730, d1yauK_, 0.8700, 2.24, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
731, d1yarK_, 0.8700, 2.24, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
732, d1j2qM_, 0.8700, 2.14, 0.310, 202, 200, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
733, d3unbN_, 0.8699, 1.90, 0.264, 202, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
734, p3jtlH_, 0.8699, 2.24, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
735, d3jrmL_, 0.8699, 2.26, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
736, d3jrmK_, 0.8699, 2.26, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
737, d3jrmJ_, 0.8699, 2.26, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
738, d3jrmI_, 0.8699, 2.26, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
739, d3jrmH_, 0.8699, 2.26, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
740, d1yarL_, 0.8699, 2.24, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
741, p5lezb_, 0.8697, 1.89, 0.269, 203, 201, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
742, d3jrmN_, 0.8697, 2.26, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
743, d1yauI_, 0.8697, 2.26, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
744, d1yarI_, 0.8697, 2.25, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
745, d1ya7N_, 0.8696, 2.26, 0.250, 203, 200, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
746, d1yauN_, 0.8694, 2.27, 0.250, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
747, d1yarN_, 0.8694, 2.25, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
748, d1yauH_, 0.8693, 2.26, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
749, d1yarH_, 0.8689, 2.25, 0.255, 203, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
750, d3krdV_, 0.8682, 2.73, 0.229, 229, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
751, d3h4pl_, 0.8682, 2.12, 0.291, 202, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
752, d5lf3N1, 0.8679, 1.86, 0.265, 201, 200, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
753, p3h4pf_, 0.8678, 2.14, 0.291, 202, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
754, d3krdR_, 0.8677, 2.74, 0.229, 229, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
755, p3h4pg_, 0.8675, 2.26, 0.285, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
756, d3h4pj_, 0.8674, 2.14, 0.291, 202, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
757, p5l4gAA_, 0.8673, 1.65, 0.273, 199, 198, 
758, d3h4ph_, 0.8672, 2.14, 0.291, 202, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
759, p3h4pd_, 0.8672, 2.13, 0.291, 202, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
760, p3h4pa_, 0.8672, 2.15, 0.291, 202, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
761, p3j9iZ_, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
762, p3j9iY_, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
763, p3j9iX_, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
764, p3j9iW_, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
765, p3j9iV_, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
766, p3j9iN_, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
767, p3j9iM_, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
768, p3j9iL_, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
769, p3j9iK_, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
770, p3j9iJ_, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
771, p3j9iI_, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
772, p3j9iH_, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
773, p3j9i2_, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
774, p3j9i1_, 0.8671, 2.31, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
775, d3h4pi_, 0.8668, 2.14, 0.291, 202, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
776, d3h4pk_, 0.8667, 2.14, 0.291, 202, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
777, d3hfaX_, 0.8666, 2.44, 0.233, 224, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
778, d1q5qN_, 0.8666, 2.18, 0.265, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
779, d1q5qJ_, 0.8666, 2.18, 0.265, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
780, d1q5qL_, 0.8665, 2.18, 0.265, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
781, d1q5qK_, 0.8665, 2.18, 0.265, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
782, d1q5qH_, 0.8665, 2.18, 0.265, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
783, d1q5qM_, 0.8664, 2.19, 0.265, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
784, d1q5qI_, 0.8664, 2.19, 0.265, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
785, d3h4pm_, 0.8663, 2.13, 0.291, 202, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
786, p3h4pc_, 0.8663, 2.14, 0.291, 202, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
787, d3hfaZ_, 0.8662, 2.48, 0.233, 224, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
788, d3h4pn_, 0.8662, 2.13, 0.291, 202, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
789, d3hfaV_, 0.8660, 2.49, 0.233, 226, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
790, p3h4pb_, 0.8660, 2.14, 0.291, 202, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
791, p3h4pe_, 0.8658, 2.15, 0.291, 202, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
792, p6bdfZ_, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
793, p6bdfX_, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
794, p6bdfV_, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
795, p6bdfT_, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
796, p6bdfR_, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
797, p6bdfP_, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
798, p6bdfN_, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
799, p6bdfL_, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
800, p6bdfJ_, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
801, p6bdfH_, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
802, p6bdfF_, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
803, p6bdfD_, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
804, p6bdfB_, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
805, p6bdf1_, 0.8655, 2.21, 0.256, 201, 199, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
806, d3hfaT_, 0.8654, 2.39, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
807, d3hfaN_, 0.8653, 2.39, 0.239, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
808, d3hfaE_, 0.8653, 2.39, 0.239, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
809, d3mi0L_, 0.8651, 2.40, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
810, d3hfaH_, 0.8650, 2.40, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
811, d3mi02_, 0.8649, 2.39, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
812, d3mi0E_, 0.8647, 2.39, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
813, d3mi0Z_, 0.8645, 2.39, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
814, d3mi0T_, 0.8645, 2.40, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
815, p5l4gBA_, 0.8643, 1.34, 0.250, 194, 192, 
816, d4q1sV_, 0.8643, 1.34, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
817, d5trgL_, 0.8642, 2.38, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
818, d5le5H_, 0.8642, 1.36, 0.250, 220, 192, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
819, d4r3oI_, 0.8641, 1.35, 0.250, 220, 192, HUMAN CONSTITUTIVE 20S PROTEASOME
820, d4q1sH_, 0.8641, 1.34, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
821, p3unhN_, 0.8641, 1.67, 0.278, 199, 198, MOUSE 20S IMMUNOPROTEASOME
822, p3unhb_, 0.8641, 1.67, 0.278, 199, 198, MOUSE 20S IMMUNOPROTEASOME
823, d3tddV_, 0.8641, 1.34, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
824, d3tddH_, 0.8641, 1.34, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
825, d3mi0X_, 0.8640, 2.41, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
826, d4r3oW_, 0.8639, 1.35, 0.250, 220, 192, HUMAN CONSTITUTIVE 20S PROTEASOME
827, d5lf1H_, 0.8638, 1.36, 0.250, 220, 192, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
828, p5lzpU_, 0.8637, 2.41, 0.229, 223, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
829, p5gjrOA_, 0.8637, 1.35, 0.250, 195, 192, 
830, d5trrL_, 0.8636, 2.40, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
831, d5le5V_, 0.8636, 1.36, 0.250, 220, 192, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
832, d3hfaR_, 0.8636, 2.35, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
833, p6avoE_, 0.8635, 1.24, 0.277, 193, 191, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
834, p6avoB_, 0.8635, 1.24, 0.277, 193, 191, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
835, p5lzpO_, 0.8635, 2.41, 0.229, 223, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
836, d5lf1V_, 0.8635, 1.36, 0.250, 220, 192, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
837, d5l6cV_, 0.8635, 1.35, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
838, d5l6cH_, 0.8635, 1.35, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
839, d3e47H_, 0.8635, 1.35, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
840, d4j70H_, 0.8634, 1.35, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
841, d3e47V_, 0.8634, 1.35, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
842, d5trsL_, 0.8633, 2.40, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
843, d4j70V_, 0.8633, 1.35, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
844, d3unfN_, 0.8633, 1.67, 0.283, 199, 198, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
845, d3unfb_, 0.8633, 1.67, 0.283, 199, 198, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
846, d3mg6V_, 0.8633, 1.34, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
847, d3hfaL_, 0.8633, 2.36, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
848, d1iruW_, 0.8633, 1.36, 0.250, 220, 192, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
849, d3hfaP_, 0.8632, 2.37, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
850, d3hfaG_, 0.8632, 2.37, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
851, d3hfaC_, 0.8632, 2.37, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
852, d3hfa2_, 0.8632, 2.36, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
853, d2fnyV_, 0.8632, 1.35, 0.276, 222, 192,  
854, d2fnyH_, 0.8632, 1.35, 0.276, 222, 192,  
855, d1iruI_, 0.8632, 1.36, 0.250, 220, 192, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
856, d5trgY_, 0.8631, 2.39, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
857, d5l67V_, 0.8631, 1.35, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
858, d5l67H_, 0.8631, 1.35, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
859, d5l5vV_, 0.8631, 1.35, 0.276, 226, 192,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
860, d5l5vH_, 0.8631, 1.35, 0.276, 226, 192,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
861, d5l5pV_, 0.8631, 1.35, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
862, d5l5pH_, 0.8631, 1.35, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
863, p4r67y_, 0.8631, 1.36, 0.250, 195, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
864, p4r67k_, 0.8631, 1.36, 0.250, 195, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
865, d3mi0N_, 0.8631, 2.38, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
866, d3l5qY_, 0.8631, 1.35, 0.276, 222, 192,  
867, d3l5qM_, 0.8631, 1.35, 0.276, 222, 192,  
868, p5lzpI_, 0.8630, 2.42, 0.229, 223, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
869, d5l64V_, 0.8630, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
870, d5l64H_, 0.8630, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
871, d5l5tV_, 0.8630, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
872, d5l5tH_, 0.8630, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
873, d4z1lH_, 0.8630, 1.35, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
874, d4r67W_, 0.8630, 1.36, 0.250, 220, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
875, d4r67I_, 0.8630, 1.36, 0.250, 220, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
876, p3unex_, 0.8630, 1.37, 0.250, 195, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
877, d3hfaJ_, 0.8630, 2.37, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
878, d1vsyW_, 0.8630, 1.35, 0.276, 222, 192,  
879, d5lf3H_, 0.8629, 1.38, 0.250, 220, 192, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
880, d5lexH_, 0.8629, 1.37, 0.250, 220, 192, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
881, d5l5qV_, 0.8629, 1.35, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
882, d5l5qH_, 0.8629, 1.35, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
883, d4z1lV_, 0.8629, 1.35, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
884, d3mg8V_, 0.8629, 1.35, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
885, d3mg7V_, 0.8629, 1.35, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
886, d1vsyI_, 0.8629, 1.35, 0.276, 222, 192,  
887, p5lzpC_, 0.8628, 2.41, 0.229, 223, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
888, d5l5uH_, 0.8628, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
889, d5l5oV_, 0.8628, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
890, d4y8mV_, 0.8628, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
891, d4y8mH_, 0.8628, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
892, d3unfH_, 0.8628, 1.34, 0.276, 219, 192, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
893, p3uneV_, 0.8628, 1.38, 0.250, 195, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
894, d5tryL_, 0.8627, 2.41, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
895, d5lttV_, 0.8627, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
896, d5lttH_, 0.8627, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
897, d5laiH_, 0.8627, 1.36, 0.276, 226, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
898, d5l6aV_, 0.8627, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
899, d5l6aH_, 0.8627, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
900, d5l5uV_, 0.8627, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
901, d5l5oH_, 0.8627, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
902, d5cz4H_, 0.8627, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
903, d5bouH_, 0.8627, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
904, d4r17V_, 0.8627, 1.36, 0.276, 226, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
905, d4r17H_, 0.8627, 1.36, 0.276, 226, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
906, d3unfV_, 0.8627, 1.34, 0.276, 219, 192, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
907, d3sdiH_, 0.8627, 1.35, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
908, d5thoL_, 0.8626, 2.40, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
909, d5lf3V_, 0.8626, 1.38, 0.250, 220, 192, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
910, p5lf0H_, 0.8626, 1.38, 0.250, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
911, d5laiV_, 0.8626, 1.36, 0.276, 226, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
912, p5l4gN_, 0.8626, 1.37, 0.250, 195, 192, 
913, d5bouV_, 0.8626, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
914, d3oevV_, 0.8626, 1.35, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
915, d3dy4V_, 0.8626, 1.36, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
916, d3dy4H_, 0.8626, 1.36, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
917, d5trsY_, 0.8625, 2.39, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
918, p5trrb_, 0.8625, 2.42, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
919, p5lzpT_, 0.8625, 2.42, 0.229, 223, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
920, d5lajV_, 0.8625, 1.36, 0.276, 226, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
921, d5lajH_, 0.8625, 1.36, 0.276, 226, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
922, d5l69V_, 0.8625, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
923, d5l69H_, 0.8625, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
924, d5l62V_, 0.8625, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
925, d5l62H_, 0.8625, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
926, d5l5hV_, 0.8625, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
927, d5l5hH_, 0.8625, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
928, d5fg9H_, 0.8625, 1.36, 0.276, 230, 192, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
929, d3sdiV_, 0.8625, 1.36, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
930, d5lf7H_, 0.8624, 1.38, 0.250, 220, 192, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
931, d5lexV_, 0.8624, 1.38, 0.250, 220, 192, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
932, d5l61V_, 0.8624, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
933, d5l61H_, 0.8624, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
934, d5l5sV_, 0.8624, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
935, d5l5sH_, 0.8624, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
936, d5fg9V_, 0.8624, 1.36, 0.276, 230, 192, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
937, p5cghV_, 0.8624, 1.36, 0.276, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
938, p5cghH_, 0.8624, 1.36, 0.276, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
939, d4rurV_, 0.8624, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
940, d4rurH_, 0.8624, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
941, p3unej_, 0.8624, 1.38, 0.250, 195, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
942, d3mi0J_, 0.8624, 2.38, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
943, d5m2bH_, 0.8623, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
944, p5lf0V_, 0.8623, 1.38, 0.250, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
945, d5l60V_, 0.8623, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
946, d5l60H_, 0.8623, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
947, d4ya1H_, 0.8623, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT
948, p5trga_, 0.8622, 2.41, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
949, d5m2bV_, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
950, p5lzpR_, 0.8622, 2.43, 0.229, 223, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
951, d5l63V_, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
952, d5l5rV_, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
953, d5l5rH_, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
954, d5l5jV_, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
955, d5l5jH_, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
956, d5l5iV_, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
957, d5l5iH_, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
958, d4ya1V_, 0.8622, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT
959, p4y6vV_, 0.8622, 1.37, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
960, p4y6vH_, 0.8622, 1.37, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
961, d4r00V_, 0.8622, 1.36, 0.276, 226, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
962, d4r00H_, 0.8622, 1.36, 0.276, 226, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
963, d4qz7V_, 0.8622, 1.36, 0.276, 222, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
964, d4qz7H_, 0.8622, 1.36, 0.276, 222, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
965, d4inrV_, 0.8622, 1.36, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
966, p3uneH_, 0.8622, 1.38, 0.250, 195, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
967, d3oevH_, 0.8622, 1.35, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
968, d3oeuV_, 0.8622, 1.36, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
969, d3mi0G_, 0.8622, 2.38, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
970, d3mg7H_, 0.8622, 1.37, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
971, p5trra_, 0.8621, 2.43, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
972, p5leyH_, 0.8621, 1.39, 0.250, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
973, d5l68V_, 0.8621, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
974, d5l68H_, 0.8621, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
975, d5l63H_, 0.8621, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
976, d5l5bV_, 0.8621, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
977, d5l5bH_, 0.8621, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
978, d5cz4V_, 0.8621, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
979, d5cgfV_, 0.8621, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT
980, d5cgfH_, 0.8621, 1.36, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT
981, d4qzzV_, 0.8621, 1.37, 0.276, 226, 192, YCP IN COMPLEX WITH OMURALIDE
982, d4qzzH_, 0.8621, 1.37, 0.276, 226, 192, YCP IN COMPLEX WITH OMURALIDE
983, d4quxV_, 0.8621, 1.37, 0.276, 226, 192, YCP BETA5-A49T-MUTANT
984, d4inuV_, 0.8621, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
985, d4inuH_, 0.8621, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
986, d4eu2W_, 0.8621, 1.36, 0.276, 222, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
987, d3mi0C_, 0.8621, 2.38, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
988, d3mg8H_, 0.8621, 1.36, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
989, d3mg6H_, 0.8621, 1.36, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
990, d5trrW_, 0.8620, 2.42, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
991, d5trgI_, 0.8620, 2.37, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
992, d5lf7V_, 0.8620, 1.38, 0.250, 220, 192, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
993, d5lf4H_, 0.8620, 1.38, 0.250, 220, 192, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
994, p5leyV_, 0.8620, 1.38, 0.250, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
995, d5d0xV_, 0.8620, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
996, p4y8nV_, 0.8620, 1.37, 0.276, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
997, p4y8nH_, 0.8620, 1.37, 0.276, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
998, d4r02H_, 0.8620, 1.37, 0.276, 226, 192, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
999, d4qw3V_, 0.8620, 1.37, 0.276, 226, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1000, d4qw3H_, 0.8620, 1.37, 0.276, 226, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1001, d4quxH_, 0.8620, 1.37, 0.276, 226, 192, YCP BETA5-A49T-MUTANT
1002, d4inrH_, 0.8620, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1003, d3un8V_, 0.8620, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1004, d3nzwV_, 0.8620, 1.36, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1005, d3nzwH_, 0.8620, 1.36, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1006, p3ipmM_, 0.8620, 2.34, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1007, p3ipmL_, 0.8620, 2.34, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1008, p3ipmK_, 0.8620, 2.34, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1009, p3ipmJ_, 0.8620, 2.34, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1010, d5trgK_, 0.8619, 2.42, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1011, d5l5aV_, 0.8619, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1012, d5l55V_, 0.8619, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1013, d5d0xH_, 0.8619, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1014, p4x6zW_, 0.8619, 1.37, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1015, d4r02V_, 0.8619, 1.37, 0.276, 226, 192, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1016, d4qlvV_, 0.8619, 1.36, 0.276, 222, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1017, d4qlvH_, 0.8619, 1.36, 0.276, 222, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1018, d4hnpV_, 0.8619, 1.37, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1019, d3sdkV_, 0.8619, 1.36, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1020, p3ipmN_, 0.8619, 2.34, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1021, p3ipmI_, 0.8619, 2.34, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1022, p3ipmH_, 0.8619, 2.34, 0.255, 203, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1023, d1z7qW1, 0.8619, 1.37, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1024, d1z7qI1, 0.8619, 1.37, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1025, d5trgW_, 0.8618, 2.41, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1026, d5lf4V_, 0.8618, 1.39, 0.250, 220, 192, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1027, d5l5wV_, 0.8618, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1028, d5l5wH_, 0.8618, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1029, d5l5aH_, 0.8618, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1030, d5l55H_, 0.8618, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1031, d5d0wV_, 0.8618, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1032, d5d0wH_, 0.8618, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1033, d5cz6V_, 0.8618, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1034, d5cz6H_, 0.8618, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1035, d4eu2I_, 0.8618, 1.37, 0.276, 222, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1036, p3unhV_, 0.8618, 1.27, 0.272, 193, 191, MOUSE 20S IMMUNOPROTEASOME
1037, p3unhH_, 0.8618, 1.28, 0.272, 193, 191, MOUSE 20S IMMUNOPROTEASOME
1038, p3unbx_, 0.8618, 1.38, 0.250, 195, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1039, d3sdkH_, 0.8618, 1.36, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1040, d3oeuH_, 0.8618, 1.36, 0.276, 222, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1041, d5ts0W_, 0.8617, 2.41, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1042, d5l6bV_, 0.8617, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1043, d5l6bH_, 0.8617, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1044, d5fgaV_, 0.8617, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1045, d5fgaH_, 0.8617, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1046, d5czaV_, 0.8617, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1047, d5czaH_, 0.8617, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1048, p4y7xV_, 0.8617, 1.37, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1049, p4y7xH_, 0.8617, 1.37, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1050, d4qw0V_, 0.8617, 1.37, 0.276, 226, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1051, d4qw0H_, 0.8617, 1.37, 0.276, 226, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1052, d4qvvV_, 0.8617, 1.37, 0.276, 226, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1053, d4qvvH_, 0.8617, 1.37, 0.276, 226, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1054, d4qv7V_, 0.8617, 1.37, 0.276, 226, 192, YCP BETA5-A50V MUTANT
1055, d4qv7H_, 0.8617, 1.37, 0.276, 226, 192, YCP BETA5-A50V MUTANT
1056, d4hnpH_, 0.8617, 1.37, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1057, d3hyeV_, 0.8617, 1.37, 0.276, 222, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1058, d3hyeH_, 0.8617, 1.37, 0.276, 222, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1059, d5ts0L_, 0.8616, 2.41, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1060, d5l5zH_, 0.8616, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1061, d5l5fV_, 0.8616, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1062, d5l5fH_, 0.8616, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1063, d5l5dV_, 0.8616, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1064, d5l5dH_, 0.8616, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1065, p5gjrAA_, 0.8616, 1.29, 0.251, 193, 191, 
1066, d5d0tV_, 0.8616, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1067, d5d0tH_, 0.8616, 1.37, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1068, d5cz7V_, 0.8616, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1069, d5cz7H_, 0.8616, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1070, d4ya4H_, 0.8616, 1.37, 0.281, 226, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1071, d4y9yV_, 0.8616, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1072, p4x6zI_, 0.8616, 1.37, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1073, d4qvyV_, 0.8616, 1.38, 0.276, 226, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1074, d4qvyH_, 0.8616, 1.38, 0.276, 226, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1075, d4qvmV_, 0.8616, 1.38, 0.276, 226, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1076, d4qvmH_, 0.8616, 1.38, 0.276, 226, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1077, d4qv3V_, 0.8616, 1.37, 0.276, 226, 192, YCP BETA5-M45V MUTANT
1078, d4qv3H_, 0.8616, 1.37, 0.276, 226, 192, YCP BETA5-M45V MUTANT
1079, d4jsqV_, 0.8616, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1080, d4jsqH_, 0.8616, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1081, d4intV_, 0.8616, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1082, d3un8H_, 0.8616, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1083, d3mi0H_, 0.8616, 2.39, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
1084, d3gptV_, 0.8616, 1.38, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1085, p5tryb_, 0.8615, 2.43, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1086, d5trgV_, 0.8615, 2.42, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1087, p5trgb_, 0.8615, 2.42, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1088, p5lzpG_, 0.8615, 2.39, 0.230, 222, 204, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1089, d5l66V_, 0.8615, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1090, d5l66H_, 0.8615, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1091, d5l5zV_, 0.8615, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1092, d5dkiV_, 0.8615, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1093, d4ya4V_, 0.8615, 1.38, 0.281, 226, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1094, d4y9yH_, 0.8615, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1095, d3mi0P_, 0.8615, 2.40, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
1096, d3gptH_, 0.8615, 1.38, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1097, p5lezH_, 0.8614, 1.39, 0.250, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1098, p5fghV_, 0.8614, 1.38, 0.276, 196, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1099, p5fghH_, 0.8614, 1.38, 0.276, 196, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1100, d5dkjV_, 0.8614, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1101, d5dkjH_, 0.8614, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1102, d5dkiH_, 0.8614, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1103, d4y8rV_, 0.8614, 1.38, 0.281, 226, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1104, d4y8rH_, 0.8614, 1.38, 0.281, 226, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1105, d4qv1H_, 0.8614, 1.37, 0.276, 226, 192, YCP BETA5-M45A MUTANT
1106, d4intH_, 0.8614, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1107, d3wxrI_, 0.8614, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1108, d3nzjV_, 0.8614, 1.37, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1109, d3nzjH_, 0.8614, 1.37, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1110, d3mg0H_, 0.8614, 1.38, 0.276, 222, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1111, p1fntW_, 0.8614, 1.38, 0.276, 195, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1112, d5trrI_, 0.8613, 2.37, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1113, p5thoa_, 0.8613, 2.43, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1114, d5l52V_, 0.8613, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1115, d5l52H_, 0.8613, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1116, d5jhsV_, 0.8613, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1117, d5jhsH_, 0.8613, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1118, d4qzxV_, 0.8613, 1.38, 0.276, 222, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1119, d4qzxH_, 0.8613, 1.38, 0.276, 222, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1120, d4qvqV_, 0.8613, 1.38, 0.276, 226, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1121, d4qvqH_, 0.8613, 1.38, 0.276, 226, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1122, d4qv8H_, 0.8613, 1.37, 0.276, 226, 192, YCP BETA5-C52F MUTANT
1123, d4qv4V_, 0.8613, 1.38, 0.276, 226, 192, YCP BETA5-M45T MUTANT
1124, d4qv4H_, 0.8613, 1.38, 0.276, 226, 192, YCP BETA5-M45T MUTANT
1125, d4qv1V_, 0.8613, 1.38, 0.276, 226, 192, YCP BETA5-M45A MUTANT
1126, d4quyV_, 0.8613, 1.38, 0.276, 226, 192, YCP BETA5-A49S-MUTANT
1127, d4quyH_, 0.8613, 1.38, 0.276, 226, 192, YCP BETA5-A49S-MUTANT
1128, p1fntI_, 0.8613, 1.38, 0.276, 195, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1129, d5trrV_, 0.8612, 2.43, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1130, p5thob_, 0.8612, 2.42, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1131, p5lf6H_, 0.8612, 1.40, 0.250, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1132, p4y8kV_, 0.8612, 1.38, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1133, p4y8kH_, 0.8612, 1.38, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1134, d4r18V_, 0.8612, 1.37, 0.276, 226, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1135, d4r18H_, 0.8612, 1.37, 0.276, 226, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1136, d4qvwV_, 0.8612, 1.38, 0.276, 226, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1137, d4qvwH_, 0.8612, 1.38, 0.276, 226, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1138, d4qv8V_, 0.8612, 1.37, 0.276, 226, 192, YCP BETA5-C52F MUTANT
1139, d3nzxV_, 0.8612, 1.38, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1140, d3mg0V_, 0.8612, 1.38, 0.276, 222, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1141, d2fakV_, 0.8612, 1.38, 0.276, 222, 192, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1142, d2fakH_, 0.8612, 1.38, 0.276, 222, 192, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1143, d1g0uH_, 0.8612, 1.38, 0.276, 222, 192, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1144, p5trya_, 0.8611, 2.43, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1145, p5lzpA_, 0.8611, 2.40, 0.230, 222, 204, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1146, d5l5xV_, 0.8611, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1147, d5l5eV_, 0.8611, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1148, d5l5eH_, 0.8611, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1149, d5l54V_, 0.8611, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1150, d5l54H_, 0.8611, 1.37, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1151, d4qwjV_, 0.8611, 1.38, 0.276, 222, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1152, d4qwjH_, 0.8611, 1.38, 0.276, 222, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1153, d4qvpV_, 0.8611, 1.39, 0.276, 226, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1154, d4qvpH_, 0.8611, 1.39, 0.276, 226, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1155, d4qv5V_, 0.8611, 1.38, 0.276, 226, 192, YCP BETA5-M45I MUTANT
1156, d4qv5H_, 0.8611, 1.38, 0.276, 226, 192, YCP BETA5-M45I MUTANT
1157, d4qluV_, 0.8611, 1.37, 0.276, 222, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1158, d4qluH_, 0.8611, 1.37, 0.276, 222, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1159, d4qlsH_, 0.8611, 1.37, 0.276, 222, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1160, d3nzxH_, 0.8611, 1.38, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1161, d3d29V_, 0.8611, 1.38, 0.276, 222, 192, PROTEASOME INHIBITION BY FELLUTAMIDE B
1162, d3d29H_, 0.8611, 1.38, 0.276, 222, 192, PROTEASOME INHIBITION BY FELLUTAMIDE B
1163, d5trrY_, 0.8610, 2.41, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1164, d5thoW_, 0.8610, 2.41, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1165, p5lezV_, 0.8610, 1.40, 0.250, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1166, d5l5xH_, 0.8610, 1.38, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1167, p5cggV_, 0.8610, 1.38, 0.276, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1168, p5cggH_, 0.8610, 1.38, 0.276, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1169, p4y8hV_, 0.8610, 1.38, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1170, d4qvlV_, 0.8610, 1.39, 0.276, 226, 192, YCP IN COMPLEX WITH BORTEZOMIB
1171, d4qvlH_, 0.8610, 1.39, 0.276, 226, 192, YCP IN COMPLEX WITH BORTEZOMIB
1172, d4qv0V_, 0.8610, 1.38, 0.276, 226, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1173, d4qv0H_, 0.8610, 1.38, 0.276, 226, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1174, d4qlsV_, 0.8610, 1.37, 0.276, 222, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1175, d4ltcV_, 0.8610, 1.38, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1176, d3wxrW_, 0.8610, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1177, d1g0uV_, 0.8610, 1.38, 0.276, 222, 192, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1178, p6gopV_, 0.8609, 1.39, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1179, p6gopH_, 0.8609, 1.39, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1180, p5lzpF_, 0.8609, 2.40, 0.230, 222, 204, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1181, d5jhrH_, 0.8609, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1182, p4zzgI_, 0.8609, 1.29, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1183, p4y8hH_, 0.8609, 1.38, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1184, d4qz0V_, 0.8609, 1.38, 0.276, 222, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1185, d4qz0H_, 0.8609, 1.38, 0.276, 222, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1186, d4qxjV_, 0.8609, 1.38, 0.276, 222, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1187, d4qxjH_, 0.8609, 1.38, 0.276, 222, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1188, d4qv9V_, 0.8609, 1.38, 0.276, 226, 192, YCP BETA5-C63F MUTANT
1189, d4qv9H_, 0.8609, 1.38, 0.276, 226, 192, YCP BETA5-C63F MUTANT
1190, d3mg4V_, 0.8609, 1.37, 0.276, 222, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1191, d5tryI_, 0.8608, 2.39, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1192, p5lf6V_, 0.8608, 1.40, 0.250, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1193, d5l65V_, 0.8608, 1.39, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1194, d5l65H_, 0.8608, 1.39, 0.276, 226, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1195, d5jhrV_, 0.8608, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1196, p4v7oI_, 0.8608, 1.29, 0.277, 194, 191, 
1197, d4qz2V_, 0.8608, 1.38, 0.276, 222, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1198, d4qz2H_, 0.8608, 1.38, 0.276, 222, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1199, d4lqiV_, 0.8608, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1200, d4lqiH_, 0.8608, 1.38, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1201, d3unbH_, 0.8608, 1.40, 0.250, 220, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1202, d3mg4H_, 0.8608, 1.37, 0.276, 222, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1203, p6bgoZ_, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1204, p6bgoY_, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1205, p6bgoX_, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1206, p6bgoW_, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1207, p6bgoV_, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1208, p6bgoU_, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1209, p6bgoT_, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1210, p6bgoS_, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1211, p6bgoR_, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1212, p6bgoQ_, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1213, p6bgoP_, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1214, p6bgoc_, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1215, p6bgob_, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1216, p6bgoa_, 0.8607, 2.41, 0.235, 222, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1217, p6bglZ_, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1218, p6bglY_, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1219, p6bglX_, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1220, p6bglW_, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1221, p6bglV_, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1222, p6bglU_, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1223, p6bglT_, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1224, p6bglS_, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1225, p6bglR_, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1226, p6bglQ_, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1227, p6bglP_, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1228, p6bglc_, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1229, p6bglb_, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1230, p6bgla_, 0.8607, 2.41, 0.235, 222, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1231, p5trsb_, 0.8607, 2.42, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1232, p5trsa_, 0.8607, 2.44, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1233, d5thoV_, 0.8607, 2.43, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1234, p5lzpL_, 0.8607, 2.41, 0.230, 222, 204, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1235, d5l5yV_, 0.8607, 1.39, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1236, d5l5yH_, 0.8607, 1.39, 0.276, 226, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1237, d5fgiV_, 0.8607, 1.38, 0.271, 234, 192, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1238, d5fg7H_, 0.8607, 1.38, 0.271, 228, 192, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1239, d4y8mN_, 0.8607, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1240, p4y8mb_, 0.8607, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1241, p4y8gV_, 0.8607, 1.38, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1242, p4y8gH_, 0.8607, 1.38, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1243, p4v7oW_, 0.8607, 1.29, 0.277, 194, 191, 
1244, p4v7oEB_, 0.8607, 1.29, 0.277, 194, 191, 
1245, d4qw1V_, 0.8607, 1.39, 0.276, 226, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1246, d4qw1H_, 0.8607, 1.39, 0.276, 226, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1247, d4q1sb_, 0.8607, 1.56, 0.256, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1248, d4no9V_, 0.8607, 1.38, 0.276, 222, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1249, d3gpwV_, 0.8607, 1.39, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1250, d3gpwH_, 0.8607, 1.39, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1251, d3dy3V_, 0.8607, 1.38, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1252, d3dy3H_, 0.8607, 1.38, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1253, d3bdmV_, 0.8607, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1254, d3bdmH_, 0.8607, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1255, d2f16V_, 0.8607, 1.39, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1256, d2f16H_, 0.8607, 1.39, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1257, d5trsW_, 0.8606, 2.43, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1258, p5nifI_, 0.8606, 1.29, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1259, d5fg7V_, 0.8606, 1.38, 0.271, 228, 192, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1260, d5czaN_, 0.8606, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1261, p5czab_, 0.8606, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1262, p4z1lb_, 0.8606, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1263, p4y8qV_, 0.8606, 1.38, 0.276, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1264, p4y8qH_, 0.8606, 1.38, 0.276, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1265, p4y8lH_, 0.8606, 1.39, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1266, p4v7oQA_, 0.8606, 1.29, 0.277, 194, 191, 
1267, d4qzwV_, 0.8606, 1.39, 0.276, 222, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1268, d4qzwH_, 0.8606, 1.39, 0.276, 222, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1269, d4qwkV_, 0.8606, 1.38, 0.276, 222, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1270, d4qwkH_, 0.8606, 1.38, 0.276, 222, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1271, d4qvnH_, 0.8606, 1.40, 0.276, 226, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1272, d4no9H_, 0.8606, 1.39, 0.276, 222, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1273, d4ltcH_, 0.8606, 1.38, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1274, d5tryW_, 0.8605, 2.42, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1275, d5trgX_, 0.8605, 2.38, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1276, d4z1lN_, 0.8605, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1277, p4y82V_, 0.8605, 1.39, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1278, p4y82H_, 0.8605, 1.39, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1279, d4qz1V_, 0.8605, 1.39, 0.276, 222, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1280, d4qz1H_, 0.8605, 1.39, 0.276, 222, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1281, d4qvnV_, 0.8605, 1.40, 0.276, 226, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1282, d4qv6V_, 0.8605, 1.39, 0.276, 226, 192, YCP BETA5-A49V MUTANT
1283, d4qv6H_, 0.8605, 1.39, 0.276, 226, 192, YCP BETA5-A49V MUTANT
1284, d4qltV_, 0.8605, 1.38, 0.276, 222, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1285, d4qlqV_, 0.8605, 1.39, 0.276, 222, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1286, d4qlqH_, 0.8605, 1.39, 0.276, 222, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1287, d2gplV_, 0.8605, 1.39, 0.276, 222, 192, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1288, d2gplH_, 0.8605, 1.39, 0.276, 222, 192, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1289, d4ya1N_, 0.8604, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1290, p4ya1b_, 0.8604, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1291, p4y81V_, 0.8604, 1.39, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1292, p4y81H_, 0.8604, 1.39, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1293, d4qwgV_, 0.8604, 1.39, 0.276, 222, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1294, d4qwgH_, 0.8604, 1.39, 0.276, 222, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1295, d4qltH_, 0.8604, 1.38, 0.276, 222, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1296, d4g4sI_, 0.8604, 1.38, 0.276, 220, 192, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1297, d4fzcV_, 0.8604, 1.40, 0.276, 222, 192, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1298, d3oeuN_, 0.8604, 1.56, 0.256, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1299, p5ts0a_, 0.8603, 2.45, 0.239, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1300, d5trsI_, 0.8603, 2.39, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1301, d5trgM_, 0.8603, 2.38, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1302, p5nifW_, 0.8603, 1.29, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1303, p5lzpE_, 0.8603, 2.41, 0.230, 222, 204, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1304, d5lajN_, 0.8603, 1.57, 0.262, 196, 195, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1305, p5lajb_, 0.8603, 1.57, 0.262, 196, 195, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1306, d5fhsV_, 0.8603, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1307, d5fhsH_, 0.8603, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1308, d5fgaN_, 0.8603, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1309, p5fgab_, 0.8603, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1310, d5cgfN_, 0.8603, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1311, p5cgfb_, 0.8603, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1312, p5bxlb_, 0.8603, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1313, d5bouN_, 0.8603, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1314, p5boub_, 0.8603, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1315, d4qz3V_, 0.8603, 1.39, 0.276, 222, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1316, d4qz3H_, 0.8603, 1.39, 0.276, 222, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1317, d4jt0V_, 0.8603, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1318, d4jt0H_, 0.8603, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1319, d4fzcH_, 0.8603, 1.40, 0.276, 222, 192, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1320, d3sdkN_, 0.8603, 1.56, 0.256, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1321, p5vfuNA_, 0.8602, 1.31, 0.251, 193, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1322, p5vfto_, 0.8602, 1.31, 0.251, 193, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1323, d5thoM_, 0.8602, 2.43, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1324, p5mp92_, 0.8602, 1.38, 0.276, 196, 192, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1325, p5lzpK_, 0.8602, 2.41, 0.230, 222, 204, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1326, d5l5bN_, 0.8602, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1327, p5l5bb_, 0.8602, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1328, d5fgiH_, 0.8602, 1.39, 0.271, 234, 192, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1329, d5fgdV_, 0.8602, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1330, d5fgdH_, 0.8602, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1331, d5cz9V_, 0.8602, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1332, d5cz9H_, 0.8602, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1333, d5bxlN_, 0.8602, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1334, d4ya4N_, 0.8602, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1335, p4ya4b_, 0.8602, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1336, d4y9yN_, 0.8602, 1.56, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1337, p4y8iV_, 0.8602, 1.39, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1338, d4qwxV_, 0.8602, 1.39, 0.276, 222, 192, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1339, d4qwxH_, 0.8602, 1.39, 0.276, 222, 192, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1340, d4qv7N_, 0.8602, 1.56, 0.262, 196, 195, YCP BETA5-A50V MUTANT
1341, p4qv7b_, 0.8602, 1.56, 0.262, 196, 195, YCP BETA5-A50V MUTANT
1342, d5trsN_, 0.8601, 2.42, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1343, d5trgN_, 0.8601, 2.43, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1344, d5l5aN_, 0.8601, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1345, p5l5ab_, 0.8601, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1346, d5fg9N_, 0.8601, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1347, p5fg9b_, 0.8601, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1348, d5d0wN_, 0.8601, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1349, p5d0wb_, 0.8601, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1350, d5cz5N_, 0.8601, 1.56, 0.256, 206, 195, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1351, d5cz4N_, 0.8601, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1352, p5cz4b_, 0.8601, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1353, p4zzgW_, 0.8601, 1.30, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1354, p4y9yb_, 0.8601, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1355, p4y8iH_, 0.8601, 1.39, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1356, d4qwuV_, 0.8601, 1.40, 0.276, 226, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1357, d4qwuH_, 0.8601, 1.40, 0.276, 226, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1358, d4qv3N_, 0.8601, 1.57, 0.262, 196, 195, YCP BETA5-M45V MUTANT
1359, p4qv3b_, 0.8601, 1.57, 0.262, 196, 195, YCP BETA5-M45V MUTANT
1360, d4quxN_, 0.8601, 1.57, 0.262, 196, 195, YCP BETA5-A49T-MUTANT
1361, p4quxb_, 0.8601, 1.57, 0.262, 196, 195, YCP BETA5-A49T-MUTANT
1362, d4no1V_, 0.8601, 1.40, 0.276, 222, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1363, d4no1H_, 0.8601, 1.40, 0.276, 222, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1364, d3oevN_, 0.8601, 1.56, 0.256, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1365, d3mg62_, 0.8601, 1.57, 0.256, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1366, d3gpjV_, 0.8601, 1.40, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1367, d3gpjH_, 0.8601, 1.40, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1368, p5ts0b_, 0.8600, 2.43, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1369, d5tryY_, 0.8600, 2.43, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1370, d5fgeV_, 0.8600, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1371, d5fgeH_, 0.8600, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1372, d5fg7N_, 0.8600, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1373, p5fg7b_, 0.8600, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1374, d5cz6N_, 0.8600, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1375, p5cz6b_, 0.8600, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1376, d5cz5V_, 0.8600, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1377, d5cz5H_, 0.8600, 1.39, 0.276, 222, 192, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1378, p4y77V_, 0.8600, 1.40, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1379, p4y77H_, 0.8600, 1.40, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1380, d4rurN_, 0.8600, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1381, p4rurb_, 0.8600, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1382, d4r18N_, 0.8600, 1.57, 0.262, 196, 195, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1383, d4r18b_, 0.8600, 1.57, 0.262, 196, 195, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1384, d4r17N_, 0.8600, 1.57, 0.262, 196, 195, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1385, p4r17b_, 0.8600, 1.57, 0.262, 196, 195, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1386, p4qzzb_, 0.8600, 1.57, 0.262, 196, 195, YCP IN COMPLEX WITH OMURALIDE
1387, d4qwiV_, 0.8600, 1.39, 0.276, 222, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1388, d4qwiH_, 0.8600, 1.39, 0.276, 222, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1389, p4hnpb_, 0.8600, 1.56, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1390, d3sdk2_, 0.8600, 1.57, 0.256, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1391, d2gplN_, 0.8600, 1.56, 0.262, 196, 195, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1392, d2gpl2_, 0.8600, 1.56, 0.262, 196, 195, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1393, d5laiN_, 0.8599, 1.57, 0.262, 196, 195, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1394, p5laib_, 0.8599, 1.57, 0.262, 196, 195, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1395, d5l5rN_, 0.8599, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1396, p5l5rb_, 0.8599, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1397, d5jhrN_, 0.8599, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1398, p5jhrb_, 0.8599, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1399, d4y8rN_, 0.8599, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1400, p4y8rb_, 0.8599, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1401, d4qzzN_, 0.8599, 1.57, 0.262, 196, 195, YCP IN COMPLEX WITH OMURALIDE
1402, d4qz6V_, 0.8599, 1.40, 0.276, 222, 192, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1403, d4qz6H_, 0.8599, 1.40, 0.276, 222, 192, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1404, d4qwsV_, 0.8599, 1.40, 0.276, 222, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1405, d4qwsH_, 0.8599, 1.40, 0.276, 222, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1406, d4qv8N_, 0.8599, 1.57, 0.262, 196, 195, YCP BETA5-C52F MUTANT
1407, p4qv8b_, 0.8599, 1.57, 0.262, 196, 195, YCP BETA5-C52F MUTANT
1408, d4qv4N_, 0.8599, 1.57, 0.262, 196, 195, YCP BETA5-M45T MUTANT
1409, p4qv4b_, 0.8599, 1.57, 0.262, 196, 195, YCP BETA5-M45T MUTANT
1410, d4quyN_, 0.8599, 1.57, 0.262, 196, 195, YCP BETA5-A49S-MUTANT
1411, d4jsuV_, 0.8599, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1412, d4jsuH_, 0.8599, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1413, d3shjV_, 0.8599, 1.39, 0.276, 222, 192, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1414, d3shjH_, 0.8599, 1.39, 0.276, 222, 192, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1415, d3oev2_, 0.8599, 1.57, 0.256, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1416, d5thoY_, 0.8598, 2.42, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1417, p5lttb_, 0.8598, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1418, d5d0sV_, 0.8598, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1419, d5d0sH_, 0.8598, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1420, p5cghN_, 0.8598, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1421, p5cghb_, 0.8598, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1422, p4y6vN_, 0.8598, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1423, p4y6aN_, 0.8598, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1424, p4y6ab_, 0.8598, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1425, d4r00N_, 0.8598, 1.57, 0.262, 196, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1426, p4r00b_, 0.8598, 1.57, 0.262, 196, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1427, d4qv5N_, 0.8598, 1.57, 0.262, 196, 195, YCP BETA5-M45I MUTANT
1428, p4qv5b_, 0.8598, 1.57, 0.262, 196, 195, YCP BETA5-M45I MUTANT
1429, d4qv1N_, 0.8598, 1.57, 0.262, 196, 195, YCP BETA5-M45A MUTANT
1430, p4qv1b_, 0.8598, 1.57, 0.262, 196, 195, YCP BETA5-M45A MUTANT
1431, p4quyb_, 0.8598, 1.57, 0.262, 196, 195, YCP BETA5-A49S-MUTANT
1432, d4no8V_, 0.8598, 1.39, 0.276, 222, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1433, d4no8H_, 0.8598, 1.39, 0.276, 222, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1434, d3mg72_, 0.8598, 1.57, 0.256, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1435, d5lttN_, 0.8597, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1436, p4ya5V_, 0.8597, 1.31, 0.283, 194, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1437, p4ya5H_, 0.8597, 1.31, 0.283, 194, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1438, p4ya3V_, 0.8597, 1.31, 0.277, 194, 191, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1439, p4ya3H_, 0.8597, 1.31, 0.277, 194, 191, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1440, p4y8ub_, 0.8597, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1441, p4y6vb_, 0.8597, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1442, d4qv9N_, 0.8597, 1.57, 0.262, 196, 195, YCP BETA5-C63F MUTANT
1443, p4qv9b_, 0.8597, 1.57, 0.262, 196, 195, YCP BETA5-C63F MUTANT
1444, d4no6V_, 0.8597, 1.40, 0.276, 222, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1445, d4no6H_, 0.8597, 1.40, 0.276, 222, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1446, d4lqiN_, 0.8597, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1447, d4eu2V_, 0.8597, 1.57, 0.262, 196, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1448, d1rypI_, 0.8597, 1.40, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1449, d5trsK_, 0.8596, 2.46, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1450, d5trrM_, 0.8596, 2.39, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1451, d5trgH_, 0.8596, 2.39, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1452, p5m2bb_, 0.8596, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1453, d5l5oN_, 0.8596, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1454, p5l5ob_, 0.8596, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1455, p4ya5N_, 0.8596, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1456, p4y8uN_, 0.8596, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1457, d4qz4V_, 0.8596, 1.40, 0.276, 222, 192, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1458, d4qz4H_, 0.8596, 1.40, 0.276, 222, 192, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1459, d4qw0N_, 0.8596, 1.57, 0.262, 196, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1460, p4qw0b_, 0.8596, 1.57, 0.262, 196, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1461, d4qvyN_, 0.8596, 1.57, 0.262, 196, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1462, p4qvyb_, 0.8596, 1.57, 0.262, 196, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1463, d4qv0N_, 0.8596, 1.57, 0.262, 196, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1464, p4qv0b_, 0.8596, 1.57, 0.262, 196, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1465, d4q1sN_, 0.8596, 1.58, 0.256, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1466, d4no9N_, 0.8596, 1.57, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1467, p4no9b_, 0.8596, 1.57, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1468, d4hrdN_, 0.8596, 1.57, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1469, d5trrZ_, 0.8595, 2.38, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1470, d5thoI_, 0.8595, 2.40, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1471, d5m2bN_, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1472, d5l6cN_, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1473, p5l6cb_, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1474, d5l6aN_, 0.8595, 1.58, 0.256, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1475, p5l6ab_, 0.8595, 1.58, 0.256, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1476, d5l67N_, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1477, p5l67b_, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1478, d5l5vN_, 0.8595, 1.58, 0.262, 196, 195,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1479, p5l5vb_, 0.8595, 1.58, 0.262, 196, 195,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1480, d5l5pN_, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1481, p5l5pb_, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1482, d5l5eN_, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1483, p5l5eb_, 0.8595, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1484, d5l55N_, 0.8595, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1485, p5l55b_, 0.8595, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1486, d5d0zV_, 0.8595, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1487, d5d0zH_, 0.8595, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1488, p4ya5b_, 0.8595, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1489, p4y8oH_, 0.8595, 1.40, 0.276, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1490, p4y69V_, 0.8595, 1.31, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1491, p4y69b_, 0.8595, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1492, d4qz5V_, 0.8595, 1.40, 0.276, 222, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1493, d4qz5H_, 0.8595, 1.40, 0.276, 222, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1494, d4qwrV_, 0.8595, 1.40, 0.276, 222, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1495, d4qwrH_, 0.8595, 1.40, 0.276, 222, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1496, d4qvvN_, 0.8595, 1.57, 0.262, 196, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1497, p4qvvb_, 0.8595, 1.57, 0.262, 196, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1498, p3unbj_, 0.8595, 1.42, 0.250, 195, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1499, p3un4V_, 0.8595, 1.40, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1500, p3un4H_, 0.8595, 1.40, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1501, d3tddN_, 0.8595, 1.57, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1502, d3tdd2_, 0.8595, 1.57, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1503, d3sdiN_, 0.8595, 1.57, 0.262, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1504, d3mg8N_, 0.8595, 1.58, 0.256, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1505, d3mg82_, 0.8595, 1.57, 0.256, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1506, d5trrK_, 0.8594, 2.46, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1507, p5mpai_, 0.8594, 1.38, 0.276, 196, 192, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1508, d5l64N_, 0.8594, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1509, p5l64b_, 0.8594, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1510, d5l5hN_, 0.8594, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1511, p5l5hb_, 0.8594, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1512, d5fggV_, 0.8594, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1513, d5fggH_, 0.8594, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1514, d5fgfV_, 0.8594, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1515, d5fgfH_, 0.8594, 1.40, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1516, p5cggN_, 0.8594, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1517, p5cggb_, 0.8594, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1518, p4y8oV_, 0.8594, 1.40, 0.276, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1519, p4y69N_, 0.8594, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1520, p4ltcb_, 0.8594, 1.57, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1521, p4j70b_, 0.8594, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1522, d4hnpN_, 0.8594, 1.57, 0.256, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1523, d3unbV_, 0.8594, 1.41, 0.250, 220, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1524, d3sdi2_, 0.8594, 1.58, 0.256, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1525, d3mg7N_, 0.8594, 1.58, 0.256, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1526, d3mg6N_, 0.8594, 1.58, 0.256, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1527, d5trsV_, 0.8593, 2.44, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1528, d5thoK_, 0.8593, 2.45, 0.234, 223, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1529, d5l5tN_, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1530, p5l5tb_, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1531, d5l5qN_, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1532, d5l5iN_, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1533, p5l5ib_, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1534, p5jhsb_, 0.8593, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1535, d5fgeN_, 0.8593, 1.57, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1536, p5fgeb_, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1537, d5cz7N_, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1538, p5cz7b_, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1539, p4ya3b_, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1540, p4y8pV_, 0.8593, 1.41, 0.276, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1541, p4y8pH_, 0.8593, 1.41, 0.276, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1542, p4y7xN_, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1543, p4y7xb_, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1544, p4y69H_, 0.8593, 1.31, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1545, p4x6zH_, 0.8593, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1546, d4qlvN_, 0.8593, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1547, d4qlvb_, 0.8593, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1548, d4qlsN_, 0.8593, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1549, d4qlsb_, 0.8593, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1550, d4no1N_, 0.8593, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1551, p4no1b_, 0.8593, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1552, d4hrcH_, 0.8593, 1.41, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1553, d4fzgV_, 0.8593, 1.41, 0.276, 222, 192, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1554, d4fzgH_, 0.8593, 1.41, 0.276, 222, 192, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1555, d2zcyV_, 0.8593, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1556, d1rypW_, 0.8593, 1.41, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1557, d5ts0I_, 0.8592, 2.40, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1558, d5l5uN_, 0.8592, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1559, p5l5ub_, 0.8592, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1560, p5l5qb_, 0.8592, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1561, d5l5fN_, 0.8592, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1562, d5jhsN_, 0.8592, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1563, d5cz9N_, 0.8592, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1564, p4y8nN_, 0.8592, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1565, p4y6aV_, 0.8592, 1.31, 0.283, 194, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1566, p4y6aH_, 0.8592, 1.31, 0.283, 194, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1567, d4qwlV_, 0.8592, 1.41, 0.276, 222, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1568, d4qwlH_, 0.8592, 1.40, 0.276, 222, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1569, d4qw4V_, 0.8592, 1.41, 0.276, 222, 192, YCP IN COMPLEX WITH CARFILZOMIB
1570, d4qw4H_, 0.8592, 1.41, 0.276, 222, 192, YCP IN COMPLEX WITH CARFILZOMIB
1571, d4qw3N_, 0.8592, 1.58, 0.262, 196, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1572, p4qw3b_, 0.8592, 1.58, 0.262, 196, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1573, d4qvwN_, 0.8592, 1.58, 0.262, 196, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1574, p4qvwb_, 0.8592, 1.58, 0.262, 196, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1575, d4qvmN_, 0.8592, 1.58, 0.262, 196, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1576, d4j70N_, 0.8592, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1577, d3nzwN_, 0.8592, 1.57, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1578, d3nzw2_, 0.8592, 1.57, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1579, d3e47N_, 0.8592, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1580, d2zcyH_, 0.8592, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1581, d1g65V_, 0.8592, 1.42, 0.276, 222, 192, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1582, p5vfuZ_, 0.8591, 1.33, 0.251, 193, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1583, p5vftO_, 0.8591, 1.33, 0.251, 193, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1584, d5trsZ_, 0.8591, 2.38, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1585, d5trsH_, 0.8591, 2.40, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1586, d5trrN_, 0.8591, 2.43, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1587, d5l65N_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1588, p5l65b_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1589, d5l63N_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1590, p5l63b_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1591, d5l62N_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1592, p5l62b_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1593, d5l5wN_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1594, p5l5wb_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1595, d5l5sN_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1596, p5l5sb_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1597, p5l5fb_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1598, d5l5dN_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1599, p5l5db_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1600, d5l54N_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1601, p5l54b_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1602, p5gjqb_, 0.8591, 1.33, 0.251, 193, 191, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1603, d5fhsN_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1604, p5fhsb_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1605, p5fghN_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1606, p5fghb_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1607, d5fgfN_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1608, p5fgfb_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1609, d5d0xN_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1610, p5d0xb_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1611, d5d0tN_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1612, p5d0tb_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1613, p5cz9b_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1614, p4ya3N_, 0.8591, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1615, p4ya0V_, 0.8591, 1.32, 0.277, 194, 191, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1616, p4x6zV_, 0.8591, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1617, d4qw7V_, 0.8591, 1.41, 0.276, 222, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1618, d4qw7H_, 0.8591, 1.41, 0.276, 222, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1619, d4qw6V_, 0.8591, 1.41, 0.276, 222, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1620, d4qw6H_, 0.8591, 1.41, 0.276, 222, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1621, d4qvpN_, 0.8591, 1.58, 0.262, 196, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1622, p4qvpb_, 0.8591, 1.58, 0.262, 196, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1623, p4qvmb_, 0.8591, 1.58, 0.262, 196, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1624, d4ltcN_, 0.8591, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1625, d4hrdH_, 0.8591, 1.41, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1626, d3okjV_, 0.8591, 1.41, 0.276, 222, 192, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1627, d3okjH_, 0.8591, 1.41, 0.276, 222, 192, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1628, d3oeu2_, 0.8591, 1.58, 0.256, 196, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1629, d3e472_, 0.8591, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1630, d5l68N_, 0.8590, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1631, p5l68b_, 0.8590, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1632, d5l60N_, 0.8590, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1633, p5l60b_, 0.8590, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1634, d5fgdN_, 0.8590, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1635, p5fgdb_, 0.8590, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1636, d5bxnV_, 0.8590, 1.58, 0.269, 222, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1637, p4ya0H_, 0.8590, 1.32, 0.277, 194, 191, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1638, p4y8uV_, 0.8590, 1.32, 0.283, 194, 191, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1639, p4y8uH_, 0.8590, 1.32, 0.283, 194, 191, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1640, p4y8nb_, 0.8590, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1641, p4y84V_, 0.8590, 1.32, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1642, p4y75V_, 0.8590, 1.41, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1643, p4y70N_, 0.8590, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1644, p4y70b_, 0.8590, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1645, d4r02N_, 0.8590, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1646, d4qwsN_, 0.8590, 1.58, 0.262, 196, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1647, d4qw5V_, 0.8590, 1.41, 0.276, 222, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1648, d4qw5H_, 0.8590, 1.41, 0.276, 222, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1649, d4qltN_, 0.8590, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1650, d4qltb_, 0.8590, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1651, p4hrdb_, 0.8590, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1652, d3nzxN_, 0.8590, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1653, d3nzx2_, 0.8590, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1654, d2fnyN_, 0.8590, 1.58, 0.262, 196, 195,  
1655, d2fny2_, 0.8590, 1.58, 0.262, 196, 195,  
1656, d1g65H_, 0.8590, 1.41, 0.276, 222, 192, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1657, d5ts0V_, 0.8589, 2.44, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1658, d5l69N_, 0.8589, 1.59, 0.256, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1659, p5l69b_, 0.8589, 1.59, 0.256, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1660, d5l5jN_, 0.8589, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1661, p5l5jb_, 0.8589, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1662, p5d0zb_, 0.8589, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1663, d5cz8V_, 0.8589, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1664, d5cz8H_, 0.8589, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1665, d5ahjH_, 0.8589, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1666, p4y8kb_, 0.8589, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1667, p4y84H_, 0.8589, 1.32, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1668, p4y80N_, 0.8589, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1669, p4y80b_, 0.8589, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1670, p4y7yN_, 0.8589, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1671, p4y7yb_, 0.8589, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1672, p4y75H_, 0.8589, 1.41, 0.276, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1673, p4r02b_, 0.8589, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1674, p4qwsb_, 0.8589, 1.58, 0.262, 196, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1675, d4qvlN_, 0.8589, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH BORTEZOMIB
1676, p4qvlb_, 0.8589, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH BORTEZOMIB
1677, d4qluN_, 0.8589, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1678, d4qlub_, 0.8589, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1679, d4eu2H_, 0.8589, 1.57, 0.262, 196, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1680, p6gopN_, 0.8588, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1681, p6gopb_, 0.8588, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1682, d5ts0H_, 0.8588, 2.40, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1683, d5trrH_, 0.8588, 2.40, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1684, d5l6bN_, 0.8588, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1685, p5l6bb_, 0.8588, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1686, d5l66N_, 0.8588, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1687, p5l66b_, 0.8588, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1688, d5fggN_, 0.8588, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1689, d5d0zN_, 0.8588, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1690, p5cz5b_, 0.8588, 1.58, 0.256, 206, 195, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1691, d5ahjV_, 0.8588, 1.41, 0.276, 222, 192, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1692, d4qwjN_, 0.8588, 1.58, 0.262, 196, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1693, p4qwjb_, 0.8588, 1.58, 0.262, 196, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1694, d4qw1N_, 0.8588, 1.58, 0.262, 196, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1695, p4qw1b_, 0.8588, 1.58, 0.262, 196, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1696, d4qvnN_, 0.8588, 1.58, 0.262, 196, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1697, p4qvnb_, 0.8588, 1.58, 0.262, 196, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1698, d4qv6N_, 0.8588, 1.58, 0.262, 196, 195, YCP BETA5-A49V MUTANT
1699, p4qv6b_, 0.8588, 1.58, 0.262, 196, 195, YCP BETA5-A49V MUTANT
1700, d4fzgN_, 0.8588, 1.58, 0.262, 196, 195, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1701, d3nzjN_, 0.8588, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1702, d3nzj2_, 0.8588, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1703, d3krdL_, 0.8588, 2.40, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1704, d5trgZ_, 0.8587, 2.41, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1705, d5l61N_, 0.8587, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1706, p5l61b_, 0.8587, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1707, d5l5zN_, 0.8587, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1708, p5l5zb_, 0.8587, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1709, d5l5yN_, 0.8587, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1710, p5l5yb_, 0.8587, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1711, p5fggb_, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1712, d5dkjN_, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1713, p5dkjb_, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1714, d5d0sN_, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1715, p5d0sb_, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1716, p5cgiV_, 0.8587, 1.33, 0.277, 194, 191, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1717, p5cgiH_, 0.8587, 1.32, 0.277, 194, 191, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1718, d5bxnN_, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1719, d5bxnH_, 0.8587, 1.61, 0.269, 222, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1720, p5bxnb_, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1721, p4ya0N_, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1722, p4y8tV_, 0.8587, 1.42, 0.281, 196, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1723, p4y8tH_, 0.8587, 1.42, 0.281, 196, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1724, p4y8kN_, 0.8587, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1725, d4qwkN_, 0.8587, 1.58, 0.262, 196, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1726, d4qwiN_, 0.8587, 1.58, 0.262, 196, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1727, d4qwfV_, 0.8587, 1.41, 0.276, 222, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1728, d4qwfH_, 0.8587, 1.41, 0.276, 222, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1729, d4qw7N_, 0.8587, 1.58, 0.262, 196, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1730, p4qw7b_, 0.8587, 1.58, 0.262, 196, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1731, d4qvqN_, 0.8587, 1.58, 0.262, 196, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1732, d4no8N_, 0.8587, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1733, p4no8b_, 0.8587, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1734, d4nnnN_, 0.8587, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH MG132
1735, d4nnnH_, 0.8587, 1.41, 0.276, 222, 192, YCP IN COMPLEX WITH MG132
1736, d4jt0N_, 0.8587, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1737, p4jt0b_, 0.8587, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1738, p4fzgb_, 0.8587, 1.58, 0.262, 196, 195, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1739, p3un8b_, 0.8587, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1740, d3krdT_, 0.8587, 2.40, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1741, d3hyeN_, 0.8587, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1742, d3hye2_, 0.8587, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1743, d3gptN_, 0.8587, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1744, d3gpt2_, 0.8587, 1.58, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1745, d5ts0K_, 0.8586, 2.46, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1746, d5thoZ_, 0.8586, 2.39, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1747, p5lzpP_, 0.8586, 2.39, 0.232, 221, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1748, p5gjqp_, 0.8586, 1.33, 0.251, 193, 191, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1749, d5ahjN_, 0.8586, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1750, p5ahjb_, 0.8586, 1.58, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1751, p4ya0b_, 0.8586, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1752, p4y74N_, 0.8586, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1753, p4qwkb_, 0.8586, 1.58, 0.262, 196, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1754, p4qwib_, 0.8586, 1.58, 0.262, 196, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1755, p4qvqb_, 0.8586, 1.58, 0.262, 196, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1756, d4nnnV_, 0.8586, 1.42, 0.276, 222, 192, YCP IN COMPLEX WITH MG132
1757, p4nnnb_, 0.8586, 1.58, 0.262, 196, 195, YCP IN COMPLEX WITH MG132
1758, d4hrdV_, 0.8586, 1.42, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1759, d3mg4N_, 0.8586, 1.58, 0.262, 196, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1760, d3krdE_, 0.8586, 2.39, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1761, p4y7wN_, 0.8585, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1762, p4y7wb_, 0.8585, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1763, p4y78b_, 0.8585, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1764, p4y74b_, 0.8585, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1765, d4qwrN_, 0.8585, 1.59, 0.262, 196, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1766, p4qwrb_, 0.8585, 1.59, 0.262, 196, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1767, d4qwgN_, 0.8585, 1.59, 0.262, 196, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1768, p4qwgb_, 0.8585, 1.59, 0.262, 196, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1769, d4qw6N_, 0.8585, 1.58, 0.262, 196, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1770, p4qw6b_, 0.8585, 1.58, 0.262, 196, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1771, d4qlqN_, 0.8585, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1772, d4qlqb_, 0.8585, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1773, d4hrcV_, 0.8585, 1.42, 0.276, 222, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1774, d3un8N_, 0.8585, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1775, d5tryK_, 0.8584, 2.47, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1776, d5trrJ_, 0.8584, 2.41, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1777, d5thoH_, 0.8584, 2.41, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1778, p5mp9i_, 0.8584, 1.31, 0.277, 194, 191, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1779, d5l5xN_, 0.8584, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1780, p5l5xb_, 0.8584, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1781, d5d0vV_, 0.8584, 1.42, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1782, d5d0vN_, 0.8584, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1783, d5d0vH_, 0.8584, 1.42, 0.276, 222, 192, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1784, p5d0vb_, 0.8584, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1785, p4y8tN_, 0.8584, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1786, p4y8tb_, 0.8584, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1787, p4y78N_, 0.8584, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1788, p4y6zb_, 0.8584, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1789, p4qwlb_, 0.8584, 1.58, 0.262, 196, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1790, d4qw5N_, 0.8584, 1.59, 0.262, 196, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1791, p4qw5b_, 0.8584, 1.58, 0.262, 196, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1792, d4no6N_, 0.8584, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1793, p4no6b_, 0.8584, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1794, d3krdJ_, 0.8584, 2.41, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1795, d5trrX_, 0.8583, 2.41, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1796, p5t0cGB_, 0.8583, 1.33, 0.251, 193, 191, 
1797, p5t0cAA_, 0.8583, 1.33, 0.251, 193, 191, 
1798, p4ya7N_, 0.8583, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1799, p4ya7b_, 0.8583, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1800, p4y8jN_, 0.8583, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1801, p4y80V_, 0.8583, 1.33, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1802, p4y80H_, 0.8583, 1.33, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1803, p4y77N_, 0.8583, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1804, d4qwlN_, 0.8583, 1.58, 0.262, 196, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1805, d4qwfN_, 0.8583, 1.59, 0.262, 196, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1806, p4qwfb_, 0.8583, 1.59, 0.262, 196, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1807, d4qw4N_, 0.8583, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH CARFILZOMIB
1808, p4qw4b_, 0.8583, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH CARFILZOMIB
1809, p4qbyV_, 0.8583, 1.33, 0.277, 194, 191, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1810, p4qbyH_, 0.8583, 1.33, 0.277, 194, 191, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1811, d4jsuN_, 0.8583, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1812, p4jsub_, 0.8583, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1813, d4hrcN_, 0.8583, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1814, p4fzcb_, 0.8583, 1.59, 0.262, 196, 195, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1815, d3shjN_, 0.8583, 1.59, 0.262, 196, 195, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1816, d3shj2_, 0.8583, 1.59, 0.262, 196, 195, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1817, d3krdN_, 0.8583, 2.41, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1818, d5tryV_, 0.8582, 2.46, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1819, p5dkib_, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1820, d5cz8N_, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1821, p5cz8b_, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1822, p5cgiN_, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1823, p5cgib_, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1824, p4ya9N_, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1825, p4ya9b_, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1826, p4y8sN_, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1827, p4y8sb_, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1828, p4y6zN_, 0.8582, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1829, d4qzxN_, 0.8582, 1.59, 0.262, 196, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1830, p4qzxb_, 0.8582, 1.59, 0.262, 196, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1831, p4qz0b_, 0.8582, 1.59, 0.262, 196, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1832, d4qwuN_, 0.8582, 1.59, 0.262, 196, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1833, p4qwub_, 0.8582, 1.59, 0.262, 196, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1834, d4fzcN_, 0.8582, 1.59, 0.262, 196, 195, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1835, d3mkaV_, 0.8582, 2.45, 0.229, 249, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1836, d3mg42_, 0.8582, 1.59, 0.262, 196, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1837, d3krd2_, 0.8582, 2.40, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1838, d5l52N_, 0.8581, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1839, p5l52b_, 0.8581, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1840, d5fgiN_, 0.8581, 1.59, 0.256, 213, 195, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1841, p5fgib_, 0.8581, 1.59, 0.256, 213, 195, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1842, d5dkiN_, 0.8581, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1843, p4y8lV_, 0.8581, 1.33, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1844, p4y8lb_, 0.8581, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1845, p4y75b_, 0.8581, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1846, p4y6zH_, 0.8581, 1.33, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1847, d4qzwN_, 0.8581, 1.59, 0.262, 196, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1848, p4qzwb_, 0.8581, 1.59, 0.262, 196, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1849, d4qz6N_, 0.8581, 1.59, 0.262, 196, 195, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1850, p4qz6b_, 0.8581, 1.59, 0.262, 196, 195, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1851, d4qz0N_, 0.8581, 1.59, 0.262, 196, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1852, d1g0uN_, 0.8581, 1.60, 0.256, 196, 195, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1853, d5trgJ_, 0.8580, 2.41, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1854, d5thoJ_, 0.8580, 2.42, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1855, p4y9zb_, 0.8580, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1856, p4y8jb_, 0.8580, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1857, p4y82b_, 0.8580, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1858, p4y7yH_, 0.8580, 1.33, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1859, p4y77b_, 0.8580, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1860, p4y6zV_, 0.8580, 1.33, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1861, d4qwxN_, 0.8580, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1862, p4qwxb_, 0.8580, 1.59, 0.262, 196, 195, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1863, d4inrN_, 0.8580, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1864, d3gpwN_, 0.8580, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1865, d3gpw2_, 0.8580, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1866, p5vfsI_, 0.8579, 1.45, 0.255, 193, 192, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1867, p4y9zN_, 0.8579, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1868, p4y8lN_, 0.8579, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1869, p4y84N_, 0.8579, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1870, p4y84b_, 0.8579, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1871, p4y82N_, 0.8579, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1872, p4y7yV_, 0.8579, 1.33, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1873, d4qz2N_, 0.8579, 1.59, 0.262, 196, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1874, p4qz2b_, 0.8579, 1.59, 0.262, 196, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1875, p4inrb_, 0.8579, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1876, d2f16N_, 0.8579, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1877, d2f162_, 0.8579, 1.59, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1878, d1g0u2_, 0.8579, 1.60, 0.256, 196, 195, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1879, d5ts0Y_, 0.8578, 2.44, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1880, d5tryZ_, 0.8578, 2.41, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1881, d5tryN_, 0.8578, 2.44, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1882, d5trsM_, 0.8578, 2.42, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1883, p4y8ib_, 0.8578, 1.59, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1884, d4qz7N_, 0.8578, 1.60, 0.262, 196, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1885, p4qz7b_, 0.8578, 1.60, 0.262, 196, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1886, d4qz3N_, 0.8578, 1.59, 0.262, 196, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1887, p4qz3b_, 0.8578, 1.59, 0.262, 196, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1888, d4qxjN_, 0.8578, 1.59, 0.262, 196, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1889, p4qxjb_, 0.8578, 1.59, 0.262, 196, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1890, d3mkaL_, 0.8578, 2.53, 0.228, 251, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1891, d3mg0N_, 0.8578, 1.60, 0.262, 196, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1892, d3mg02_, 0.8578, 1.60, 0.262, 196, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1893, d3krdC_, 0.8578, 2.42, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1894, d5ts0N_, 0.8577, 2.44, 0.234, 223, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1895, d5tryH_, 0.8577, 2.42, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1896, d5thoN_, 0.8577, 2.40, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1897, p4zzgH_, 0.8577, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1898, d4qz1N_, 0.8577, 1.60, 0.262, 196, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1899, p4qz1b_, 0.8577, 1.60, 0.262, 196, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1900, p4hrcb_, 0.8577, 1.60, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1901, p4y8hN_, 0.8576, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1902, p4y70V_, 0.8576, 1.34, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1903, p4y70H_, 0.8576, 1.34, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1904, p4qbyN_, 0.8576, 1.60, 0.262, 196, 195, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1905, p4qbyb_, 0.8576, 1.60, 0.262, 196, 195, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1906, p4y8pN_, 0.8575, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1907, p4y8iN_, 0.8575, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1908, p4y8hb_, 0.8575, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1909, p4y8gN_, 0.8575, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1910, p4y75N_, 0.8575, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1911, d4qz4N_, 0.8575, 1.60, 0.262, 196, 195, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1912, p4qz4b_, 0.8575, 1.60, 0.262, 196, 195, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1913, d4jsqN_, 0.8575, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1914, p4jsqb_, 0.8575, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1915, d4intN_, 0.8575, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1916, d3krdG_, 0.8575, 2.42, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1917, p5nifH_, 0.8574, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1918, p4y8qN_, 0.8574, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1919, p4y8pb_, 0.8574, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1920, d4qz5N_, 0.8574, 1.60, 0.262, 196, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1921, p4qz5b_, 0.8574, 1.60, 0.262, 196, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1922, p4gk7N_, 0.8574, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1923, d3wxrH_, 0.8574, 1.61, 0.262, 196, 195, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1924, d1rypH_, 0.8574, 1.60, 0.256, 205, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1925, d1jd2O_, 0.8574, 1.44, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1926, d1jd2H_, 0.8574, 1.44, 0.276, 222, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1927, d5thoX_, 0.8573, 2.42, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1928, p5lzpN_, 0.8573, 2.39, 0.232, 221, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1929, p4ya2N_, 0.8573, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1930, p4ya2b_, 0.8573, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1931, p4y8jV_, 0.8573, 1.34, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1932, p4y8jH_, 0.8573, 1.34, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1933, p4y8gb_, 0.8573, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1934, p4y7wH_, 0.8573, 1.34, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1935, p4gk7b_, 0.8573, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1936, d3wxrV_, 0.8573, 1.61, 0.256, 199, 195, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1937, d2fakN_, 0.8573, 1.60, 0.262, 196, 195, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1938, d2fak2_, 0.8573, 1.60, 0.262, 196, 195, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1939, p5vfsHA_, 0.8572, 1.46, 0.255, 193, 192, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1940, d5trsX_, 0.8572, 2.42, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1941, p4y8qb_, 0.8572, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1942, p4y81N_, 0.8572, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1943, p4y81b_, 0.8572, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1944, p4y7wV_, 0.8572, 1.34, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1945, p4y78V_, 0.8572, 1.34, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1946, p4y78H_, 0.8572, 1.34, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1947, p4y74V_, 0.8572, 1.35, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1948, p4y74H_, 0.8572, 1.35, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1949, p4nnwb_, 0.8572, 1.60, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1950, p4intb_, 0.8572, 1.60, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1951, d3krdZ_, 0.8572, 2.41, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1952, d3krdX_, 0.8572, 2.43, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1953, d5trsJ_, 0.8571, 2.43, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1954, p4y8ob_, 0.8571, 1.61, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1955, d4nnwN_, 0.8571, 1.60, 0.262, 196, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1956, d5ts0Z_, 0.8570, 2.41, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1957, d5tryM_, 0.8570, 2.42, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1958, p4y8oN_, 0.8570, 1.61, 0.262, 196, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1959, p4inub_, 0.8570, 1.61, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1960, d1rypV_, 0.8570, 1.61, 0.256, 205, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1961, d5tryX_, 0.8569, 2.42, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1962, d4nnwV_, 0.8569, 1.44, 0.276, 222, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1963, d4nnwH_, 0.8569, 1.44, 0.276, 222, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1964, d4inuN_, 0.8569, 1.61, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1965, p4zzgV_, 0.8568, 1.61, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1966, d3dy3N_, 0.8568, 1.62, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1967, d3dy32_, 0.8568, 1.62, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1968, d2fhhH_, 0.8568, 2.43, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1969, p2fhgX_, 0.8568, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
1970, p2fhgP_, 0.8568, 2.44, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
1971, d5ts0X_, 0.8567, 2.43, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1972, d5ts0M_, 0.8567, 2.43, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1973, d5ts0J_, 0.8567, 2.43, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1974, p5nifV_, 0.8567, 1.61, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1975, d3dy4N_, 0.8567, 1.62, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1976, d3dy42_, 0.8567, 1.62, 0.262, 196, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1977, d2fhhX_, 0.8567, 2.43, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1978, d2fhhG_, 0.8567, 2.43, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1979, p2fhgH_, 0.8567, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
1980, p2fhgC_, 0.8567, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
1981, d5bxlV_, 0.8566, 1.61, 0.269, 222, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1982, d5bxlH_, 0.8566, 1.61, 0.269, 222, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1983, p4ya2V_, 0.8566, 1.35, 0.277, 194, 191, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1984, p4ya2H_, 0.8566, 1.35, 0.277, 194, 191, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1985, p3un4N_, 0.8566, 1.61, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1986, p3un4b_, 0.8566, 1.61, 0.262, 196, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1987, d3mkaP_, 0.8566, 2.42, 0.230, 250, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1988, d3mkaE_, 0.8566, 2.45, 0.229, 248, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1989, d2fhhZ_, 0.8566, 2.43, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1990, p2fhgV_, 0.8566, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
1991, p2fhgN_, 0.8566, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
1992, p2fhgG_, 0.8566, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
1993, p4y9zV_, 0.8565, 1.36, 0.277, 194, 191, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1994, p4y9zH_, 0.8565, 1.35, 0.277, 194, 191, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1995, d3mkaR_, 0.8565, 2.43, 0.230, 246, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1996, d3krdH_, 0.8565, 2.43, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1997, d2fhhP_, 0.8565, 2.43, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1998, d2fhhC_, 0.8565, 2.43, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1999, p2fhgZ_, 0.8565, 2.45, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2000, p2fhgJ_, 0.8565, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2001, p2fhg2_, 0.8565, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2002, p4y8sH_, 0.8564, 1.36, 0.283, 194, 191, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2003, d3mfeP_, 0.8564, 2.42, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2004, d2fhhR_, 0.8564, 2.43, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2005, d2fhhN_, 0.8564, 2.43, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2006, d2fhhE_, 0.8564, 2.43, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2007, p2fhgR_, 0.8564, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2008, p2fhgL_, 0.8564, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2009, p2fhgE_, 0.8564, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2010, p4ya7V_, 0.8563, 1.36, 0.283, 194, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2011, p4ya7H_, 0.8563, 1.36, 0.283, 194, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2012, p4y8sV_, 0.8563, 1.36, 0.283, 194, 191, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2013, d3krdP_, 0.8563, 2.44, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
2014, d2fhhT_, 0.8563, 2.43, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2015, p2fhgT_, 0.8563, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2016, d1jd2N_, 0.8563, 1.62, 0.256, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2017, d1g65N_, 0.8563, 1.61, 0.262, 196, 195, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2018, d2fhhL_, 0.8562, 2.44, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2019, d2fhhJ_, 0.8562, 2.44, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2020, d2fhh2_, 0.8562, 2.44, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2021, d4g4sH_, 0.8561, 1.63, 0.256, 196, 195, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2022, d1jd2U_, 0.8561, 1.63, 0.256, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2023, d1g652_, 0.8561, 1.61, 0.262, 196, 195, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2024, d3okjN_, 0.8560, 1.62, 0.262, 196, 195, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2025, d2fhhV_, 0.8560, 2.44, 0.230, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2026, d3mkaH_, 0.8559, 2.42, 0.230, 249, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2027, d3mkaG_, 0.8558, 2.43, 0.230, 251, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2028, p4ya9V_, 0.8557, 1.37, 0.283, 194, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2029, p4ya9H_, 0.8557, 1.37, 0.283, 194, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2030, d3gpj2_, 0.8557, 1.62, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2031, d3bdm1_, 0.8557, 1.63, 0.262, 196, 195, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2032, p4gk7V_, 0.8556, 1.37, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2033, p4gk7H_, 0.8556, 1.37, 0.277, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2034, d3gpjN_, 0.8556, 1.63, 0.262, 196, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2035, d3bdmN_, 0.8556, 1.63, 0.262, 196, 195, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2036, d5tryJ_, 0.8554, 2.44, 0.235, 222, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
2037, d3mkaT_, 0.8554, 2.44, 0.230, 250, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2038, d3mkaN_, 0.8554, 2.50, 0.229, 252, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2039, d3mka2_, 0.8554, 2.44, 0.230, 246, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2040, p5t0gO_, 0.8552, 1.38, 0.251, 193, 191, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2041, p5mp9h_, 0.8552, 1.63, 0.256, 196, 195, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2042, p5vfoO_, 0.8550, 1.50, 0.260, 193, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2043, p5a5b2_, 0.8550, 1.52, 0.276, 197, 192, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2044, p4v7oV_, 0.8550, 1.64, 0.251, 196, 195, 
2045, p4cr32_, 0.8550, 1.52, 0.276, 197, 192, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2046, p3jcpRA_, 0.8549, 1.46, 0.276, 196, 192, 
2047, p3jcpD_, 0.8549, 1.46, 0.276, 196, 192, 
2048, d2zcyN_, 0.8548, 1.64, 0.262, 196, 195, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2049, d2zcy1_, 0.8548, 1.64, 0.262, 196, 195, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2050, p5mpa2_, 0.8547, 1.45, 0.276, 196, 192, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2051, p5m32V_, 0.8547, 1.39, 0.251, 193, 191, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2052, p5m32H_, 0.8547, 1.39, 0.251, 193, 191, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2053, p4v7oPA_, 0.8547, 1.64, 0.251, 196, 195, 
2054, p4v7oH_, 0.8547, 1.64, 0.251, 196, 195, 
2055, d3mfeC_, 0.8547, 2.42, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2056, p5vfoo_, 0.8546, 1.51, 0.260, 193, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2057, p5mp91_, 0.8546, 1.64, 0.256, 196, 195, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2058, d3d292_, 0.8545, 1.64, 0.262, 196, 195, PROTEASOME INHIBITION BY FELLUTAMIDE B
2059, p5vfpGA_, 0.8544, 1.52, 0.255, 193, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2060, d3mfeH_, 0.8544, 2.41, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2061, d3d29N_, 0.8544, 1.64, 0.262, 196, 195, PROTEASOME INHIBITION BY FELLUTAMIDE B
2062, d3mkaJ_, 0.8542, 2.45, 0.230, 252, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2063, d3mkaC_, 0.8541, 2.45, 0.230, 250, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2064, p5vfqHA_, 0.8539, 1.51, 0.260, 193, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2065, d1z7qV1, 0.8539, 1.58, 0.253, 195, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2066, d1z7qH1, 0.8539, 1.58, 0.253, 195, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2067, p5vfpI_, 0.8538, 1.51, 0.260, 193, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2068, p1fntV_, 0.8538, 1.65, 0.256, 196, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2069, p5vfqI_, 0.8537, 1.51, 0.260, 193, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2070, p1fntH_, 0.8536, 1.65, 0.256, 196, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2071, p5ln35_, 0.8534, 1.69, 0.663, 195, 193, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2072, p5vfro_, 0.8532, 1.54, 0.255, 193, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2073, d3mfeG_, 0.8532, 2.46, 0.235, 222, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2074, d3mfeV_, 0.8528, 2.56, 0.233, 224, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2075, p3jcpC_, 0.8528, 1.64, 0.262, 205, 195, 
2076, p3jcpQA_, 0.8527, 1.65, 0.262, 205, 195, 
2077, p5vfrO_, 0.8526, 1.53, 0.260, 193, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2078, p5mpcI_, 0.8523, 1.50, 0.276, 194, 192, 
2079, p5mpbH_, 0.8519, 1.66, 0.262, 196, 195, 
2080, p5mpah_, 0.8515, 1.69, 0.262, 196, 195, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2081, d3okj2_, 0.8514, 1.62, 0.263, 195, 194, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2082, p5mpa1_, 0.8510, 1.69, 0.256, 196, 195, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2083, d3l5qD1, 0.8507, 1.64, 0.253, 195, 194,  
2084, d1vsyV1, 0.8505, 1.64, 0.253, 195, 194,  
2085, d3l5qB1, 0.8504, 1.64, 0.253, 195, 194,  
2086, d1vsyH1, 0.8504, 1.64, 0.253, 195, 194,  
2087, p5mpbV_, 0.8502, 1.67, 0.262, 196, 195, 
2088, p4cr42_, 0.8497, 1.55, 0.276, 197, 192, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2089, p3jcoC_, 0.8497, 1.68, 0.262, 205, 195, 
2090, d3mfeT_, 0.8496, 2.45, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2091, p3jcoQA_, 0.8495, 1.68, 0.262, 205, 195, 
2092, p5t0jO_, 0.8492, 1.73, 0.254, 195, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2093, p5mpcV_, 0.8492, 1.71, 0.262, 196, 195, 
2094, p3jcoRA_, 0.8484, 1.56, 0.276, 196, 192, 
2095, p3jcoD_, 0.8484, 1.56, 0.276, 196, 192, 
2096, d2h6jI1, 0.8479, 2.25, 0.265, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2097, d2h6jK1, 0.8478, 2.24, 0.265, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2098, d2h6jH1, 0.8478, 2.24, 0.265, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2099, d3mfe2_, 0.8477, 2.48, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2100, d2h6jM1, 0.8477, 2.25, 0.265, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2101, d2h6jL1, 0.8477, 2.25, 0.265, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2102, d4cr22_, 0.8476, 1.63, 0.276, 223, 192, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2103, d2h6jJ1, 0.8475, 2.25, 0.265, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2104, d2h6jN1, 0.8474, 2.25, 0.265, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2105, d3mkaZ_, 0.8471, 2.51, 0.230, 245, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2106, d3mfeZ_, 0.8471, 2.49, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2107, d3mfeR_, 0.8469, 2.48, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2108, d3mfeN_, 0.8468, 2.48, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2109, d3mfeJ_, 0.8468, 2.49, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2110, d3mkaX_, 0.8465, 2.51, 0.230, 249, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2111, d3mfeX_, 0.8464, 2.49, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2112, d3mfeE_, 0.8463, 2.49, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2113, d3mfeL_, 0.8457, 2.49, 0.232, 221, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2114, p5mpcH_, 0.8451, 1.77, 0.262, 196, 195, 
2115, d1q5rM_, 0.8451, 2.37, 0.264, 251, 201, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2116, d1q5rL_, 0.8451, 2.38, 0.264, 251, 201, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2117, d1q5rI_, 0.8451, 2.37, 0.264, 251, 201, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2118, d1q5rH_, 0.8451, 2.38, 0.264, 251, 201, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2119, d1q5rN_, 0.8450, 2.38, 0.264, 251, 201, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2120, d1q5rK_, 0.8450, 2.38, 0.264, 251, 201, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2121, d1q5rJ_, 0.8450, 2.38, 0.264, 251, 201, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2122, p5mpcW_, 0.8441, 1.62, 0.276, 196, 192, 
2123, p5vfon_, 0.8439, 1.46, 0.274, 191, 190, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2124, p5a0qW_, 0.8437, 1.58, 0.257, 198, 191, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2125, p5a0qI_, 0.8437, 1.58, 0.257, 198, 191, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2126, p5fmgZ_, 0.8435, 1.35, 0.473, 189, 188, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2127, p5fmgL_, 0.8435, 1.35, 0.473, 189, 188, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2128, p5vfpFA_, 0.8430, 1.48, 0.274, 191, 190, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2129, p5vfoN_, 0.8426, 1.49, 0.274, 191, 190, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2130, p5vfqGA_, 0.8424, 1.49, 0.274, 191, 190, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2131, p5t0hO_, 0.8422, 1.82, 0.254, 195, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2132, p5vfqH_, 0.8417, 1.50, 0.274, 191, 190, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2133, p5wvkH_, 0.8416, 1.82, 0.256, 196, 195, 
2134, p5wvkA_, 0.8412, 1.81, 0.256, 196, 195, 
2135, p5vfpH_, 0.8412, 1.51, 0.274, 191, 190, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2136, d3unfM_, 0.8410, 2.20, 0.230, 216, 200, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2137, p5vfuY_, 0.8407, 1.51, 0.274, 191, 190, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2138, p5vftN_, 0.8407, 1.51, 0.274, 191, 190, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2139, d4g4sN_, 0.8407, 2.32, 0.178, 233, 202, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2140, d3h6fR_, 0.8407, 2.86, 0.223, 222, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2141, p5wviFA_, 0.8405, 1.63, 0.276, 196, 192, 
2142, p5vfsH_, 0.8404, 1.51, 0.274, 191, 190, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2143, p5vfrn_, 0.8404, 1.52, 0.274, 191, 190, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2144, d5le5M_, 0.8404, 2.19, 0.230, 216, 200, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2145, p5a5b1_, 0.8404, 1.81, 0.262, 205, 195, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2146, p4cr31_, 0.8404, 1.81, 0.262, 205, 195, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2147, d3h6iR_, 0.8403, 2.86, 0.223, 222, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2148, d4r3oN_, 0.8402, 2.20, 0.230, 217, 200, HUMAN CONSTITUTIVE 20S PROTEASOME
2149, d4r3o2_, 0.8402, 2.19, 0.230, 217, 200, HUMAN CONSTITUTIVE 20S PROTEASOME
2150, d3sdkM_, 0.8400, 2.35, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2151, d5lf7M_, 0.8399, 2.19, 0.230, 216, 200, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2152, d5lf4M_, 0.8398, 2.19, 0.230, 216, 200, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2153, p5vfrN_, 0.8397, 1.53, 0.274, 191, 190, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2154, d3sdk1_, 0.8396, 2.35, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2155, d5lf3M_, 0.8394, 2.20, 0.230, 216, 200, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2156, d4r67N_, 0.8394, 2.20, 0.230, 217, 200, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2157, d4r672_, 0.8394, 2.20, 0.230, 217, 200, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2158, d4eu22_, 0.8394, 2.34, 0.178, 233, 202, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2159, d3mg41_, 0.8394, 2.34, 0.178, 233, 202, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2160, p5mpbI_, 0.8393, 1.86, 0.275, 196, 193, 
2161, d5fggM_, 0.8393, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2162, d1rypN_, 0.8393, 2.34, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2163, d1ryp2_, 0.8393, 2.33, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2164, d5lf1M_, 0.8392, 2.20, 0.230, 216, 200, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2165, d5l5rM_, 0.8392, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2166, d5bxnM_, 0.8392, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2167, d3mg61_, 0.8392, 2.36, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2168, d2fakM_, 0.8392, 2.34, 0.178, 233, 202, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2169, d5l5uM_, 0.8391, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2170, d3unb3_, 0.8391, 2.20, 0.230, 216, 200, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2171, d2fak1_, 0.8391, 2.34, 0.178, 233, 202, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2172, p5mpbW_, 0.8390, 1.66, 0.276, 196, 192, 
2173, d5l5bM_, 0.8390, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2174, d4qvnM_, 0.8390, 2.34, 0.178, 233, 202, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2175, d3gpjM_, 0.8390, 2.34, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2176, d3gpj1_, 0.8390, 2.34, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2177, d3dy31_, 0.8390, 2.34, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2178, d4qwuM_, 0.8389, 2.33, 0.178, 233, 202, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2179, d3mg71_, 0.8389, 2.37, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2180, d3dy3M_, 0.8389, 2.34, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2181, d2zcyM_, 0.8389, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2182, d2zcy0_, 0.8389, 2.34, 0.178, 233, 202, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2183, p5vfuMA_, 0.8388, 1.53, 0.274, 191, 190, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2184, p5vftn_, 0.8388, 1.53, 0.274, 191, 190, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2185, d5lexM_, 0.8388, 2.20, 0.230, 216, 200, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2186, d4ya4M_, 0.8387, 2.35, 0.178, 229, 202, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2187, d4r18M_, 0.8387, 2.36, 0.178, 233, 202, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2188, d1g0u1_, 0.8387, 2.35, 0.178, 233, 202, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2189, d5m2bM_, 0.8386, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2190, d5l66M_, 0.8386, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2191, d5l63M_, 0.8386, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2192, d5l61M_, 0.8386, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2193, d5l5yM_, 0.8386, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2194, d5bxlM_, 0.8386, 2.36, 0.178, 229, 202, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2195, d5ahjM_, 0.8386, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2196, d4qltM_, 0.8386, 2.34, 0.178, 233, 202, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2197, d3mg81_, 0.8386, 2.37, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2198, d3bdmM_, 0.8386, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2199, d3bdm0_, 0.8386, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2200, d5l6aM_, 0.8385, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2201, d5l5sM_, 0.8385, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2202, d5l65M_, 0.8384, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2203, d5l62M_, 0.8384, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2204, d5l5zM_, 0.8384, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2205, d5l5tM_, 0.8384, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2206, d5l5dM_, 0.8384, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2207, d5d0wM_, 0.8384, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2208, d4r17M_, 0.8384, 2.36, 0.178, 233, 202, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2209, d4qz7M_, 0.8384, 2.35, 0.178, 232, 202, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2210, d4qz0M_, 0.8384, 2.35, 0.178, 233, 202, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2211, d4qw6M_, 0.8384, 2.34, 0.178, 233, 202, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2212, d4fzgM_, 0.8384, 2.35, 0.178, 233, 202, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2213, d3mg7M_, 0.8384, 2.37, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2214, d3gpwM_, 0.8384, 2.34, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2215, d3gpw1_, 0.8384, 2.34, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2216, d5lajM_, 0.8383, 2.36, 0.178, 228, 202, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2217, d5l6bM_, 0.8383, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2218, d5l5wM_, 0.8383, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2219, d5l5pM_, 0.8383, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2220, d5l54M_, 0.8383, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2221, d5d0sM_, 0.8383, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2222, d5czaM_, 0.8383, 2.36, 0.178, 229, 202, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2223, d4qwfM_, 0.8383, 2.34, 0.178, 233, 202, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2224, d4qvlM_, 0.8383, 2.35, 0.178, 233, 202, YCP IN COMPLEX WITH BORTEZOMIB
2225, d4qv5M_, 0.8383, 2.35, 0.178, 233, 202, YCP BETA5-M45I MUTANT
2226, d4quyM_, 0.8383, 2.35, 0.178, 233, 202, YCP BETA5-A49S-MUTANT
2227, d4no8M_, 0.8383, 2.34, 0.178, 233, 202, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2228, d1g0uM_, 0.8383, 2.35, 0.178, 233, 202, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2229, d5l6cM_, 0.8382, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2230, d5l64M_, 0.8382, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2231, d5l5oM_, 0.8382, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2232, d5l5jM_, 0.8382, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2233, d5l5hM_, 0.8382, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2234, d5jhsM_, 0.8382, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2235, d4qwlM_, 0.8382, 2.34, 0.178, 233, 202, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2236, d4qv9M_, 0.8382, 2.35, 0.178, 233, 202, YCP BETA5-C63F MUTANT
2237, d3oev1_, 0.8382, 2.37, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2238, d1jd2T_, 0.8382, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2239, d5l60M_, 0.8381, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2240, d5l55M_, 0.8381, 2.35, 0.178, 228, 202, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2241, d5l52M_, 0.8381, 2.35, 0.178, 225, 202, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2242, d5fgiM_, 0.8381, 2.35, 0.178, 232, 202, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2243, d5fgaM_, 0.8381, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2244, d5dkjM_, 0.8381, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2245, d5d0tM_, 0.8381, 2.36, 0.178, 231, 202, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2246, d4y8rM_, 0.8381, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2247, d4qv6M_, 0.8381, 2.35, 0.178, 233, 202, YCP BETA5-A49V MUTANT
2248, d4qv0M_, 0.8381, 2.36, 0.178, 233, 202, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2249, d3shjM_, 0.8381, 2.35, 0.178, 233, 202, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2250, d3shj1_, 0.8381, 2.35, 0.178, 233, 202, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2251, d3sdi1_, 0.8381, 2.37, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2252, d3mg4M_, 0.8381, 2.36, 0.178, 233, 202, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2253, d3hyeM_, 0.8381, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2254, d3hye1_, 0.8381, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2255, d1jd2M_, 0.8381, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2256, p5vfsGA_, 0.8380, 1.54, 0.274, 191, 190, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2257, d5l67M_, 0.8380, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2258, d5l5qM_, 0.8380, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2259, d5fgfM_, 0.8380, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2260, d5fgeM_, 0.8380, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2261, d5fg7M_, 0.8380, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2262, d5cz9M_, 0.8380, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2263, d4qw5M_, 0.8380, 2.35, 0.178, 233, 202, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2264, d4qw1M_, 0.8380, 2.35, 0.178, 233, 202, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2265, d4qvqM_, 0.8380, 2.35, 0.178, 233, 202, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2266, d4qvpM_, 0.8380, 2.35, 0.178, 233, 202, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2267, d4qv7M_, 0.8380, 2.36, 0.178, 233, 202, YCP BETA5-A50V MUTANT
2268, d4qv3M_, 0.8380, 2.36, 0.178, 233, 202, YCP BETA5-M45V MUTANT
2269, d4qv1M_, 0.8380, 2.36, 0.178, 233, 202, YCP BETA5-M45A MUTANT
2270, d4q1sM_, 0.8380, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2271, d3unbM_, 0.8380, 2.23, 0.230, 216, 200, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2272, d3e47M_, 0.8380, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2273, d3e471_, 0.8380, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2274, d2fnyM_, 0.8380, 2.36, 0.178, 233, 202,  
2275, d2fny1_, 0.8380, 2.36, 0.178, 233, 202,  
2276, d5laiM_, 0.8379, 2.37, 0.178, 233, 202, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2277, d5l69M_, 0.8379, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2278, d5l68M_, 0.8379, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2279, d5l5vM_, 0.8379, 2.37, 0.178, 233, 202,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2280, d5l5fM_, 0.8379, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2281, d5jhrM_, 0.8379, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2282, d5fhsM_, 0.8379, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2283, d5d0vM_, 0.8379, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2284, d5cgfM_, 0.8379, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2285, d4qz1M_, 0.8379, 2.35, 0.178, 231, 202, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2286, d4qw7M_, 0.8379, 2.35, 0.178, 233, 202, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2287, d4qv4M_, 0.8379, 2.36, 0.178, 233, 202, YCP BETA5-M45T MUTANT
2288, d4eu2N_, 0.8379, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2289, d3oeu1_, 0.8379, 2.37, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2290, d3nzjM_, 0.8379, 2.37, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2291, d3nzj1_, 0.8379, 2.37, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2292, d3mg8M_, 0.8379, 2.37, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2293, d3d29M_, 0.8379, 2.34, 0.178, 233, 202, PROTEASOME INHIBITION BY FELLUTAMIDE B
2294, d3d291_, 0.8379, 2.34, 0.178, 233, 202, PROTEASOME INHIBITION BY FELLUTAMIDE B
2295, d1iruN_, 0.8379, 2.23, 0.230, 217, 200, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2296, d1iru2_, 0.8379, 2.23, 0.230, 217, 200, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2297, p5wvkI_, 0.8378, 1.61, 0.277, 194, 191, 
2298, d5l5xM_, 0.8378, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2299, d5l5iM_, 0.8378, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2300, d5fgdM_, 0.8378, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2301, d5d0zM_, 0.8378, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2302, d4ya1M_, 0.8378, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2303, d4r02M_, 0.8378, 2.37, 0.178, 233, 202, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2304, d4qzzM_, 0.8378, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH OMURALIDE
2305, d4qvwM_, 0.8378, 2.36, 0.178, 233, 202, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2306, d4qlvM_, 0.8378, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2307, d3wxrN_, 0.8378, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2308, d3wxr2_, 0.8378, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2309, d3tddM_, 0.8378, 2.37, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2310, d3tdd1_, 0.8378, 2.37, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2311, d3okjM_, 0.8378, 2.35, 0.178, 233, 202, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2312, d5lttM_, 0.8377, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2313, d5cz7M_, 0.8377, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2314, d4y9yM_, 0.8377, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2315, d4qz4M_, 0.8377, 2.35, 0.178, 225, 202, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2316, d4qv8M_, 0.8377, 2.36, 0.178, 233, 202, YCP BETA5-C52F MUTANT
2317, d4qlsM_, 0.8377, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2318, d4no6M_, 0.8377, 2.35, 0.178, 233, 202, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2319, d4ltcM_, 0.8377, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2320, d4intM_, 0.8377, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2321, d4inrM_, 0.8377, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2322, d3nzwM_, 0.8377, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2323, d3nzw1_, 0.8377, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2324, d3mg01_, 0.8377, 2.36, 0.178, 233, 202, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2325, d2f16M_, 0.8377, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2326, d2f161_, 0.8377, 2.35, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2327, d5bouM_, 0.8376, 2.37, 0.178, 229, 202, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2328, d4qw4M_, 0.8376, 2.35, 0.178, 233, 202, YCP IN COMPLEX WITH CARFILZOMIB
2329, d4qvmM_, 0.8376, 2.36, 0.178, 233, 202, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2330, d4qluM_, 0.8376, 2.35, 0.178, 233, 202, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2331, d4lqiM_, 0.8376, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2332, p4cr41_, 0.8376, 1.83, 0.256, 205, 195, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2333, d3oevM_, 0.8376, 2.38, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2334, d3mg6M_, 0.8376, 2.38, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2335, d3gptM_, 0.8376, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2336, d3gpt1_, 0.8376, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2337, d5l5aM_, 0.8375, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2338, d5cz6M_, 0.8375, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2339, d4qz6M_, 0.8375, 2.35, 0.178, 233, 202, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2340, d4qvyM_, 0.8375, 2.37, 0.178, 233, 202, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2341, d4nnnM_, 0.8375, 2.35, 0.178, 233, 202, YCP IN COMPLEX WITH MG132
2342, d3dy41_, 0.8375, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2343, d5l5eM_, 0.8374, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2344, d5cz8M_, 0.8374, 2.35, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2345, d4qwrM_, 0.8374, 2.36, 0.178, 233, 202, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2346, d4quxM_, 0.8374, 2.37, 0.178, 233, 202, YCP BETA5-A49T-MUTANT
2347, d4nnwM_, 0.8374, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2348, d4j70M_, 0.8374, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2349, d3un8M_, 0.8374, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2350, d3sdiM_, 0.8374, 2.38, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2351, d3oeuM_, 0.8374, 2.38, 0.178, 233, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2352, d3nzxM_, 0.8374, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2353, d3nzx1_, 0.8374, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2354, d3mg0M_, 0.8374, 2.36, 0.178, 233, 202, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2355, d3dy4M_, 0.8374, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2356, d5fg9M_, 0.8373, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2357, d4r00M_, 0.8373, 2.37, 0.178, 233, 202, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2358, d4qz2M_, 0.8373, 2.36, 0.178, 233, 202, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2359, d4qlqM_, 0.8373, 2.37, 0.178, 233, 202, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2360, d4jsqM_, 0.8373, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2361, d4fzcM_, 0.8373, 2.37, 0.178, 233, 202, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2362, d1g65M_, 0.8373, 2.37, 0.178, 233, 202, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2363, d4z1lM_, 0.8372, 2.37, 0.178, 229, 202, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2364, d4qz3M_, 0.8371, 2.36, 0.178, 233, 202, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2365, d4qwxM_, 0.8371, 2.36, 0.178, 233, 202, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2366, d4inuM_, 0.8371, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2367, d1g651_, 0.8371, 2.37, 0.178, 233, 202, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2368, d5dkiM_, 0.8370, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2369, d5cz5M_, 0.8370, 2.36, 0.178, 233, 202, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2370, d4rurM_, 0.8370, 2.38, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2371, d4qz5M_, 0.8370, 2.35, 0.178, 225, 202, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2372, d4no9M_, 0.8370, 2.37, 0.178, 233, 202, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2373, d4no1M_, 0.8370, 2.37, 0.178, 233, 202, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2374, p4y77a_, 0.8369, 2.28, 0.174, 223, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2375, d4qzwM_, 0.8369, 2.37, 0.178, 233, 202, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2376, d4qwkM_, 0.8369, 2.36, 0.178, 230, 202, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2377, d4qwiM_, 0.8369, 2.36, 0.178, 233, 202, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2378, d4qw3M_, 0.8369, 2.37, 0.178, 233, 202, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2379, d5d0xM_, 0.8367, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2380, d4qw0M_, 0.8367, 2.38, 0.178, 233, 202, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2381, d4jsuM_, 0.8367, 2.37, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2382, d4hrdM_, 0.8367, 2.36, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2383, d4cr21_, 0.8367, 1.89, 0.262, 205, 195, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2384, p5wviC_, 0.8366, 1.61, 0.277, 194, 191, 
2385, d4jt0M_, 0.8366, 2.38, 0.178, 233, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2386, d2gpl1_, 0.8366, 2.38, 0.178, 233, 202, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2387, d4qwsM_, 0.8365, 2.37, 0.178, 233, 202, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2388, d2gplM_, 0.8365, 2.39, 0.178, 233, 202, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2389, d4hnpM_, 0.8364, 2.37, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2390, d4qzxM_, 0.8362, 2.37, 0.178, 231, 202, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2391, d4qxjM_, 0.8362, 2.37, 0.178, 228, 202, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2392, d4qwgM_, 0.8362, 2.38, 0.178, 233, 202, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2393, d3h6fV_, 0.8362, 2.86, 0.224, 221, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2394, d3h6iV_, 0.8361, 2.87, 0.224, 220, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2395, d4qwjM_, 0.8360, 2.37, 0.178, 230, 202, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2396, p5wvkM_, 0.8359, 1.84, 0.197, 222, 193, 
2397, d5cz4M_, 0.8359, 2.39, 0.178, 229, 202, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2398, p4y8ma_, 0.8358, 2.20, 0.175, 222, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2399, d4qvvM_, 0.8358, 2.38, 0.178, 233, 202, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2400, p4y8na_, 0.8357, 2.33, 0.174, 223, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2401, p4v7oAA_, 0.8355, 2.04, 0.196, 222, 194, 
2402, d3l5q3_, 0.8355, 2.04, 0.196, 222, 194,  
2403, d4y8mM_, 0.8354, 2.22, 0.175, 222, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2404, p4v7oM_, 0.8353, 2.04, 0.196, 222, 194, 
2405, p4v7oIB_, 0.8353, 2.04, 0.196, 222, 194, 
2406, d3l5qQ_, 0.8353, 2.04, 0.196, 222, 194,  
2407, d1vsyM_, 0.8353, 2.04, 0.196, 222, 194,  
2408, d1vsy1_, 0.8353, 2.04, 0.196, 222, 194,  
2409, p4y8oM_, 0.8351, 2.12, 0.176, 222, 199, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2410, d4hrcM_, 0.8351, 2.38, 0.178, 233, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2411, p3hf9e_, 0.8351, 2.55, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2412, p4y8qM_, 0.8350, 2.21, 0.175, 222, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2413, p4y8qa_, 0.8350, 2.21, 0.175, 222, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2414, p3hf9r_, 0.8350, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2415, d3hf9P_, 0.8349, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2416, d1z7qN1, 0.8349, 2.42, 0.178, 233, 202, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2417, d3hf9X_, 0.8348, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2418, p4y8oa_, 0.8347, 2.21, 0.175, 222, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2419, d3hf94_, 0.8347, 2.57, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2420, p3hf9z_, 0.8346, 2.55, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2421, p3hf9l_, 0.8346, 2.55, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2422, d3hf9G_, 0.8346, 2.55, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2423, p3hf9v_, 0.8345, 2.68, 0.227, 218, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2424, p3hf9n_, 0.8345, 2.55, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2425, d3hf9H_, 0.8345, 2.55, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2426, d3hf9Z_, 0.8344, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2427, p3hf9x_, 0.8344, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2428, d5l5wZ_, 0.8343, 1.88, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2429, d5l5wL_, 0.8343, 1.88, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2430, d3l5qR_, 0.8343, 2.39, 0.178, 233, 202,  
2431, d3l5q4_, 0.8343, 2.39, 0.178, 233, 202,  
2432, p3hf9t_, 0.8343, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2433, d1vsy2_, 0.8343, 2.39, 0.178, 233, 202,  
2434, d5cgfL_, 0.8342, 2.05, 0.196, 222, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2435, p4ya3Z_, 0.8342, 2.05, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2436, p4ya3L_, 0.8342, 2.05, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2437, p4y8uZ_, 0.8342, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2438, p4y8uL_, 0.8342, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2439, d3hf9J_, 0.8342, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2440, p4y8tZ_, 0.8341, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2441, p4y8tL_, 0.8341, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2442, d3hf9R_, 0.8341, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2443, p3hf9p_, 0.8341, 2.57, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2444, d3hf92_, 0.8341, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2445, d1vsyN_, 0.8340, 2.39, 0.178, 233, 202,  
2446, p4zzg1_, 0.8339, 2.05, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2447, d3hf9L_, 0.8339, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2448, p3hf9j_, 0.8339, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2449, p5mpbN_, 0.8338, 2.20, 0.175, 222, 200, 
2450, d5lajZ_, 0.8338, 1.89, 0.197, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2451, d3hf9T_, 0.8338, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2452, p3hf9g_, 0.8338, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2453, d3hf9C_, 0.8338, 2.57, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2454, p5wvkF_, 0.8337, 2.03, 0.196, 222, 194, 
2455, d5lajL_, 0.8337, 1.89, 0.197, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2456, d5l5bZ_, 0.8337, 1.89, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2457, d5l5bL_, 0.8337, 1.89, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2458, d5fgfZ_, 0.8337, 1.88, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2459, d5fgfL_, 0.8337, 1.88, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2460, p4ya0Z_, 0.8337, 2.06, 0.191, 222, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2461, p4ya0L_, 0.8337, 2.06, 0.191, 222, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2462, p4y6aL_, 0.8337, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2463, p4y69Z_, 0.8337, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2464, p4y69L_, 0.8337, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2465, d3hf9N_, 0.8337, 2.56, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2466, d1z7qM1, 0.8337, 2.04, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2467, d5laiL_, 0.8336, 2.06, 0.196, 222, 194, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2468, d5l65Z_, 0.8336, 1.89, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2469, d4z1lZ_, 0.8336, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2470, d4z1lL_, 0.8336, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2471, p4y6aZ_, 0.8336, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2472, d4j70Z_, 0.8336, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2473, p1z7qa_, 0.8336, 2.05, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2474, d5l65L_, 0.8335, 1.89, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2475, d5l5rZ_, 0.8335, 1.89, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2476, d5l5rL_, 0.8335, 1.89, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2477, d5l5aZ_, 0.8335, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2478, d5l5aL_, 0.8335, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2479, d5fgdZ_, 0.8335, 1.88, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2480, d5fgdL_, 0.8335, 1.88, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2481, d5cgfZ_, 0.8335, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2482, d5bouZ_, 0.8335, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2483, d5bouL_, 0.8335, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2484, d5m2bZ_, 0.8334, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2485, d5m2bL_, 0.8334, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2486, d5fgaZ_, 0.8334, 2.06, 0.191, 222, 194, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2487, p4y8nZ_, 0.8334, 2.06, 0.191, 222, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2488, p4y8nL_, 0.8334, 2.06, 0.191, 222, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2489, d5l5eZ_, 0.8333, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2490, d5l5eL_, 0.8333, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2491, d5fgaL_, 0.8333, 2.06, 0.191, 222, 194, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2492, p4ya5Z_, 0.8333, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2493, p4ya5L_, 0.8333, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2494, d4y8rZ_, 0.8333, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2495, d4y8rL_, 0.8333, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2496, d4j70L_, 0.8333, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2497, p5t0cZ_, 0.8332, 1.62, 0.274, 191, 190, 
2498, p5t0cFB_, 0.8332, 1.62, 0.274, 191, 190, 
2499, d5laiZ_, 0.8332, 2.06, 0.191, 222, 194, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2500, d5cz7Z_, 0.8332, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2501, d5cz7L_, 0.8332, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2502, d5l6bZ_, 0.8331, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2503, d5l6bL_, 0.8331, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2504, d5l66Z_, 0.8331, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2505, d5l66L_, 0.8331, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2506, d4ya1Z_, 0.8331, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2507, d4ya1L_, 0.8331, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2508, d4r17Z_, 0.8331, 2.06, 0.196, 222, 194, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2509, d4r17L_, 0.8331, 2.06, 0.196, 222, 194, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2510, d5l6cZ_, 0.8330, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2511, d5l6cL_, 0.8330, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2512, d5fg9Z_, 0.8330, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2513, d5fg9L_, 0.8330, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2514, d4r18Z_, 0.8330, 1.90, 0.197, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2515, d4r18L_, 0.8330, 1.90, 0.197, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2516, d4qv9Z_, 0.8330, 1.90, 0.197, 222, 193, YCP BETA5-C63F MUTANT
2517, d4qv9L_, 0.8330, 1.90, 0.197, 222, 193, YCP BETA5-C63F MUTANT
2518, d3wxr1_, 0.8330, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2519, p5nif1_, 0.8329, 1.89, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2520, d5fg7Z_, 0.8329, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2521, d5fg7L_, 0.8329, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2522, d4y8mZ_, 0.8329, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2523, p4y6vZ_, 0.8329, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2524, p4y6vL_, 0.8329, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2525, d4qv7Z_, 0.8329, 1.90, 0.197, 222, 193, YCP BETA5-A50V MUTANT
2526, d4qv7L_, 0.8329, 1.90, 0.197, 222, 193, YCP BETA5-A50V MUTANT
2527, d4q1sZ_, 0.8329, 2.07, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2528, d1rypM_, 0.8329, 1.90, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2529, d5l67Z_, 0.8328, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2530, d5l67L_, 0.8328, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2531, d5czaZ_, 0.8328, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2532, d5cz4Z_, 0.8328, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2533, d5cz4L_, 0.8328, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2534, d4y8mL_, 0.8328, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2535, d5czaL_, 0.8327, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2536, d4ya4Z_, 0.8327, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2537, d4ya4L_, 0.8327, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2538, d4y9yZ_, 0.8327, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2539, d4quyZ_, 0.8327, 1.90, 0.197, 222, 193, YCP BETA5-A49S-MUTANT
2540, d4quyL_, 0.8327, 1.90, 0.197, 222, 193, YCP BETA5-A49S-MUTANT
2541, d4quxZ_, 0.8327, 1.90, 0.197, 222, 193, YCP BETA5-A49T-MUTANT
2542, d4quxL_, 0.8327, 1.90, 0.197, 222, 193, YCP BETA5-A49T-MUTANT
2543, d3hf9E_, 0.8327, 2.59, 0.229, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2544, d1ryp1_, 0.8327, 1.90, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2545, d5l5fZ_, 0.8326, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2546, d5l5fL_, 0.8326, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2547, p4zzgM_, 0.8326, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2548, d4y9yL_, 0.8326, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2549, d3wxrM_, 0.8326, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2550, p1fntM_, 0.8326, 2.03, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2551, d5l5zZ_, 0.8325, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2552, d5l5zL_, 0.8325, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2553, d5bxlZ_, 0.8325, 2.06, 0.191, 222, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2554, d5bxlL_, 0.8325, 2.06, 0.191, 222, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2555, d4r00Z_, 0.8325, 1.91, 0.197, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2556, d4qv3Z_, 0.8325, 1.90, 0.197, 222, 193, YCP BETA5-M45V MUTANT
2557, d4qv3L_, 0.8325, 1.90, 0.197, 222, 193, YCP BETA5-M45V MUTANT
2558, d3hf9V_, 0.8325, 2.63, 0.233, 217, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2559, p1fnta_, 0.8325, 2.03, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2560, d5fgeZ_, 0.8324, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2561, d5fgeL_, 0.8324, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2562, d5d0wZ_, 0.8324, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2563, d5d0wL_, 0.8324, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2564, d4r00L_, 0.8324, 1.91, 0.197, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2565, d4qv4Z_, 0.8324, 1.91, 0.197, 222, 193, YCP BETA5-M45T MUTANT
2566, d4qv4L_, 0.8324, 1.91, 0.197, 222, 193, YCP BETA5-M45T MUTANT
2567, d5l6aZ_, 0.8323, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2568, d5l6aL_, 0.8322, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2569, d5l68Z_, 0.8322, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2570, d5l68L_, 0.8322, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2571, d5l5pZ_, 0.8322, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2572, d5l5pL_, 0.8322, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2573, d4rurZ_, 0.8322, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2574, d4rurL_, 0.8322, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2575, d4qzzZ_, 0.8322, 1.91, 0.197, 222, 193, YCP IN COMPLEX WITH OMURALIDE
2576, d4qzzL_, 0.8322, 1.91, 0.197, 222, 193, YCP IN COMPLEX WITH OMURALIDE
2577, d4qwuZ_, 0.8322, 1.91, 0.197, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2578, d4qvvL_, 0.8322, 2.07, 0.196, 222, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2579, d4qv8Z_, 0.8322, 1.91, 0.197, 222, 193, YCP BETA5-C52F MUTANT
2580, d4qv5Z_, 0.8322, 1.91, 0.197, 222, 193, YCP BETA5-M45I MUTANT
2581, d4qv5L_, 0.8322, 1.91, 0.197, 222, 193, YCP BETA5-M45I MUTANT
2582, d4qv1Z_, 0.8322, 1.91, 0.197, 222, 193, YCP BETA5-M45A MUTANT
2583, d4qv1L_, 0.8322, 1.91, 0.197, 222, 193, YCP BETA5-M45A MUTANT
2584, p5nifM_, 0.8321, 1.90, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2585, d5l5dZ_, 0.8321, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2586, d5l5dL_, 0.8321, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2587, p4x6z1_, 0.8321, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2588, d4qwuL_, 0.8321, 1.91, 0.197, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2589, d4qv8L_, 0.8321, 1.91, 0.197, 222, 193, YCP BETA5-C52F MUTANT
2590, p3jcpH_, 0.8321, 1.90, 0.197, 222, 193, 
2591, p5wviEA_, 0.8320, 1.94, 0.251, 205, 195, 
2592, p5mp96_, 0.8320, 2.04, 0.196, 222, 194, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2593, d5l5uZ_, 0.8320, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2594, d5l5uL_, 0.8320, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2595, p4x6zM_, 0.8320, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2596, d4qw0Z_, 0.8320, 1.91, 0.197, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2597, d4qw0L_, 0.8320, 1.91, 0.197, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2598, d4qvyZ_, 0.8320, 1.91, 0.197, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2599, d4qvyL_, 0.8320, 1.91, 0.197, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2600, d5l64Z_, 0.8319, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2601, d5l64L_, 0.8319, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2602, d5l5oZ_, 0.8319, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2603, d5l5oL_, 0.8319, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2604, d5l5jZ_, 0.8319, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2605, d5l5jL_, 0.8319, 1.90, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2606, d5cz6Z_, 0.8319, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2607, d5cz6L_, 0.8319, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2608, d4lqiZ_, 0.8319, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2609, d4lqiL_, 0.8319, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2610, p3jcpA_, 0.8319, 1.90, 0.197, 222, 193, 
2611, d5l5tZ_, 0.8318, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2612, d5l5tL_, 0.8318, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2613, d4qv0Z_, 0.8318, 1.91, 0.197, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2614, d4qv0L_, 0.8318, 1.91, 0.197, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2615, d4q1sL_, 0.8317, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2616, p6gopZ_, 0.8316, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2617, p6gopL_, 0.8316, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2618, d3dy4Z_, 0.8316, 1.91, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2619, p5wviQA_, 0.8315, 1.93, 0.256, 205, 195, 
2620, d5l62Z_, 0.8315, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2621, d5l62L_, 0.8315, 1.91, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2622, p5fghZ_, 0.8315, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2623, p5fghL_, 0.8315, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2624, d4qvwL_, 0.8315, 1.92, 0.197, 222, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2625, d3dy4L_, 0.8315, 1.92, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2626, d5l69Z_, 0.8314, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2627, d5l63Z_, 0.8314, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2628, d5l63L_, 0.8314, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2629, d5l61Z_, 0.8314, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2630, d5l61L_, 0.8314, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2631, d5l60Z_, 0.8314, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2632, d5l60L_, 0.8314, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2633, d5fhsZ_, 0.8314, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2634, d5d0xZ_, 0.8314, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2635, d5d0xL_, 0.8314, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2636, d4qvwZ_, 0.8314, 1.92, 0.197, 222, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2637, d4qvvZ_, 0.8314, 1.92, 0.197, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2638, d3un8Z_, 0.8314, 2.08, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2639, d3hyeL_, 0.8314, 1.92, 0.197, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2640, d3gpwZ_, 0.8314, 1.92, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2641, d3gpwL_, 0.8314, 1.92, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2642, d3gptL_, 0.8314, 1.92, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2643, d2fnyZ_, 0.8314, 1.93, 0.197, 222, 193,  
2644, d2fnyL_, 0.8314, 1.93, 0.197, 222, 193,  
2645, d5l69L_, 0.8313, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2646, d5l5xZ_, 0.8313, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2647, d5l5iZ_, 0.8313, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2648, d5l5iL_, 0.8313, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2649, d5fhsL_, 0.8313, 1.91, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2650, d4qvlZ_, 0.8313, 1.92, 0.197, 222, 193, YCP IN COMPLEX WITH BORTEZOMIB
2651, d4qvlL_, 0.8313, 1.92, 0.197, 222, 193, YCP IN COMPLEX WITH BORTEZOMIB
2652, d3hyeZ_, 0.8313, 1.92, 0.197, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2653, d3gptZ_, 0.8313, 1.92, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2654, p6epc5_, 0.8312, 2.05, 0.081, 201, 198, GROUND STATE 26S PROTEASOME (GS2)
2655, d5l5xL_, 0.8312, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2656, d5l5vZ_, 0.8312, 1.92, 0.192, 222, 193,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2657, d5l5vL_, 0.8312, 1.92, 0.192, 222, 193,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2658, d3e47Z_, 0.8312, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2659, d3e47L_, 0.8312, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2660, d2gplZ_, 0.8312, 1.93, 0.197, 222, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2661, d2gplL_, 0.8312, 1.93, 0.197, 222, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2662, d3tddZ_, 0.8311, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2663, d3tddL_, 0.8311, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2664, d1g0uZ_, 0.8311, 1.92, 0.197, 222, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2665, p5mp9m_, 0.8310, 2.05, 0.196, 222, 194, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2666, d4eu21_, 0.8310, 1.92, 0.197, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2667, d5lttZ_, 0.8309, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2668, d5lttL_, 0.8309, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2669, d4qw3Z_, 0.8309, 1.93, 0.197, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2670, d4qw3L_, 0.8309, 1.93, 0.197, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2671, d3h6iJ_, 0.8308, 2.54, 0.230, 215, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2672, p5lf6I_, 0.8307, 2.07, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2673, d5l5yZ_, 0.8307, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2674, d5l5yL_, 0.8307, 1.92, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2675, d5l5sZ_, 0.8307, 1.93, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2676, d5l5sL_, 0.8307, 1.93, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2677, d5bxnZ_, 0.8307, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2678, d4qvmZ_, 0.8307, 1.93, 0.197, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2679, d4qvmL_, 0.8307, 1.93, 0.197, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2680, d4eu2M_, 0.8307, 1.92, 0.197, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2681, d5d0tZ_, 0.8306, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2682, d5d0tL_, 0.8306, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2683, d5bxnL_, 0.8306, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2684, p5lf6W_, 0.8305, 2.07, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2685, d5fggZ_, 0.8305, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2686, d5fggL_, 0.8305, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2687, d4qwrZ_, 0.8305, 1.92, 0.197, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2688, d4qw1Z_, 0.8305, 1.93, 0.197, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2689, d4qw1L_, 0.8305, 1.93, 0.197, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2690, d4qluL_, 0.8305, 2.08, 0.196, 222, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2691, d3oevZ_, 0.8305, 2.09, 0.196, 222, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2692, d2fakL_, 0.8305, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2693, d1g0uL_, 0.8305, 1.93, 0.197, 222, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2694, d4qwrL_, 0.8304, 1.92, 0.197, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2695, d4qv6Z_, 0.8304, 1.92, 0.197, 222, 193, YCP BETA5-A49V MUTANT
2696, d4qv6L_, 0.8304, 1.93, 0.197, 222, 193, YCP BETA5-A49V MUTANT
2697, d4qluZ_, 0.8304, 2.08, 0.196, 222, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2698, d3h6iE_, 0.8304, 2.54, 0.230, 215, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2699, d3dy3Z_, 0.8304, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2700, d3dy3L_, 0.8304, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2701, d2fakZ_, 0.8304, 1.93, 0.197, 222, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2702, d5l5qZ_, 0.8303, 1.93, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2703, d5l5qL_, 0.8303, 1.93, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2704, d5cz9Z_, 0.8303, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2705, p4y8sZ_, 0.8303, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2706, p4y8sL_, 0.8303, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2707, p4y8kZ_, 0.8303, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2708, d4r02L_, 0.8303, 1.92, 0.197, 222, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2709, d3nzjZ_, 0.8303, 2.09, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2710, d3nzjL_, 0.8303, 2.09, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2711, d3h6fJ_, 0.8303, 2.56, 0.230, 215, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2712, d1z7qX1, 0.8303, 1.99, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2713, d5l5hZ_, 0.8302, 1.93, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2714, d5l5hL_, 0.8302, 1.93, 0.192, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2715, d5cz9L_, 0.8302, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2716, p4y8kL_, 0.8302, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2717, d4r02Z_, 0.8302, 1.92, 0.197, 222, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2718, d1z7qJ1, 0.8302, 1.99, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2719, d5dkiZ_, 0.8301, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2720, d5dkiL_, 0.8301, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2721, d4qwjZ_, 0.8301, 2.09, 0.196, 222, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2722, d4qwjL_, 0.8301, 2.08, 0.196, 222, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2723, d3un8L_, 0.8301, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2724, d3h6iT_, 0.8301, 2.55, 0.225, 215, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2725, d3h6fE_, 0.8301, 2.55, 0.230, 215, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2726, d5l64W_, 0.8300, 1.99, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2727, d5l64I_, 0.8300, 1.99, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2728, p4y7xZ_, 0.8300, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2729, p4y7xL_, 0.8300, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2730, d4qvqZ_, 0.8300, 1.93, 0.197, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2731, d4qvqL_, 0.8300, 1.93, 0.197, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2732, d4qvpZ_, 0.8300, 1.93, 0.197, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2733, d4qvpL_, 0.8300, 1.93, 0.197, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2734, d4jt0Z_, 0.8300, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2735, d4jt0L_, 0.8300, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2736, d3h6iL_, 0.8300, 2.55, 0.225, 215, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2737, p5ln37_, 0.8299, 2.44, 0.219, 218, 201, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2738, d5dkjZ_, 0.8299, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2739, d5dkjL_, 0.8299, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2740, p5cghZ_, 0.8299, 1.92, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2741, p5cghL_, 0.8299, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2742, d3h6fT_, 0.8299, 2.55, 0.225, 215, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2743, d3h6fL_, 0.8299, 2.55, 0.225, 215, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2744, d4qzwZ_, 0.8298, 1.93, 0.197, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2745, d4qzwL_, 0.8298, 1.93, 0.197, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2746, d3oevL_, 0.8298, 1.93, 0.197, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2747, d5l63W_, 0.8297, 1.99, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2748, d5l63I_, 0.8297, 1.99, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2749, d4qvnZ_, 0.8297, 1.93, 0.197, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2750, d4qvnL_, 0.8297, 1.93, 0.197, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2751, d4qlvL_, 0.8297, 1.93, 0.197, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2752, d4qlsZ_, 0.8297, 1.93, 0.197, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2753, d4qlsL_, 0.8297, 1.93, 0.197, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2754, d3sdkZ_, 0.8297, 2.09, 0.196, 222, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2755, d3mg0Z_, 0.8297, 2.10, 0.196, 222, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2756, d3h6iP_, 0.8297, 2.55, 0.225, 215, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2757, d3h6iG_, 0.8297, 2.56, 0.225, 215, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2758, d3h6fG_, 0.8297, 2.57, 0.230, 215, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2759, d2zcyZ_, 0.8297, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2760, d5l61W_, 0.8296, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2761, d5l61I_, 0.8296, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2762, d5l5vW_, 0.8296, 2.00, 0.192, 204, 193,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2763, d5l5vI_, 0.8296, 2.00, 0.192, 204, 193,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2764, p5fmgV_, 0.8296, 1.56, 0.202, 191, 188, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2765, p5fmgH_, 0.8296, 1.56, 0.202, 191, 188, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2766, d5cz5Z_, 0.8296, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2767, d5cz5L_, 0.8296, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2768, d4qlvZ_, 0.8296, 1.93, 0.197, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2769, d3h6iX_, 0.8296, 2.56, 0.230, 215, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2770, d2zcyL_, 0.8296, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2771, d5l62W_, 0.8295, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2772, d5l62I_, 0.8295, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2773, d5d0vZ_, 0.8295, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2774, d5d0vL_, 0.8295, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2775, d5d0sZ_, 0.8295, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2776, d3mg7Z_, 0.8295, 1.93, 0.197, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2777, p5mpa7_, 0.8294, 2.00, 0.179, 218, 196, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2778, d5m2bW_, 0.8294, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2779, d5m2bI_, 0.8294, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2780, d5l67W_, 0.8294, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2781, d5l67I_, 0.8294, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2782, d5l5yW_, 0.8294, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2783, d5l5yI_, 0.8294, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2784, d5jhsZ_, 0.8294, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2785, d5jhsL_, 0.8294, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2786, d5fgiZ_, 0.8294, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2787, d5fgiL_, 0.8294, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2788, d5d0zZ_, 0.8294, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2789, d5d0zL_, 0.8294, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2790, d5d0sL_, 0.8294, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2791, d5cz8Z_, 0.8294, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2792, d3shjZ_, 0.8294, 1.95, 0.197, 222, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2793, d3shjL_, 0.8294, 1.95, 0.197, 222, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2794, d5lf3W_, 0.8293, 2.08, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2795, p5leyW_, 0.8293, 2.07, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2796, d5l5wW_, 0.8293, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2797, d5l5wI_, 0.8293, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2798, d5l5qI_, 0.8293, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2799, d5cz8L_, 0.8293, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2800, p5cggZ_, 0.8293, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2801, p5cggL_, 0.8293, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2802, p4ya2Z_, 0.8293, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2803, d4qwsZ_, 0.8293, 1.93, 0.197, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2804, d4qwsL_, 0.8293, 1.93, 0.197, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2805, d3mg4Z_, 0.8293, 1.95, 0.197, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2806, d5lf7W_, 0.8292, 2.08, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2807, d5l5oW_, 0.8292, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2808, p4ya2L_, 0.8292, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2809, p4y8qZ_, 0.8292, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2810, p4y8qL_, 0.8292, 1.93, 0.197, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2811, d4qw5Z_, 0.8292, 1.93, 0.197, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2812, d3oeuZ_, 0.8292, 1.93, 0.197, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2813, p5leyI_, 0.8291, 2.08, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2814, d5le5I_, 0.8291, 2.08, 0.206, 204, 194, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2815, d5l6cW_, 0.8291, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2816, d5l6cI_, 0.8291, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2817, d5l6aW_, 0.8291, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2818, d5l6aI_, 0.8291, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2819, d5l60W_, 0.8291, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2820, d5l60I_, 0.8291, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2821, d5l5tW_, 0.8291, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2822, d5l5tI_, 0.8291, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2823, d4qz6Z_, 0.8291, 1.93, 0.197, 222, 193, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2824, d4qz6L_, 0.8291, 1.93, 0.197, 222, 193, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2825, d4qwiZ_, 0.8291, 1.93, 0.197, 222, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2826, d4qwiL_, 0.8291, 1.93, 0.197, 222, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2827, d4qw7Z_, 0.8291, 1.93, 0.197, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2828, d4qw6Z_, 0.8291, 1.93, 0.197, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2829, d4qw6L_, 0.8291, 1.93, 0.197, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2830, d4qw5L_, 0.8291, 1.93, 0.197, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2831, d5lf3I_, 0.8290, 2.08, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2832, p5lezI_, 0.8290, 2.08, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2833, d5l5rW_, 0.8290, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2834, d5l5qW_, 0.8290, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2835, d5l54Z_, 0.8290, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2836, d5l54L_, 0.8290, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2837, p5fmgW_, 0.8290, 1.35, 0.249, 186, 185, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2838, p5fmgI_, 0.8290, 1.35, 0.249, 186, 185, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2839, d4qwkZ_, 0.8290, 1.94, 0.197, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2840, d4qwkL_, 0.8290, 1.94, 0.197, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2841, d4qw7L_, 0.8290, 1.93, 0.197, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2842, d4qltZ_, 0.8290, 2.09, 0.196, 222, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2843, d4qltL_, 0.8290, 2.09, 0.196, 222, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2844, d4no1Z_, 0.8290, 1.93, 0.197, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2845, d4no1L_, 0.8290, 1.93, 0.197, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2846, d4inrZ_, 0.8290, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2847, d4inrL_, 0.8290, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2848, d3sdkL_, 0.8290, 2.09, 0.196, 222, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2849, d3oeuL_, 0.8290, 1.94, 0.197, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2850, d3h6fX_, 0.8290, 2.58, 0.230, 215, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2851, d5lf1W_, 0.8289, 2.08, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2852, d5l5pW_, 0.8289, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2853, p3jcoA_, 0.8289, 1.94, 0.197, 222, 193, 
2854, d5lf1I_, 0.8288, 2.08, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2855, d5lexI_, 0.8288, 2.08, 0.206, 204, 194, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2856, d5l5sW_, 0.8288, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2857, d5l5sI_, 0.8288, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2858, d5l5rI_, 0.8288, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2859, d5l5pI_, 0.8288, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2860, d5l5oI_, 0.8288, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2861, d5l5hW_, 0.8288, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2862, d5l5hI_, 0.8288, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2863, d5l5bW_, 0.8288, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2864, d5l5bI_, 0.8288, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2865, d5jhrZ_, 0.8288, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2866, d5jhrL_, 0.8288, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2867, p4y78Z_, 0.8288, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2868, p4y78L_, 0.8288, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2869, d4qwgZ_, 0.8288, 1.94, 0.197, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2870, d4qwgL_, 0.8288, 1.94, 0.197, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2871, d4qwfZ_, 0.8288, 1.94, 0.197, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2872, d4qwfL_, 0.8288, 1.94, 0.197, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2873, d3gpjZ_, 0.8288, 1.94, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2874, d3gpjL_, 0.8288, 1.94, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2875, p5mpan_, 0.8287, 2.04, 0.179, 218, 196, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2876, d5lttW_, 0.8287, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2877, d5lttI_, 0.8287, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2878, d5lexW_, 0.8287, 2.08, 0.206, 204, 194, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2879, d5le5W_, 0.8287, 2.08, 0.206, 204, 194, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2880, d5l5zW_, 0.8287, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2881, d5l5xW_, 0.8287, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2882, d5l5xI_, 0.8287, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2883, d5l5uW_, 0.8287, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2884, d5l5uI_, 0.8287, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2885, d5l5jI_, 0.8287, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2886, d4no8W_, 0.8287, 2.00, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2887, d4no8I_, 0.8287, 2.00, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2888, d4fzcZ_, 0.8287, 1.95, 0.197, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2889, d3mg0L_, 0.8287, 1.95, 0.197, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2890, p3jcoH_, 0.8287, 1.94, 0.197, 222, 193, 
2891, p5vfsM_, 0.8286, 2.06, 0.201, 213, 194, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2892, d5l69W_, 0.8286, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2893, d5l69I_, 0.8286, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2894, d5l66W_, 0.8286, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2895, d5l66I_, 0.8286, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2896, d5l5zI_, 0.8286, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2897, d5l5jW_, 0.8286, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2898, p4y82Z_, 0.8286, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2899, p4y82L_, 0.8286, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2900, d4fzcL_, 0.8286, 1.95, 0.197, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2901, d3h6fP_, 0.8286, 2.57, 0.225, 215, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2902, d5l65W_, 0.8285, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2903, d5l65I_, 0.8285, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2904, p5cgiZ_, 0.8285, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2905, d4r02I_, 0.8285, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2906, d4qwlZ_, 0.8285, 1.94, 0.197, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2907, d4qwlL_, 0.8285, 1.94, 0.197, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2908, d4g4sM_, 0.8285, 1.93, 0.197, 222, 193, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2909, d4fzgZ_, 0.8285, 1.95, 0.197, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2910, d3okjL_, 0.8285, 1.95, 0.197, 222, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2911, p6avoX_, 0.8284, 1.94, 0.207, 213, 193, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2912, p6avoS_, 0.8284, 1.94, 0.207, 213, 193, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2913, p5t0iO_, 0.8284, 1.82, 0.255, 193, 192, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2914, p5mp9n_, 0.8284, 1.99, 0.179, 217, 195, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2915, d5lf7I_, 0.8284, 2.09, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2916, d5lf4W_, 0.8284, 2.08, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2917, p5lezW_, 0.8284, 2.09, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2918, p5cgiL_, 0.8284, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2919, p4y8pZ_, 0.8284, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2920, d4r18W_, 0.8284, 2.00, 0.192, 204, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2921, d4r18I_, 0.8284, 2.00, 0.192, 204, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2922, d4r02W_, 0.8284, 2.00, 0.192, 204, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2923, d4qz7Z_, 0.8284, 1.94, 0.197, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2924, d4qw4Z_, 0.8284, 1.94, 0.197, 222, 193, YCP IN COMPLEX WITH CARFILZOMIB
2925, d4qw4L_, 0.8284, 1.94, 0.197, 222, 193, YCP IN COMPLEX WITH CARFILZOMIB
2926, d4fzgL_, 0.8284, 1.96, 0.197, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2927, d5l6bW_, 0.8283, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2928, d5l6bI_, 0.8283, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2929, d5l68W_, 0.8283, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2930, d5l68I_, 0.8283, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2931, d5l5fW_, 0.8283, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2932, d5l5fI_, 0.8283, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2933, d5l54W_, 0.8283, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2934, p4y8pL_, 0.8283, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2935, p4y8lZ_, 0.8283, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2936, p4y8lL_, 0.8283, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2937, p4y81Z_, 0.8283, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2938, p4y81L_, 0.8283, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2939, p4y7yL_, 0.8283, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2940, d4qz7L_, 0.8283, 1.94, 0.197, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2941, d4q1sW_, 0.8283, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2942, d3nzwL_, 0.8283, 1.95, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2943, d3bdmZ_, 0.8283, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2944, p5vfuDA_, 0.8282, 2.10, 0.206, 213, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2945, p5vftS_, 0.8282, 2.10, 0.206, 213, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2946, d5lf4I_, 0.8282, 2.09, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2947, d5l55W_, 0.8282, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2948, d5l55I_, 0.8282, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2949, d5fggW_, 0.8282, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2950, d5fggI_, 0.8282, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2951, p4y7yZ_, 0.8282, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2952, d4qlsW_, 0.8282, 2.00, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2953, d4qlsI_, 0.8282, 2.00, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2954, d3nzwZ_, 0.8282, 1.95, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2955, d3mg7L_, 0.8282, 1.94, 0.197, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2956, d3bdmL_, 0.8282, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2957, p5lf0W_, 0.8281, 2.09, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2958, d5lajW_, 0.8281, 2.01, 0.192, 204, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2959, d5lajI_, 0.8281, 2.01, 0.192, 204, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2960, d5l5iW_, 0.8281, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2961, d5l5eW_, 0.8281, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2962, d5l5eI_, 0.8281, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2963, d5l5dW_, 0.8281, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2964, d5l5dI_, 0.8281, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2965, d5l52Z_, 0.8281, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2966, d5l52L_, 0.8281, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2967, p4ya9Z_, 0.8281, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2968, p4ya9L_, 0.8281, 1.94, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2969, p4y80Z_, 0.8281, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2970, p4y80L_, 0.8281, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2971, d4qv7W_, 0.8281, 2.01, 0.192, 204, 193, YCP BETA5-A50V MUTANT
2972, d4qv7I_, 0.8281, 2.01, 0.192, 204, 193, YCP BETA5-A50V MUTANT
2973, d4qv3W_, 0.8281, 2.01, 0.192, 204, 193, YCP BETA5-M45V MUTANT
2974, d4qv3I_, 0.8281, 2.01, 0.192, 204, 193, YCP BETA5-M45V MUTANT
2975, d4nnwW_, 0.8281, 2.00, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2976, d4nnwI_, 0.8281, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2977, d4jsuZ_, 0.8281, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2978, d4jsuL_, 0.8281, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2979, d3unbI_, 0.8281, 2.09, 0.211, 204, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2980, p6avoU_, 0.8280, 2.09, 0.206, 204, 194, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2981, d5l5iI_, 0.8280, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2982, d5l54I_, 0.8280, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2983, d5jhrW_, 0.8280, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2984, d5jhrI_, 0.8280, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2985, p4y9zZ_, 0.8280, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2986, p4y9zL_, 0.8280, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2987, p4y77Z_, 0.8280, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2988, p4y77L_, 0.8280, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2989, p4x6zX_, 0.8280, 1.99, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2990, d4qzxZ_, 0.8280, 1.95, 0.197, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2991, d4qzxL_, 0.8280, 1.95, 0.197, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2992, d4qz0Z_, 0.8280, 1.95, 0.197, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2993, d4qz0L_, 0.8280, 1.95, 0.197, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2994, d4qv4W_, 0.8280, 2.01, 0.192, 204, 193, YCP BETA5-M45T MUTANT
2995, d4qv4I_, 0.8280, 2.01, 0.192, 204, 193, YCP BETA5-M45T MUTANT
2996, d4qv1W_, 0.8280, 2.01, 0.192, 204, 193, YCP BETA5-M45A MUTANT
2997, d4qv1I_, 0.8280, 2.01, 0.192, 204, 193, YCP BETA5-M45A MUTANT
2998, d4intL_, 0.8280, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2999, p5lf0I_, 0.8279, 2.09, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3000, d5l52I_, 0.8279, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3001, d5fgeI_, 0.8279, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3002, d5fgdW_, 0.8279, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3003, d5fgdI_, 0.8279, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3004, d5fg7I_, 0.8279, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3005, d5ahjZ_, 0.8279, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3006, d5ahjL_, 0.8279, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3007, p4ya7Z_, 0.8279, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3008, p4ya7L_, 0.8279, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3009, p4y8jZ_, 0.8279, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3010, p4y8jL_, 0.8279, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3011, p4y8iZ_, 0.8279, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3012, p4y8iL_, 0.8279, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3013, d4qz7W_, 0.8279, 2.01, 0.192, 204, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3014, d4qz7I_, 0.8279, 2.01, 0.192, 204, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3015, d4qz5Z_, 0.8279, 1.95, 0.197, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3016, d4qv5W_, 0.8279, 2.01, 0.192, 204, 193, YCP BETA5-M45I MUTANT
3017, d4qv5I_, 0.8279, 2.01, 0.192, 204, 193, YCP BETA5-M45I MUTANT
3018, d4jsqZ_, 0.8279, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3019, d4jsqL_, 0.8279, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3020, d4intZ_, 0.8279, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3021, d3nzjW_, 0.8279, 2.01, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3022, d3nzjI_, 0.8279, 2.01, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3023, d5l52W_, 0.8278, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3024, p5gjqr_, 0.8278, 2.05, 0.179, 199, 195, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3025, d5fgiW_, 0.8278, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3026, d5fgiI_, 0.8278, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3027, d5fg7W_, 0.8278, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3028, d5d0tW_, 0.8278, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3029, d5d0tI_, 0.8278, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3030, p4y7wZ_, 0.8278, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3031, p4y7wL_, 0.8278, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3032, d4qzzW_, 0.8278, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH OMURALIDE
3033, d4qzzI_, 0.8278, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH OMURALIDE
3034, d4qz5L_, 0.8278, 1.95, 0.197, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3035, d4qz3Z_, 0.8278, 1.95, 0.197, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3036, d4qz3L_, 0.8278, 1.95, 0.197, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3037, d4hnpZ_, 0.8278, 1.95, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3038, p3unek_, 0.8278, 1.95, 0.212, 204, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3039, d3dy4W_, 0.8278, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3040, d1iruJ_, 0.8278, 2.11, 0.206, 204, 194, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3041, p5mpbAA_, 0.8277, 2.06, 0.196, 222, 194, 
3042, p5l5ra_, 0.8277, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3043, d5fgfW_, 0.8277, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3044, d5fgfI_, 0.8277, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3045, p5cghI_, 0.8277, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3046, d5bxnW_, 0.8277, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3047, d5bxnI_, 0.8277, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3048, d5bxlW_, 0.8277, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3049, d5bouW_, 0.8277, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3050, d5bouI_, 0.8277, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3051, p4y8oL_, 0.8277, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3052, d4y8mW_, 0.8277, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3053, p4y75W_, 0.8277, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3054, p4y75I_, 0.8277, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3055, p4y6zZ_, 0.8277, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3056, p4y6zL_, 0.8277, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3057, d4qz2Z_, 0.8277, 1.95, 0.197, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3058, d4qz2L_, 0.8277, 1.95, 0.197, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3059, d4qxjZ_, 0.8277, 1.95, 0.197, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3060, d4qvnW_, 0.8277, 2.00, 0.192, 204, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3061, d4qvnI_, 0.8277, 2.00, 0.192, 204, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3062, d4qv9W_, 0.8277, 2.02, 0.192, 204, 193, YCP BETA5-C63F MUTANT
3063, d4qv9I_, 0.8277, 2.02, 0.192, 204, 193, YCP BETA5-C63F MUTANT
3064, d4qv8W_, 0.8277, 2.02, 0.192, 204, 193, YCP BETA5-C52F MUTANT
3065, d4qv8I_, 0.8277, 2.02, 0.192, 204, 193, YCP BETA5-C52F MUTANT
3066, d4qv6W_, 0.8277, 2.01, 0.192, 204, 193, YCP BETA5-A49V MUTANT
3067, d4qv6I_, 0.8277, 2.01, 0.192, 204, 193, YCP BETA5-A49V MUTANT
3068, d4quyW_, 0.8277, 2.02, 0.192, 204, 193, YCP BETA5-A49S-MUTANT
3069, d4quyI_, 0.8277, 2.02, 0.192, 204, 193, YCP BETA5-A49S-MUTANT
3070, d4q1sI_, 0.8277, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3071, p4q1sa_, 0.8277, 2.04, 0.184, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3072, d4no8Z_, 0.8277, 1.95, 0.197, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3073, d4no8L_, 0.8277, 1.95, 0.197, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3074, d3mg4L_, 0.8277, 1.97, 0.197, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3075, d3dy4I_, 0.8277, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3076, d1iruX_, 0.8277, 2.11, 0.206, 204, 194, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3077, p6avoY_, 0.8276, 2.09, 0.206, 204, 194, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3078, d5l55Z_, 0.8276, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3079, d5l55L_, 0.8276, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3080, d5fhsW_, 0.8276, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3081, d5fhsI_, 0.8276, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3082, p5fgga_, 0.8276, 2.04, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3083, d5fgaI_, 0.8276, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3084, d5czaW_, 0.8276, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3085, d5czaI_, 0.8276, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3086, p5cggW_, 0.8276, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3087, p5cggI_, 0.8276, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3088, d5cgfW_, 0.8276, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3089, d5cgfI_, 0.8276, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3090, p5bxna_, 0.8276, 2.04, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3091, d5bxlI_, 0.8276, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3092, d4ya1I_, 0.8276, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3093, p4y8tW_, 0.8276, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3094, p4y8tI_, 0.8276, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3095, p4y8oZ_, 0.8276, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3096, d4y8mI_, 0.8276, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3097, p4y8hZ_, 0.8276, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3098, p4y8hL_, 0.8276, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3099, d4qxjL_, 0.8276, 1.95, 0.197, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3100, d4qv0W_, 0.8276, 2.02, 0.192, 204, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3101, d4qv0I_, 0.8276, 2.02, 0.192, 204, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3102, d4qlvW_, 0.8276, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3103, d4cr26_, 0.8276, 1.95, 0.197, 222, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3104, d3mg7I_, 0.8276, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3105, p5mpam_, 0.8275, 2.06, 0.196, 222, 194, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3106, p5l5ua_, 0.8275, 2.04, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3107, p5l5ba_, 0.8275, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3108, d5l5aW_, 0.8275, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3109, d5l5aI_, 0.8275, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3110, d5jhsI_, 0.8275, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3111, p5gjqd_, 0.8275, 2.04, 0.179, 199, 195, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3112, d5fgaW_, 0.8275, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3113, d5d0sW_, 0.8275, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3114, d5d0sI_, 0.8275, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3115, d4ya4W_, 0.8275, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3116, d4ya1W_, 0.8275, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3117, p4y8hI_, 0.8275, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3118, p4y75Z_, 0.8275, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3119, p4y75L_, 0.8275, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3120, p4y70Z_, 0.8275, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3121, p4y70L_, 0.8275, 1.95, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3122, d4qluI_, 0.8275, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3123, d4nnnW_, 0.8275, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH MG132
3124, d4inrI_, 0.8275, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3125, p3uneW_, 0.8275, 2.11, 0.211, 204, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
3126, p3un4Z_, 0.8275, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3127, d3mg6L_, 0.8275, 2.11, 0.196, 222, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3128, d3e47I_, 0.8275, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3129, d2fakW_, 0.8275, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3130, p5mpa6_, 0.8274, 2.07, 0.196, 222, 194, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3131, d5laiW_, 0.8274, 2.02, 0.192, 204, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3132, d5laiI_, 0.8274, 2.02, 0.192, 204, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3133, d5jhsW_, 0.8274, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3134, d5fgeW_, 0.8274, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3135, p5cghW_, 0.8274, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3136, d5ahjW_, 0.8274, 2.00, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3137, d5ahjI_, 0.8274, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3138, d4ya4I_, 0.8274, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3139, p4y8kI_, 0.8274, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3140, p4y8hW_, 0.8274, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3141, p4qvna_, 0.8274, 2.05, 0.179, 218, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3142, d4qlvI_, 0.8274, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3143, d4qluW_, 0.8274, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3144, d4qlqW_, 0.8274, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3145, d4no1W_, 0.8274, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3146, d4no1I_, 0.8274, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3147, d4nnnI_, 0.8274, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH MG132
3148, p3un4L_, 0.8274, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3149, d3oevI_, 0.8274, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3150, d3e47W_, 0.8274, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3151, d2fnyI_, 0.8274, 2.02, 0.192, 204, 193,  
3152, d2fakI_, 0.8274, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3153, d1g65Z_, 0.8274, 1.96, 0.197, 222, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3154, d1g65L_, 0.8274, 1.96, 0.197, 222, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3155, p5vfqM_, 0.8273, 2.10, 0.206, 213, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3156, p5l61a_, 0.8273, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3157, d5fg9W_, 0.8273, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3158, d5fg9I_, 0.8273, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3159, d5cz9W_, 0.8273, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3160, p5cgiI_, 0.8273, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3161, p4y8uI_, 0.8273, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3162, p4y6aW_, 0.8273, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3163, p4y6aI_, 0.8273, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3164, d4quxW_, 0.8273, 2.02, 0.192, 204, 193, YCP BETA5-A49T-MUTANT
3165, d4quxI_, 0.8273, 2.02, 0.192, 204, 193, YCP BETA5-A49T-MUTANT
3166, d4qlqI_, 0.8273, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3167, p4qbyZ_, 0.8273, 1.95, 0.197, 222, 193, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3168, p4qbyL_, 0.8273, 1.95, 0.197, 222, 193, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3169, d4ltcZ_, 0.8273, 1.96, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3170, d4ltcL_, 0.8273, 1.96, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3171, d4inrW_, 0.8273, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3172, d4g4sJ_, 0.8273, 2.02, 0.192, 203, 193, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3173, d3tddW_, 0.8273, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3174, d3tddI_, 0.8273, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3175, p3hf9c_, 0.8273, 2.55, 0.226, 214, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
3176, d3dy3I_, 0.8273, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3177, d2fnyW_, 0.8273, 2.02, 0.192, 204, 193,  
3178, p5m2ba_, 0.8272, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3179, p5l66a_, 0.8272, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3180, p5cgiW_, 0.8272, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3181, p4ya4a_, 0.8272, 2.04, 0.184, 218, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3182, p4y8uW_, 0.8272, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3183, p4y8gZ_, 0.8272, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3184, p4y8gW_, 0.8272, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3185, p4y8gL_, 0.8272, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3186, p4y8gI_, 0.8272, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3187, d4r00W_, 0.8272, 2.01, 0.192, 204, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3188, d4r00I_, 0.8272, 2.01, 0.192, 204, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3189, d4qz1Z_, 0.8272, 1.96, 0.197, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3190, d4qz1L_, 0.8272, 1.96, 0.197, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3191, d4qz0W_, 0.8272, 2.01, 0.192, 204, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3192, d4qz0I_, 0.8272, 2.01, 0.192, 204, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3193, d4qvpW_, 0.8272, 2.01, 0.192, 204, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3194, d4qvpI_, 0.8272, 2.01, 0.192, 204, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3195, d4qltW_, 0.8272, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3196, d4qltI_, 0.8272, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3197, d4qlqZ_, 0.8272, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3198, d4qlqL_, 0.8272, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3199, d4no6W_, 0.8272, 2.02, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3200, d4no6I_, 0.8272, 2.02, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3201, d4inuZ_, 0.8272, 1.97, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3202, d3un8I_, 0.8272, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3203, d3mg6Z_, 0.8272, 2.12, 0.196, 222, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3204, p6gopI_, 0.8271, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3205, p5vfsLA_, 0.8271, 2.08, 0.201, 213, 194, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3206, p5l6aa_, 0.8271, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3207, p5l63a_, 0.8271, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3208, d5d0zW_, 0.8271, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3209, d5d0zI_, 0.8271, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3210, d5d0wW_, 0.8271, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3211, d5d0wI_, 0.8271, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3212, p5ahja_, 0.8271, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3213, d4z1lW_, 0.8271, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3214, d4z1lI_, 0.8271, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3215, p4ya2W_, 0.8271, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3216, p4ya2I_, 0.8271, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3217, p4y8qW_, 0.8271, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3218, p4y8nI_, 0.8271, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3219, p4y84Z_, 0.8271, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3220, p4y84L_, 0.8271, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3221, p4y7xW_, 0.8271, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3222, p4y7xI_, 0.8271, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3223, p4y77I_, 0.8271, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3224, p4y74L_, 0.8271, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3225, p4y6zW_, 0.8271, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3226, d4rurI_, 0.8271, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3227, d4qz5W_, 0.8271, 2.01, 0.192, 204, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3228, d4qz5I_, 0.8271, 2.02, 0.192, 204, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3229, d4qz4Z_, 0.8271, 1.96, 0.197, 222, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3230, d4qz4L_, 0.8271, 1.96, 0.197, 222, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3231, d4qwxZ_, 0.8271, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3232, d4qwxW_, 0.8271, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3233, d4qwxL_, 0.8271, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3234, d4qwxI_, 0.8271, 2.01, 0.192, 204, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3235, d4qwlW_, 0.8271, 2.01, 0.192, 204, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3236, d4qw7I_, 0.8271, 2.01, 0.192, 204, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3237, d4no9Z_, 0.8271, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3238, d4no9L_, 0.8271, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3239, d4nnwZ_, 0.8271, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3240, d4nnwL_, 0.8271, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3241, d4nnnZ_, 0.8271, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH MG132
3242, d4nnnL_, 0.8271, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH MG132
3243, d4hrcZ_, 0.8271, 1.96, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3244, d3sdkI_, 0.8271, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3245, d3oeuI_, 0.8271, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3246, p1fntX_, 0.8271, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3247, p1fntJ_, 0.8271, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3248, p5vfpM_, 0.8270, 2.11, 0.206, 213, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3249, p5l62a_, 0.8270, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3250, p5l5ya_, 0.8270, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3251, p5l5ta_, 0.8270, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3252, p5l5da_, 0.8270, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3253, p5gjrQA_, 0.8270, 1.91, 0.180, 199, 194, 
3254, p5fghW_, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3255, d5dkjW_, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3256, d5dkjI_, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3257, d5cz9I_, 0.8270, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3258, d5cz7W_, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3259, d5cz7I_, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3260, p5cggM_, 0.8270, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3261, p5cgga_, 0.8270, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3262, p4ya7W_, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3263, p4ya7I_, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3264, d4y8rW_, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3265, p4y8pW_, 0.8270, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3266, p4y8pI_, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3267, p4y8kW_, 0.8270, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3268, p4y77W_, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3269, p4y74Z_, 0.8270, 1.96, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3270, p4y6zI_, 0.8270, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3271, d4rurW_, 0.8270, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3272, p4r18a_, 0.8270, 2.05, 0.184, 218, 196, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3273, d4qz6W_, 0.8270, 2.02, 0.192, 204, 193, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3274, d4qz6I_, 0.8270, 2.02, 0.192, 204, 193, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3275, p4qwua_, 0.8270, 2.05, 0.179, 218, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3276, d4qwlI_, 0.8270, 2.01, 0.192, 204, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3277, d4qw7W_, 0.8270, 2.01, 0.192, 204, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3278, d4inuL_, 0.8270, 1.97, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3279, d4hnpL_, 0.8270, 1.96, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3280, p3uneI_, 0.8270, 1.95, 0.212, 204, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3281, d3sdiL_, 0.8270, 1.96, 0.197, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3282, d3nzxZ_, 0.8270, 1.97, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3283, d3nzxL_, 0.8270, 1.96, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3284, d3nzwW_, 0.8270, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3285, d3nzwI_, 0.8270, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3286, d2f16I_, 0.8270, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3287, p5vfrs_, 0.8269, 1.94, 0.207, 213, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3288, p5vfoS_, 0.8269, 2.11, 0.206, 213, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3289, p5vfoP_, 0.8269, 2.09, 0.206, 204, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3290, p5l6ba_, 0.8269, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3291, p5l5za_, 0.8269, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3292, p5l5sa_, 0.8269, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3293, p5l5pa_, 0.8269, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3294, p5l5oa_, 0.8269, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3295, p5l4gY_, 0.8269, 1.87, 0.238, 207, 193, 
3296, p5gjrCA_, 0.8269, 1.91, 0.180, 199, 194, 
3297, p5fmgY_, 0.8269, 1.75, 0.157, 194, 191, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3298, p5fmgK_, 0.8269, 1.75, 0.157, 194, 191, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3299, p5fghI_, 0.8269, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3300, d5cz6W_, 0.8269, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3301, p5bxla_, 0.8269, 2.05, 0.184, 218, 196, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3302, d4y9yW_, 0.8269, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3303, d4y8rI_, 0.8269, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3304, p4y8qI_, 0.8269, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3305, p4y8nW_, 0.8269, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3306, p4y8gM_, 0.8269, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3307, p4y8ga_, 0.8269, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3308, p4y82I_, 0.8269, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3309, p4y74I_, 0.8269, 2.02, 0.197, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3310, d4r17W_, 0.8269, 2.03, 0.192, 204, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3311, d4r17I_, 0.8269, 2.03, 0.192, 204, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3312, d4qz3W_, 0.8269, 2.02, 0.192, 204, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3313, d4qz3I_, 0.8269, 2.02, 0.192, 204, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3314, d4qw6W_, 0.8269, 2.02, 0.192, 204, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3315, d4qw6I_, 0.8269, 2.02, 0.192, 204, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3316, d4qvqW_, 0.8269, 2.02, 0.192, 204, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3317, d4qvlW_, 0.8269, 2.02, 0.192, 204, 193, YCP IN COMPLEX WITH BORTEZOMIB
3318, d4qvlI_, 0.8269, 2.02, 0.192, 204, 193, YCP IN COMPLEX WITH BORTEZOMIB
3319, d4jt0W_, 0.8269, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3320, d4jt0I_, 0.8269, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3321, d3un8W_, 0.8269, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3322, d3okjW_, 0.8269, 2.02, 0.192, 204, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3323, d3oevW_, 0.8269, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3324, d3mg8Z_, 0.8269, 1.96, 0.197, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3325, d3mg8I_, 0.8269, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3326, d3mg6I_, 0.8269, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3327, d2f16Z_, 0.8269, 1.97, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3328, d2f16W_, 0.8269, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3329, d2f16L_, 0.8269, 1.97, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3330, p6gopW_, 0.8268, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3331, p5vfsIA_, 0.8268, 2.11, 0.206, 204, 194, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3332, p5l6ca_, 0.8268, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3333, p5l65a_, 0.8268, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3334, p5l64a_, 0.8268, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3335, p5l5wa_, 0.8268, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3336, p5l5ja_, 0.8268, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3337, p5l5ha_, 0.8268, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3338, p5d0wa_, 0.8268, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3339, d5d0vW_, 0.8268, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3340, d5d0vI_, 0.8268, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3341, d4y9yI_, 0.8268, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3342, p4y8sW_, 0.8268, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3343, p4y82W_, 0.8268, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3344, p4y74W_, 0.8268, 2.02, 0.197, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3345, p4r17a_, 0.8268, 2.05, 0.184, 218, 196, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3346, p4qz7a_, 0.8268, 2.05, 0.179, 218, 196, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3347, d4qz4W_, 0.8268, 2.02, 0.192, 204, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3348, d4qz4I_, 0.8268, 2.02, 0.192, 204, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3349, p4qz0a_, 0.8268, 2.05, 0.179, 218, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3350, d4qw5W_, 0.8268, 2.02, 0.192, 204, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3351, d4qw5I_, 0.8268, 2.02, 0.192, 204, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3352, d4qvqI_, 0.8268, 2.02, 0.192, 204, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3353, d4no6Z_, 0.8268, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3354, d4no6L_, 0.8268, 1.96, 0.197, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3355, p4gk7Z_, 0.8268, 1.97, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3356, p4gk7L_, 0.8268, 1.97, 0.197, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3357, p3unbk_, 0.8268, 1.96, 0.212, 204, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3358, d3oeuW_, 0.8268, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3359, d3d29Z_, 0.8268, 1.97, 0.197, 222, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
3360, d3d29W_, 0.8268, 2.03, 0.192, 204, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
3361, d3d29L_, 0.8268, 1.97, 0.197, 222, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
3362, d3d29I_, 0.8268, 2.03, 0.192, 204, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
3363, p5t0gP_, 0.8267, 2.14, 0.206, 204, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3364, p5l4gW_, 0.8267, 2.06, 0.179, 199, 195, 
3365, p5czaa_, 0.8267, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3366, d5cz5I_, 0.8267, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3367, p4ya9I_, 0.8267, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3368, p4y8lW_, 0.8267, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3369, p4y8hM_, 0.8267, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3370, p4y8ha_, 0.8267, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3371, p4qv5a_, 0.8267, 2.06, 0.179, 218, 196, YCP BETA5-M45I MUTANT
3372, d4no9I_, 0.8267, 2.02, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3373, d4hrdZ_, 0.8267, 1.96, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3374, p4fzga_, 0.8267, 2.06, 0.179, 218, 196, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3375, d3unbW_, 0.8267, 2.12, 0.211, 204, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3376, d3okjI_, 0.8267, 2.02, 0.192, 204, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3377, d3nzxW_, 0.8267, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3378, d3nzxI_, 0.8267, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3379, d3gptW_, 0.8267, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3380, p5nifJ_, 0.8266, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3381, p5laja_, 0.8266, 2.05, 0.184, 218, 196, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3382, p5l60a_, 0.8266, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3383, p5l5va_, 0.8266, 2.06, 0.179, 218, 196,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3384, p5l5qa_, 0.8266, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3385, p5jhsa_, 0.8266, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3386, p5fgia_, 0.8266, 2.06, 0.179, 217, 196, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3387, p5dkja_, 0.8266, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3388, p5d0ta_, 0.8266, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3389, p5d0sa_, 0.8266, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3390, d5cz5W_, 0.8266, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3391, p5cgha_, 0.8266, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3392, p4y8lI_, 0.8266, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3393, p4y84W_, 0.8266, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3394, p4y70W_, 0.8266, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3395, p4y6vI_, 0.8266, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3396, p4y69W_, 0.8266, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3397, p4y69I_, 0.8266, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3398, d4qzxW_, 0.8266, 2.02, 0.192, 204, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3399, d4qzxI_, 0.8266, 2.02, 0.192, 204, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3400, d4qwfW_, 0.8266, 2.02, 0.192, 204, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3401, d4qwfI_, 0.8266, 2.02, 0.192, 204, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3402, p4qwfa_, 0.8266, 2.05, 0.179, 218, 196, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3403, p4qw6a_, 0.8266, 2.05, 0.179, 218, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3404, d4qvmW_, 0.8266, 2.02, 0.192, 204, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3405, d4qvmI_, 0.8266, 2.02, 0.192, 204, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3406, p4qvla_, 0.8266, 2.06, 0.179, 218, 196, YCP IN COMPLEX WITH BORTEZOMIB
3407, p4quya_, 0.8266, 2.06, 0.179, 218, 196, YCP BETA5-A49S-MUTANT
3408, p4qlta_, 0.8266, 2.04, 0.184, 218, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3409, d4no9W_, 0.8266, 2.02, 0.192, 204, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3410, p4inta_, 0.8266, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3411, d3hyeW_, 0.8266, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3412, d3hyeI_, 0.8266, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3413, d3gpwW_, 0.8266, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3414, d3gptI_, 0.8266, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3415, d3gpjW_, 0.8266, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3416, p5vfrp_, 0.8265, 2.10, 0.206, 204, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3417, p5vfqIA_, 0.8265, 2.10, 0.206, 204, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3418, p5l67a_, 0.8265, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3419, p5l5fa_, 0.8265, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3420, p5l54a_, 0.8265, 2.05, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3421, p5jhra_, 0.8265, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3422, p5fgea_, 0.8265, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3423, p5cz9a_, 0.8265, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3424, p5cghM_, 0.8265, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3425, p4ya9W_, 0.8265, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3426, p4y8sI_, 0.8265, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3427, p4y84I_, 0.8265, 2.01, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3428, p4y7wI_, 0.8265, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3429, p4y70I_, 0.8265, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3430, p4y6vW_, 0.8265, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3431, p4x6zJ_, 0.8265, 1.87, 0.193, 204, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3432, p4r67z_, 0.8265, 1.96, 0.207, 204, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3433, d4qz1W_, 0.8265, 2.02, 0.192, 204, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3434, d4qz1I_, 0.8265, 2.02, 0.192, 204, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3435, d4qwrW_, 0.8265, 2.02, 0.192, 204, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3436, p4qvpa_, 0.8265, 2.06, 0.179, 218, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3437, p4qv3a_, 0.8265, 2.06, 0.179, 218, 196, YCP BETA5-M45V MUTANT
3438, p4qv0a_, 0.8265, 2.06, 0.179, 218, 196, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3439, p4qbyW_, 0.8265, 2.03, 0.192, 204, 193, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3440, p4qbyI_, 0.8265, 2.03, 0.192, 204, 193, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3441, p4no8a_, 0.8265, 2.05, 0.179, 218, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3442, d4ltcW_, 0.8265, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3443, d4lqiW_, 0.8265, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3444, d4lqiI_, 0.8265, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3445, d4inuW_, 0.8265, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3446, p4inra_, 0.8265, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3447, d3sdkW_, 0.8265, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3448, d3sdiZ_, 0.8265, 1.97, 0.197, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3449, d3sdiI_, 0.8265, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3450, d3gpwI_, 0.8265, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3451, d3gpjI_, 0.8265, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3452, d2zcyW_, 0.8265, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3453, d2zcyI_, 0.8265, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3454, p5l68a_, 0.8264, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3455, p5l4gK_, 0.8264, 1.86, 0.238, 207, 193, 
3456, p5fgfa_, 0.8264, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3457, p5fgaa_, 0.8264, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3458, d5cz6I_, 0.8264, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3459, p4ya9M_, 0.8264, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3460, p4ya9a_, 0.8264, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3461, p4y9zI_, 0.8264, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3462, p4y7wW_, 0.8264, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3463, d4r67X_, 0.8264, 1.96, 0.207, 204, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3464, p4r67l_, 0.8264, 1.96, 0.207, 204, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3465, d4r67J_, 0.8264, 1.96, 0.207, 204, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3466, p4r02a_, 0.8264, 2.06, 0.179, 218, 196, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3467, d4qwrI_, 0.8264, 2.02, 0.192, 204, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3468, p4qwla_, 0.8264, 2.05, 0.179, 218, 196, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3469, d4qw3W_, 0.8264, 2.03, 0.192, 204, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3470, d4qw1W_, 0.8264, 2.02, 0.192, 204, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3471, d4qw1I_, 0.8264, 2.02, 0.192, 204, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3472, d4qw0W_, 0.8264, 2.03, 0.192, 204, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3473, d4qw0I_, 0.8264, 2.03, 0.192, 204, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3474, d4qvyW_, 0.8264, 2.02, 0.192, 204, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3475, d4qvyI_, 0.8264, 2.02, 0.192, 204, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3476, p4qvqa_, 0.8264, 2.06, 0.179, 218, 196, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3477, p4qv9a_, 0.8264, 2.06, 0.179, 218, 196, YCP BETA5-C63F MUTANT
3478, p4qv7a_, 0.8264, 2.06, 0.179, 218, 196, YCP BETA5-A50V MUTANT
3479, p4qv4a_, 0.8264, 2.06, 0.179, 218, 196, YCP BETA5-M45T MUTANT
3480, p4qv1a_, 0.8264, 2.06, 0.179, 218, 196, YCP BETA5-M45A MUTANT
3481, d4ltcI_, 0.8264, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3482, d4j70I_, 0.8264, 1.87, 0.193, 204, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3483, d3mg8L_, 0.8264, 1.97, 0.197, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3484, d3mg4W_, 0.8264, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3485, d3mg0W_, 0.8264, 2.03, 0.197, 204, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3486, d3h6i2_, 0.8264, 2.54, 0.226, 214, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3487, d3dy3W_, 0.8264, 1.87, 0.193, 204, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3488, p5vfsJ_, 0.8263, 2.11, 0.206, 204, 194, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3489, p5vfrP_, 0.8263, 2.11, 0.206, 204, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3490, p5vfqJ_, 0.8263, 2.11, 0.206, 204, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3491, p5laia_, 0.8263, 2.06, 0.184, 218, 196, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3492, p5l69a_, 0.8263, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3493, p5l5xa_, 0.8263, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3494, p5l5ia_, 0.8263, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3495, p5l55a_, 0.8263, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3496, p5fhsa_, 0.8263, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3497, p5fg7a_, 0.8263, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3498, p4ya5I_, 0.8263, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3499, p4ya2M_, 0.8263, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3500, p4ya2a_, 0.8263, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3501, p4y9zW_, 0.8263, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3502, p4y8ra_, 0.8263, 2.05, 0.184, 218, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3503, p4y80W_, 0.8263, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3504, p4y80I_, 0.8263, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3505, d4r3oY_, 0.8263, 1.92, 0.180, 199, 194, HUMAN CONSTITUTIVE 20S PROTEASOME
3506, d4r3oK_, 0.8263, 1.91, 0.180, 199, 194, HUMAN CONSTITUTIVE 20S PROTEASOME
3507, p4qzza_, 0.8263, 2.06, 0.179, 218, 196, YCP IN COMPLEX WITH OMURALIDE
3508, d4qz2W_, 0.8263, 2.02, 0.192, 204, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3509, d4qz2I_, 0.8263, 2.02, 0.192, 204, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3510, p4qw7a_, 0.8263, 2.06, 0.179, 218, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3511, p4qw5a_, 0.8263, 2.06, 0.179, 218, 196, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3512, p4qw1a_, 0.8263, 2.06, 0.179, 218, 196, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3513, p4qvwa_, 0.8263, 2.06, 0.179, 218, 196, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3514, p4qv6a_, 0.8263, 2.06, 0.179, 218, 196, YCP BETA5-A49V MUTANT
3515, d4j70W_, 0.8263, 1.87, 0.193, 204, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3516, d4eu2J_, 0.8263, 2.02, 0.192, 204, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3517, p3unhW_, 0.8263, 2.11, 0.211, 204, 194, MOUSE 20S IMMUNOPROTEASOME
3518, p3unhI_, 0.8263, 2.11, 0.211, 204, 194, MOUSE 20S IMMUNOPROTEASOME
3519, d3mg4I_, 0.8263, 2.03, 0.192, 204, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3520, d3h6f2_, 0.8263, 2.55, 0.231, 214, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3521, p5ltta_, 0.8262, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3522, p5fgda_, 0.8262, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3523, p5cz7a_, 0.8262, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3524, p5cgfa_, 0.8262, 2.06, 0.184, 218, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3525, p4zzgJ_, 0.8262, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3526, p4ya5W_, 0.8262, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3527, p4ya1a_, 0.8262, 2.06, 0.184, 218, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3528, p4y8oW_, 0.8262, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3529, p4y8oI_, 0.8262, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3530, p4y8ka_, 0.8262, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3531, p4y8jW_, 0.8262, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3532, p4y8jI_, 0.8262, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3533, p4y81W_, 0.8262, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3534, p4y81I_, 0.8262, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3535, d4qzwW_, 0.8262, 2.02, 0.192, 204, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3536, d4qzwI_, 0.8262, 2.02, 0.192, 204, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3537, d4qwuW_, 0.8262, 2.02, 0.192, 204, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3538, d4qwuI_, 0.8262, 2.02, 0.192, 204, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3539, d4qwkW_, 0.8262, 2.03, 0.192, 204, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3540, d4qwiW_, 0.8262, 2.03, 0.192, 204, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3541, d4jsqW_, 0.8262, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3542, d4jsqI_, 0.8262, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3543, d4hnpW_, 0.8262, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3544, d3unfW_, 0.8262, 2.10, 0.211, 204, 194, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3545, d3unfI_, 0.8262, 2.10, 0.211, 204, 194, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3546, p3uney_, 0.8262, 1.96, 0.212, 204, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3547, d3mg7W_, 0.8262, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3548, d3bdmW_, 0.8262, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3549, p6gopM_, 0.8261, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3550, p6gopa_, 0.8261, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3551, p5t0cHB_, 0.8261, 2.10, 0.206, 204, 194, 
3552, p5t0cBA_, 0.8261, 2.10, 0.206, 204, 194, 
3553, p5gjqc_, 0.8261, 1.96, 0.207, 204, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3554, d5dkiW_, 0.8261, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3555, d5dkiI_, 0.8261, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3556, p5d0za_, 0.8261, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3557, p5d0va_, 0.8261, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3558, p5boua_, 0.8261, 2.06, 0.184, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3559, p4ya3I_, 0.8261, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3560, p4y8kM_, 0.8261, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3561, p4y84M_, 0.8261, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3562, p4y84a_, 0.8261, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3563, p4qz1a_, 0.8261, 2.06, 0.179, 218, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3564, d4qxjW_, 0.8261, 2.03, 0.192, 204, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3565, d4qxjI_, 0.8261, 2.03, 0.192, 204, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3566, d4qwkI_, 0.8261, 2.03, 0.192, 204, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3567, d4qwiI_, 0.8261, 2.03, 0.192, 204, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3568, d4qw4W_, 0.8261, 2.03, 0.192, 204, 193, YCP IN COMPLEX WITH CARFILZOMIB
3569, d4qw4I_, 0.8261, 2.02, 0.192, 204, 193, YCP IN COMPLEX WITH CARFILZOMIB
3570, d4qvwW_, 0.8261, 2.03, 0.192, 204, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3571, d4qvwI_, 0.8261, 2.03, 0.192, 204, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3572, p4qv8a_, 0.8261, 2.06, 0.179, 218, 196, YCP BETA5-C52F MUTANT
3573, p4qlva_, 0.8261, 2.05, 0.184, 218, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3574, p4ltca_, 0.8261, 2.06, 0.179, 218, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3575, d4inuI_, 0.8261, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3576, d3shjW_, 0.8261, 1.87, 0.193, 204, 192, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3577, d3shjI_, 0.8261, 1.87, 0.193, 204, 192, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3578, d3mg8W_, 0.8261, 2.02, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3579, d3mg0I_, 0.8261, 2.04, 0.192, 204, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3580, d3bdmI_, 0.8261, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3581, p5vfop_, 0.8260, 2.10, 0.206, 204, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3582, p5l5aa_, 0.8260, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3583, d5d0xW_, 0.8260, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3584, d5d0xI_, 0.8260, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3585, d5cz4W_, 0.8260, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3586, d5cz4I_, 0.8260, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3587, p4ya3W_, 0.8260, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3588, p4y9ya_, 0.8260, 2.06, 0.184, 218, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3589, p4y78I_, 0.8260, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3590, d4qwsW_, 0.8260, 2.03, 0.192, 204, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3591, d4qwsI_, 0.8260, 2.03, 0.192, 204, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3592, d4qwgW_, 0.8260, 2.03, 0.192, 204, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3593, p4qvma_, 0.8260, 2.06, 0.179, 218, 196, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3594, p4qlsa_, 0.8260, 2.06, 0.179, 218, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3595, p4no6a_, 0.8260, 2.06, 0.179, 218, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3596, p5vfrS_, 0.8259, 2.11, 0.206, 213, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3597, p5vfpHA_, 0.8259, 2.10, 0.206, 204, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3598, p5vfos_, 0.8259, 1.96, 0.207, 213, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3599, p5mpbM_, 0.8259, 2.05, 0.196, 222, 194, 
3600, p5l5ea_, 0.8259, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3601, p5fghM_, 0.8259, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3602, p5fgha_, 0.8259, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3603, d5cz8W_, 0.8259, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3604, d5cz8I_, 0.8259, 2.02, 0.192, 204, 193, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3605, p5cz6a_, 0.8259, 2.06, 0.184, 218, 196, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3606, p5cgiM_, 0.8259, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3607, p5cgia_, 0.8259, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3608, p4ya7M_, 0.8259, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3609, p4ya7a_, 0.8259, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3610, p4y8tM_, 0.8259, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3611, p4y8ta_, 0.8259, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3612, p4y7yW_, 0.8259, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3613, p4y78W_, 0.8259, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3614, d4qwjW_, 0.8259, 2.03, 0.192, 204, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3615, d4qwgI_, 0.8259, 2.03, 0.192, 204, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3616, d4qw3I_, 0.8259, 2.03, 0.192, 204, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3617, p4qvya_, 0.8259, 2.07, 0.179, 218, 196, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3618, p4quxa_, 0.8259, 2.07, 0.179, 218, 196, YCP BETA5-A49T-MUTANT
3619, p4nnna_, 0.8259, 2.06, 0.179, 218, 196, YCP IN COMPLEX WITH MG132
3620, p4lqia_, 0.8259, 2.06, 0.184, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3621, p4j70a_, 0.8259, 2.08, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3622, p4inua_, 0.8259, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3623, d4intW_, 0.8259, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3624, d4intI_, 0.8259, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3625, p4fzca_, 0.8259, 2.07, 0.179, 218, 196, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3626, p4y8iW_, 0.8258, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3627, p4y8iI_, 0.8258, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3628, p4y7yI_, 0.8258, 2.03, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3629, p4y6aM_, 0.8258, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3630, p4y6aa_, 0.8258, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3631, p4qz6a_, 0.8258, 2.06, 0.179, 218, 196, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3632, d4qwjI_, 0.8258, 2.03, 0.192, 204, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3633, p4qw4a_, 0.8258, 2.06, 0.179, 218, 196, YCP IN COMPLEX WITH CARFILZOMIB
3634, p4qlua_, 0.8258, 2.06, 0.179, 218, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3635, p4nnwa_, 0.8258, 2.07, 0.179, 218, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3636, p4jsqa_, 0.8258, 2.06, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3637, p3un8a_, 0.8258, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3638, p3un4W_, 0.8258, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3639, p3un4M_, 0.8258, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3640, p3un4I_, 0.8258, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3641, d3sdiW_, 0.8258, 2.03, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3642, d1g0uW_, 0.8258, 2.04, 0.192, 204, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3643, p5fg9a_, 0.8257, 2.06, 0.184, 218, 196, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3644, p4x6zN_, 0.8257, 2.07, 0.184, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3645, p4x6z2_, 0.8257, 2.07, 0.184, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3646, p4r00a_, 0.8257, 2.07, 0.179, 218, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3647, p4qz2a_, 0.8257, 2.07, 0.179, 218, 196, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3648, p4qwra_, 0.8257, 2.06, 0.179, 218, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3649, d4jsuW_, 0.8257, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3650, d4jsuI_, 0.8257, 2.04, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3651, d4hrdL_, 0.8257, 1.97, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3652, d3mg6W_, 0.8257, 2.03, 0.192, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3653, d3h6iC_, 0.8257, 2.56, 0.226, 214, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3654, p5mpcN_, 0.8256, 2.05, 0.179, 218, 196, 
3655, p5mp97_, 0.8256, 2.07, 0.179, 218, 196, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3656, p5ln31_, 0.8256, 2.33, 0.268, 214, 198, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3657, p5gjrPA_, 0.8256, 1.98, 0.207, 204, 193, 
3658, p5gjrBA_, 0.8256, 1.98, 0.207, 204, 193, 
3659, p5gjqu_, 0.8256, 1.87, 0.238, 207, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3660, p4z1la_, 0.8256, 2.06, 0.184, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3661, d4r3oX_, 0.8256, 1.98, 0.207, 204, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
3662, d4r3oJ_, 0.8256, 1.98, 0.207, 204, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
3663, p4qbya_, 0.8256, 2.07, 0.184, 218, 196, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3664, p4no1a_, 0.8256, 2.07, 0.179, 218, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3665, p4hrda_, 0.8256, 2.06, 0.179, 218, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3666, p4hnpa_, 0.8256, 2.07, 0.179, 218, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3667, d1jd2P_, 0.8256, 2.04, 0.197, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3668, d1jd2I_, 0.8256, 2.04, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3669, p5cz8a_, 0.8255, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3670, p4y9zM_, 0.8255, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3671, p4y9za_, 0.8255, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3672, p4y8ua_, 0.8255, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3673, p4y8lM_, 0.8255, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3674, p4y8la_, 0.8255, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3675, p4y82M_, 0.8255, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3676, p4y82a_, 0.8255, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3677, p4y6vM_, 0.8255, 2.07, 0.184, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3678, p4y6va_, 0.8255, 2.07, 0.184, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3679, p4y69M_, 0.8255, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3680, p4y69a_, 0.8255, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3681, p4rura_, 0.8255, 2.07, 0.184, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3682, p4qwxa_, 0.8255, 2.07, 0.179, 218, 196, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3683, p4qlqa_, 0.8255, 2.07, 0.179, 218, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3684, p4qbyM_, 0.8255, 2.07, 0.184, 218, 196, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3685, p4no9a_, 0.8255, 2.07, 0.179, 218, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3686, d3okjZ_, 0.8255, 2.01, 0.197, 221, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3687, p5t0gN_, 0.8254, 1.73, 0.274, 191, 190, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3688, p5nif2_, 0.8254, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3689, p5cz5a_, 0.8254, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3690, p4y8uM_, 0.8254, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3691, p4y81M_, 0.8254, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3692, p4y81a_, 0.8254, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3693, p4y74M_, 0.8254, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3694, p4y6zM_, 0.8254, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3695, p4y6za_, 0.8254, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3696, p4qz3a_, 0.8254, 2.07, 0.179, 218, 196, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3697, d4hnpI_, 0.8254, 2.03, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3698, d4fzcI_, 0.8254, 1.88, 0.193, 204, 192, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3699, d3wxrX_, 0.8254, 1.88, 0.193, 204, 192, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3700, d1g0uI_, 0.8254, 2.04, 0.192, 204, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3701, p5vfuOA_, 0.8253, 2.12, 0.206, 204, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3702, p5vftp_, 0.8253, 2.12, 0.206, 204, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3703, p5vfqLA_, 0.8253, 1.97, 0.207, 213, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3704, p5vfpJ_, 0.8253, 2.12, 0.206, 204, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3705, p4zzg2_, 0.8253, 2.07, 0.184, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3706, p4ya0I_, 0.8253, 2.05, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3707, p4y7xM_, 0.8253, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3708, p4y7xa_, 0.8253, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3709, p4y74a_, 0.8253, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3710, p4qw3a_, 0.8253, 2.07, 0.179, 218, 196, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3711, d4fzcW_, 0.8253, 1.88, 0.193, 204, 192, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3712, d4cr27_, 0.8253, 2.42, 0.178, 233, 202, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3713, p3jcpI_, 0.8253, 2.05, 0.179, 218, 196, 
3714, p3jcpB_, 0.8253, 2.05, 0.179, 218, 196, 
3715, d1jd2S_, 0.8253, 1.98, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3716, d1iruM_, 0.8253, 1.99, 0.207, 213, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3717, d1iru1_, 0.8253, 1.99, 0.207, 213, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3718, p5dkia_, 0.8252, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3719, p4ya0W_, 0.8252, 2.05, 0.192, 204, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3720, p4qzwa_, 0.8252, 2.07, 0.179, 218, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3721, p4qwka_, 0.8252, 2.07, 0.179, 218, 196, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3722, p4qwia_, 0.8252, 2.07, 0.179, 218, 196, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3723, p4qw0a_, 0.8252, 2.08, 0.179, 218, 196, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3724, p4jt0a_, 0.8252, 2.08, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3725, p4gk7M_, 0.8252, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3726, p4gk7a_, 0.8252, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3727, d4eu2X_, 0.8252, 1.89, 0.193, 204, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3728, p4jsua_, 0.8251, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3729, d4hrcL_, 0.8251, 1.98, 0.197, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3730, p4hrca_, 0.8251, 2.07, 0.179, 218, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3731, d4fzgW_, 0.8251, 1.89, 0.193, 204, 192, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3732, d3h6iZ_, 0.8251, 2.56, 0.231, 214, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3733, d1rypX_, 0.8251, 2.05, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3734, p5gjrSA_, 0.8250, 1.99, 0.207, 213, 193, 
3735, p5gjrEA_, 0.8250, 1.99, 0.207, 213, 193, 
3736, p5d0xa_, 0.8250, 2.08, 0.179, 218, 196, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3737, p4y8iM_, 0.8250, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3738, p4y8ia_, 0.8250, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3739, p4v7oJ_, 0.8250, 1.89, 0.193, 204, 192, 
3740, p4qwsa_, 0.8250, 2.08, 0.179, 218, 196, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3741, d4qvvW_, 0.8250, 2.04, 0.192, 204, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3742, d4qvvI_, 0.8250, 2.04, 0.192, 204, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3743, p4gk7I_, 0.8250, 2.05, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3744, d4fzgI_, 0.8250, 1.89, 0.193, 204, 192, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3745, d3l5qN_, 0.8250, 1.89, 0.193, 204, 192,  
3746, p5gjqn_, 0.8249, 2.58, 0.136, 243, 199, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3747, p4ya5M_, 0.8249, 2.07, 0.184, 218, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3748, p4ya5a_, 0.8249, 2.07, 0.184, 218, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3749, p4y8sM_, 0.8249, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3750, p4y8sa_, 0.8249, 2.07, 0.179, 218, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3751, p4y80M_, 0.8249, 2.08, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3752, p4y80a_, 0.8249, 2.08, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3753, p4v7oRA_, 0.8249, 1.89, 0.193, 204, 192, 
3754, p4gk7W_, 0.8249, 2.05, 0.192, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3755, d2gplI_, 0.8249, 1.89, 0.193, 204, 192, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3756, d1vsyJ_, 0.8249, 1.89, 0.193, 204, 192,  
3757, d1rypJ_, 0.8249, 2.04, 0.192, 204, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3758, d1jd2L_, 0.8249, 1.99, 0.197, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3759, p4y8jM_, 0.8248, 2.08, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3760, p4y7wa_, 0.8248, 2.08, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3761, p4y70a_, 0.8248, 2.08, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3762, p4qwga_, 0.8248, 2.08, 0.179, 218, 196, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3763, d4hrcI_, 0.8248, 2.04, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3764, d3okj1_, 0.8248, 2.41, 0.175, 228, 200, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3765, d2gplW_, 0.8248, 1.89, 0.193, 204, 192, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3766, d1g65W_, 0.8248, 2.04, 0.192, 204, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3767, p5l4gI_, 0.8247, 2.06, 0.179, 199, 195, 
3768, p4y8ja_, 0.8247, 2.08, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3769, p4y7wM_, 0.8247, 2.08, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3770, p4y70M_, 0.8247, 2.08, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3771, p4v7oX_, 0.8247, 1.89, 0.193, 204, 192, 
3772, p4v7oFB_, 0.8247, 1.89, 0.193, 204, 192, 
3773, p4qzxa_, 0.8247, 2.08, 0.179, 218, 196, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3774, d3wxrJ_, 0.8247, 1.89, 0.193, 204, 192, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3775, d3l5qZ_, 0.8247, 1.89, 0.193, 204, 192,  
3776, p3hf9h_, 0.8247, 2.53, 0.227, 213, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
3777, d3h6fZ_, 0.8247, 2.57, 0.231, 214, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3778, d1vsyX_, 0.8247, 1.89, 0.193, 204, 192,  
3779, p5l4gV_, 0.8246, 2.13, 0.206, 213, 194, 
3780, d3h6fC_, 0.8246, 2.58, 0.231, 214, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3781, p6avoW_, 0.8245, 1.84, 0.240, 206, 192, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3782, p6avoa_, 0.8245, 1.84, 0.240, 206, 192, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3783, p5nifX_, 0.8245, 1.89, 0.193, 204, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3784, p5gjqX_, 0.8245, 2.63, 0.136, 243, 199, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3785, p5cz4a_, 0.8244, 2.08, 0.184, 218, 196, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3786, p4y7yM_, 0.8244, 2.08, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3787, p4y7ya_, 0.8244, 2.08, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3788, d4r3oM_, 0.8244, 2.01, 0.207, 213, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
3789, p5wvkC_, 0.8243, 1.91, 0.193, 204, 192, 
3790, p4zzgX_, 0.8243, 1.89, 0.193, 204, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3791, p4y78M_, 0.8243, 2.08, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3792, p4y78a_, 0.8243, 2.08, 0.179, 218, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3793, p4qwja_, 0.8243, 2.08, 0.179, 218, 196, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3794, d4hrdI_, 0.8243, 2.05, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3795, d4r3o1_, 0.8242, 2.01, 0.207, 213, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
3796, p4qvva_, 0.8242, 2.09, 0.179, 218, 196, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3797, p5vfuRA_, 0.8241, 2.10, 0.206, 213, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3798, p5vfuAA_, 0.8241, 2.15, 0.206, 204, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3799, p5vfts_, 0.8241, 2.10, 0.206, 213, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3800, p5vftP_, 0.8241, 2.15, 0.206, 204, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3801, p5gjrMA_, 0.8241, 2.61, 0.131, 243, 199, 
3802, d1g65I_, 0.8241, 2.04, 0.192, 204, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3803, p4ya3M_, 0.8240, 2.09, 0.184, 218, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3804, p4ya3a_, 0.8240, 2.09, 0.184, 218, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3805, d4hrcW_, 0.8240, 2.06, 0.192, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3806, p3jcpSA_, 0.8240, 2.05, 0.192, 204, 193, 
3807, p3jcpE_, 0.8240, 2.05, 0.192, 204, 193, 
3808, p5vfpKA_, 0.8239, 1.98, 0.207, 213, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3809, d4r3oU_, 0.8239, 2.64, 0.131, 245, 199, HUMAN CONSTITUTIVE 20S PROTEASOME
3810, p3unby_, 0.8239, 2.00, 0.212, 204, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3811, p5l4gH_, 0.8238, 2.15, 0.206, 213, 194, 
3812, p5gjrTA_, 0.8238, 1.89, 0.238, 207, 193, 
3813, p4ya0M_, 0.8237, 2.09, 0.184, 218, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3814, p4ya0a_, 0.8237, 2.09, 0.184, 218, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3815, d4r3oG_, 0.8237, 2.64, 0.131, 245, 199, HUMAN CONSTITUTIVE 20S PROTEASOME
3816, p5gjrY_, 0.8236, 2.62, 0.131, 243, 199, 
3817, p5gjqt_, 0.8236, 2.00, 0.207, 213, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3818, p5gjqf_, 0.8235, 2.01, 0.207, 213, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3819, p3uneL_, 0.8235, 2.01, 0.202, 213, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3820, p6avoV_, 0.8234, 1.82, 0.182, 196, 192, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3821, p6avoT_, 0.8234, 1.82, 0.182, 196, 192, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3822, p5gjqq_, 0.8233, 2.00, 0.207, 204, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3823, d4hrdW_, 0.8233, 2.06, 0.197, 204, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3824, p3unen_, 0.8233, 2.03, 0.202, 213, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3825, p5m32M_, 0.8231, 1.84, 0.240, 206, 192, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3826, p5a5bG_, 0.8231, 2.69, 0.146, 245, 198, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3827, p4cr3G_, 0.8231, 2.69, 0.146, 245, 198, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3828, p3un4a_, 0.8231, 2.04, 0.179, 217, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3829, p5mp93_, 0.8226, 2.06, 0.192, 204, 193, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3830, p5m32a_, 0.8226, 1.85, 0.240, 206, 192, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3831, p3une2_, 0.8226, 2.02, 0.202, 213, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3832, d4r67Y_, 0.8225, 1.96, 0.180, 199, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3833, p4r67m_, 0.8225, 1.96, 0.180, 199, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3834, d4r67K_, 0.8225, 1.96, 0.180, 199, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3835, d4r670_, 0.8225, 1.96, 0.180, 199, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3836, p4r67i_, 0.8223, 2.65, 0.136, 245, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3837, p5vfoQ_, 0.8222, 2.00, 0.179, 199, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3838, p5nifN_, 0.8222, 2.06, 0.179, 216, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3839, p4zzgN_, 0.8220, 2.06, 0.179, 216, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3840, p4r67w_, 0.8220, 2.65, 0.136, 245, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3841, d4r67U_, 0.8220, 2.65, 0.136, 245, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3842, p4r67p_, 0.8220, 1.92, 0.238, 207, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3843, p4r67b_, 0.8220, 1.92, 0.238, 207, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3844, p5vfoq_, 0.8219, 2.01, 0.179, 199, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3845, p1z7qb_, 0.8219, 2.07, 0.179, 217, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3846, p5vfrQ_, 0.8218, 2.00, 0.179, 199, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3847, p5mp9j_, 0.8218, 2.04, 0.197, 204, 193, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3848, d4r67G_, 0.8218, 2.65, 0.136, 245, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3849, p3uneZ_, 0.8218, 2.03, 0.202, 213, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3850, p6epf1_, 0.8217, 2.35, 0.080, 202, 199, GROUND STATE 26S PROTEASOME (GS1)
3851, p5l4gJ_, 0.8216, 2.14, 0.206, 204, 194, 
3852, d1iruY_, 0.8216, 1.97, 0.180, 199, 194, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3853, d1iruK_, 0.8216, 1.97, 0.180, 199, 194, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3854, p5t0cKB_, 0.8215, 2.03, 0.207, 213, 193, 
3855, p5t0cEA_, 0.8215, 2.03, 0.207, 213, 193, 
3856, p5gjqg_, 0.8215, 1.87, 0.240, 206, 192, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3857, p1fntN_, 0.8211, 2.07, 0.179, 217, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3858, p1fntb_, 0.8211, 2.07, 0.179, 217, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3859, d4r67M_, 0.8210, 2.04, 0.207, 213, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3860, p4r67a_, 0.8210, 2.04, 0.207, 213, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3861, d4r671_, 0.8210, 2.04, 0.207, 213, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3862, p4r67o_, 0.8209, 2.04, 0.207, 213, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3863, p5vfuBA_, 0.8208, 2.08, 0.179, 199, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3864, p5vftQ_, 0.8208, 2.08, 0.179, 199, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3865, p5t0iN_, 0.8208, 1.77, 0.274, 191, 190, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3866, p5mpcBA_, 0.8208, 2.11, 0.179, 218, 196, 
3867, p5l4gG_, 0.8208, 2.71, 0.131, 242, 199, 
3868, p3jcoSA_, 0.8208, 2.07, 0.192, 204, 193, 
3869, p3jcoE_, 0.8207, 2.07, 0.192, 204, 193, 
3870, d5le5Z_, 0.8205, 2.05, 0.207, 213, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3871, p5l4gX_, 0.8205, 2.18, 0.206, 204, 194, 
3872, p5lf6Z_, 0.8204, 2.04, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3873, p5vfqJA_, 0.8202, 2.03, 0.179, 199, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3874, p5vfpIA_, 0.8202, 2.03, 0.179, 199, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3875, p5lf6L_, 0.8202, 2.04, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3876, d3unbZ_, 0.8202, 2.05, 0.202, 213, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3877, p5vfpK_, 0.8201, 2.03, 0.179, 199, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3878, p5le5a_, 0.8201, 1.90, 0.240, 206, 192, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3879, p5l4gU_, 0.8201, 2.67, 0.131, 241, 199, 
3880, p5gjrFA_, 0.8201, 1.89, 0.240, 206, 192, 
3881, d5lexZ_, 0.8200, 2.05, 0.207, 213, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3882, p3unfa_, 0.8200, 1.92, 0.240, 206, 192, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3883, d5lexL_, 0.8199, 2.05, 0.207, 213, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3884, d5le5L_, 0.8199, 2.05, 0.207, 213, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3885, p3unea_, 0.8199, 1.92, 0.240, 206, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
3886, d3unb2_, 0.8199, 2.06, 0.202, 213, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3887, p3unhM_, 0.8198, 1.92, 0.240, 206, 192, MOUSE 20S IMMUNOPROTEASOME
3888, p3unha_, 0.8198, 1.92, 0.240, 206, 192, MOUSE 20S IMMUNOPROTEASOME
3889, p5lf7a_, 0.8197, 1.90, 0.240, 206, 192, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3890, p3unhZ_, 0.8197, 2.06, 0.202, 213, 193, MOUSE 20S IMMUNOPROTEASOME
3891, p3unhL_, 0.8197, 2.06, 0.202, 213, 193, MOUSE 20S IMMUNOPROTEASOME
3892, d3unbL_, 0.8196, 2.06, 0.202, 213, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3893, d5lf1Z_, 0.8195, 2.05, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3894, p3unez_, 0.8195, 1.88, 0.187, 196, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
3895, d3h6iN_, 0.8195, 2.54, 0.228, 212, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3896, p5vfuPA_, 0.8194, 2.10, 0.179, 199, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3897, p5vftq_, 0.8194, 2.10, 0.179, 199, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3898, d5lf3F_, 0.8194, 2.62, 0.131, 239, 198, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3899, p5lf3a_, 0.8194, 1.90, 0.240, 206, 192, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3900, d5lf1L_, 0.8194, 2.05, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3901, p5leyM_, 0.8194, 1.90, 0.240, 206, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3902, d3h6fN_, 0.8194, 2.55, 0.228, 212, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3903, p5vfuEA_, 0.8193, 1.86, 0.241, 205, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3904, p5vftT_, 0.8193, 1.86, 0.241, 205, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3905, p5leyF_, 0.8193, 2.62, 0.131, 239, 198, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3906, p5leya_, 0.8193, 1.90, 0.240, 206, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3907, p3unbn_, 0.8193, 2.06, 0.202, 213, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3908, p5vfsN_, 0.8192, 1.86, 0.241, 205, 191, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3909, p5mpcX_, 0.8192, 2.09, 0.197, 204, 193, 
3910, d5lf7F_, 0.8192, 2.63, 0.131, 239, 198, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3911, p5lf6F_, 0.8192, 2.63, 0.131, 239, 198, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3912, p5lf4a_, 0.8192, 1.90, 0.240, 206, 192, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3913, p4v7oN_, 0.8192, 2.10, 0.179, 217, 195, 
3914, p4v7oJB_, 0.8192, 2.10, 0.179, 217, 195, 
3915, p4v7oBA_, 0.8192, 2.10, 0.179, 217, 195, 
3916, p5vfoT_, 0.8191, 1.85, 0.241, 205, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3917, d5le5F_, 0.8191, 2.62, 0.131, 239, 198, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3918, p5vfuLA_, 0.8190, 2.60, 0.141, 240, 198, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3919, p5vftm_, 0.8190, 2.60, 0.141, 240, 198, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3920, p5vfqK_, 0.8190, 2.04, 0.179, 199, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3921, p5t0gS_, 0.8190, 2.06, 0.207, 213, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3922, d5lf1F_, 0.8190, 2.62, 0.131, 239, 198, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3923, p5lf0F_, 0.8190, 2.63, 0.131, 239, 198, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3924, d5lexT_, 0.8190, 2.62, 0.131, 240, 198, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3925, p4v7oVA_, 0.8190, 2.10, 0.179, 217, 195, 
3926, p5m32Z_, 0.8189, 2.02, 0.202, 213, 193, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3927, p5m32L_, 0.8189, 2.02, 0.202, 213, 193, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3928, d5lf7Z_, 0.8189, 2.06, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3929, d5lf4F_, 0.8189, 2.62, 0.131, 239, 198, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3930, p5lf6M_, 0.8188, 1.91, 0.240, 206, 192, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3931, p5leyZ_, 0.8188, 2.06, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3932, d5lexF_, 0.8188, 2.63, 0.131, 239, 198, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3933, d5lf4Z_, 0.8187, 2.06, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3934, p5mpbX_, 0.8186, 2.13, 0.187, 204, 193, 
3935, p5lf6a_, 0.8186, 1.91, 0.240, 206, 192, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3936, p5lf1a_, 0.8186, 1.91, 0.240, 206, 192, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3937, p4qxja_, 0.8186, 2.04, 0.180, 216, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3938, d4cr2G_, 0.8186, 2.69, 0.146, 245, 198, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3939, p3unhT_, 0.8186, 2.65, 0.136, 244, 198, MOUSE 20S IMMUNOPROTEASOME
3940, p3unhF_, 0.8186, 2.65, 0.136, 244, 198, MOUSE 20S IMMUNOPROTEASOME
3941, p5vfrq_, 0.8185, 2.05, 0.179, 199, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3942, p5leyL_, 0.8185, 2.06, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3943, p3une3_, 0.8185, 1.92, 0.240, 206, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
3944, p3unbh_, 0.8185, 2.65, 0.131, 244, 198, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3945, p5vfsMA_, 0.8184, 1.87, 0.241, 205, 191, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3946, p5vfpN_, 0.8184, 1.86, 0.241, 205, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3947, d5lf4L_, 0.8184, 2.07, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3948, d5lf3Z_, 0.8184, 2.07, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3949, p5lf0Z_, 0.8184, 2.06, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3950, d3unfZ_, 0.8184, 2.07, 0.202, 213, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3951, d3unfT_, 0.8184, 2.64, 0.136, 244, 198, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3952, d3unfL_, 0.8184, 2.07, 0.202, 213, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3953, d3unfF_, 0.8184, 2.64, 0.136, 244, 198, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3954, p5lf0a_, 0.8183, 1.92, 0.240, 206, 192, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3955, d1iruU_, 0.8183, 2.67, 0.136, 245, 199, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3956, d1iruG_, 0.8183, 2.67, 0.136, 245, 199, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3957, p5lf0M_, 0.8182, 1.92, 0.240, 206, 192, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3958, p5lezL_, 0.8182, 2.07, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3959, p5lf0L_, 0.8181, 2.07, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3960, p5lezZ_, 0.8181, 2.07, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3961, d3h6iH_, 0.8181, 2.56, 0.228, 212, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3962, p5vfuSA_, 0.8180, 1.86, 0.241, 205, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3963, p5vftt_, 0.8180, 1.86, 0.241, 205, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3964, p5vfsK_, 0.8180, 2.12, 0.179, 199, 195, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3965, d5lf7L_, 0.8180, 2.07, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3966, d5lf3L_, 0.8180, 2.07, 0.207, 213, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3967, p5lezF_, 0.8180, 2.63, 0.131, 239, 198, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3968, p3unhX_, 0.8180, 1.89, 0.187, 196, 192, MOUSE 20S IMMUNOPROTEASOME
3969, p3unhJ_, 0.8180, 1.89, 0.187, 196, 192, MOUSE 20S IMMUNOPROTEASOME
3970, p3uneM_, 0.8180, 1.92, 0.240, 206, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
3971, d3h6fH_, 0.8180, 2.56, 0.228, 212, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3972, p5vfpLA_, 0.8179, 1.87, 0.241, 205, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3973, p5lf6T_, 0.8179, 2.64, 0.131, 240, 198, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3974, d5lf3T_, 0.8179, 2.65, 0.131, 240, 198, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3975, d5lf1T_, 0.8179, 2.64, 0.131, 240, 198, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3976, p5lezT_, 0.8179, 2.64, 0.131, 240, 198, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3977, p5m32T_, 0.8178, 2.76, 0.131, 240, 199, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3978, d5lf7T_, 0.8178, 2.65, 0.131, 240, 198, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3979, p5lf0T_, 0.8178, 2.65, 0.131, 240, 198, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3980, p5lexa_, 0.8178, 1.92, 0.240, 206, 192, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3981, d5lf4T_, 0.8177, 2.64, 0.131, 240, 198, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3982, p5lezM_, 0.8177, 1.92, 0.240, 206, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3983, p5leyT_, 0.8177, 2.64, 0.131, 240, 198, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3984, p3uneX_, 0.8177, 1.90, 0.187, 196, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
3985, p3uneT_, 0.8177, 2.66, 0.131, 244, 198, MOUSE CONSTITUTIVE 20S PROTEASOME
3986, d3unbF_, 0.8177, 2.66, 0.131, 244, 198, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3987, p5vfsJA_, 0.8176, 2.14, 0.179, 199, 195, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3988, p5vfot_, 0.8176, 1.87, 0.241, 205, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3989, p5mpa3_, 0.8176, 2.11, 0.192, 204, 193, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3990, p3uneJ_, 0.8176, 1.90, 0.187, 196, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
3991, d3unfX_, 0.8173, 1.90, 0.187, 196, 192, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3992, d3unfJ_, 0.8173, 1.90, 0.187, 196, 192, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3993, p5vfoM_, 0.8172, 2.65, 0.146, 240, 199, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3994, p5leza_, 0.8172, 1.95, 0.240, 206, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3995, d5le5T_, 0.8172, 2.64, 0.131, 240, 198, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3996, d5le5J_, 0.8171, 1.92, 0.182, 195, 192, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3997, p4cr46_, 0.8171, 2.13, 0.196, 222, 194, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3998, p3unba_, 0.8171, 1.94, 0.240, 206, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3999, p5t0jN_, 0.8169, 1.86, 0.274, 191, 190, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4000, p3uneo_, 0.8169, 1.95, 0.240, 206, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
4001, p5vfpG_, 0.8168, 2.64, 0.146, 240, 199, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4002, p5m32W_, 0.8168, 2.20, 0.206, 204, 194, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4003, p5m32I_, 0.8168, 2.20, 0.206, 204, 194, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4004, p3unel_, 0.8168, 1.91, 0.187, 196, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
4005, p3unbv_, 0.8168, 2.67, 0.131, 244, 198, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4006, d5le5X_, 0.8167, 1.93, 0.182, 195, 192, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4007, p5vfrT_, 0.8166, 1.88, 0.241, 205, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4008, p5vfrM_, 0.8166, 2.63, 0.146, 240, 199, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4009, p5vfqMA_, 0.8166, 1.88, 0.241, 205, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4010, p4cr4E_, 0.8166, 2.93, 0.208, 243, 202, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4011, p3uneh_, 0.8166, 2.67, 0.131, 244, 198, MOUSE CONSTITUTIVE 20S PROTEASOME
4012, p3unbo_, 0.8166, 1.96, 0.240, 206, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4013, p3unbl_, 0.8165, 1.91, 0.187, 196, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4014, d5lexJ_, 0.8164, 1.93, 0.182, 195, 192, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4015, p5l52a_, 0.8164, 2.02, 0.181, 215, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4016, p3uneF_, 0.8164, 2.56, 0.137, 244, 197, MOUSE CONSTITUTIVE 20S PROTEASOME
4017, d5lf7J_, 0.8163, 1.93, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4018, d5lf1J_, 0.8163, 1.93, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4019, p5lf0J_, 0.8163, 1.93, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4020, p3unev_, 0.8163, 2.67, 0.131, 244, 198, MOUSE CONSTITUTIVE 20S PROTEASOME
4021, d3unbT_, 0.8163, 2.66, 0.141, 244, 198, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4022, d3unbJ_, 0.8163, 1.92, 0.187, 196, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4023, p5vfqN_, 0.8162, 1.89, 0.241, 205, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4024, p5lf0X_, 0.8162, 1.93, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4025, d5lexX_, 0.8162, 1.93, 0.182, 195, 192, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4026, p6avoQ_, 0.8161, 2.65, 0.131, 239, 198, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4027, p6avoJ_, 0.8161, 2.65, 0.131, 239, 198, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4028, p5leyX_, 0.8161, 1.93, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4029, d3unbX_, 0.8161, 1.92, 0.187, 196, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4030, d5lf7X_, 0.8160, 1.93, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4031, d5lf1X_, 0.8160, 1.94, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4032, p4cr4G_, 0.8160, 2.64, 0.152, 245, 197, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4033, p5vfqG_, 0.8159, 2.65, 0.146, 240, 199, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4034, p5t0hN_, 0.8159, 1.84, 0.274, 191, 190, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4035, d5lf4J_, 0.8159, 1.93, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4036, p5leyJ_, 0.8159, 1.94, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4037, p5vfqFA_, 0.8158, 2.65, 0.146, 240, 199, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4038, d5lf4X_, 0.8158, 1.94, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4039, d5lf3X_, 0.8158, 1.94, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4040, d5lf3J_, 0.8158, 1.94, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4041, p4qz4a_, 0.8158, 2.02, 0.181, 215, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4042, p3unbz_, 0.8158, 1.93, 0.187, 196, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4043, p5vfom_, 0.8156, 2.66, 0.146, 240, 199, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4044, p5t0iP_, 0.8156, 2.12, 0.207, 204, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4045, p5lezJ_, 0.8156, 1.94, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4046, p5vfuX_, 0.8155, 2.55, 0.142, 240, 197, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4047, p5vftM_, 0.8155, 2.55, 0.142, 240, 197, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4048, p5vfsG_, 0.8155, 2.71, 0.141, 240, 199, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4049, p5m32J_, 0.8154, 1.93, 0.187, 196, 192, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4050, p5mpcJ_, 0.8153, 2.11, 0.192, 204, 193, 
4051, p5lf6J_, 0.8153, 1.94, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4052, p5fmgM_, 0.8153, 1.77, 0.191, 199, 188, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4053, p5fmga_, 0.8153, 1.77, 0.191, 199, 188, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4054, p5vfrt_, 0.8152, 1.90, 0.241, 205, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4055, p5m32X_, 0.8152, 1.93, 0.187, 196, 192, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4056, p5lezX_, 0.8152, 1.94, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4057, p5dsvF_, 0.8152, 2.80, 0.136, 244, 199, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4058, p5dsvB_, 0.8152, 2.57, 0.137, 245, 197, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4059, p4qz5a_, 0.8151, 2.03, 0.181, 215, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4060, p5lf6X_, 0.8150, 1.95, 0.182, 195, 192, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4061, p5dsvL_, 0.8150, 2.80, 0.136, 245, 199, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4062, d3oeuR_, 0.8148, 2.92, 0.204, 236, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4063, p5vfsFA_, 0.8147, 2.71, 0.141, 240, 199, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4064, p5wvkJ_, 0.8145, 2.00, 0.198, 204, 192, 
4065, p5dsvA_, 0.8144, 2.81, 0.136, 244, 199, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4066, d3oevR_, 0.8144, 2.96, 0.204, 242, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4067, p5t0cIB_, 0.8142, 2.15, 0.179, 199, 195, 
4068, p5t0cCA_, 0.8142, 2.15, 0.179, 199, 195, 
4069, p5dsvN_, 0.8142, 2.80, 0.136, 244, 199, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4070, p5vfpEA_, 0.8141, 2.66, 0.146, 240, 199, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4071, p5mpaj_, 0.8141, 2.10, 0.197, 204, 193, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4072, p3jcoI_, 0.8141, 2.12, 0.179, 217, 195, 
4073, p3jcoB_, 0.8141, 2.12, 0.179, 217, 195, 
4074, p5wvkG_, 0.8140, 2.13, 0.174, 217, 195, 
4075, p5dsvE_, 0.8140, 2.81, 0.136, 245, 199, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4076, p5dsvD_, 0.8140, 2.81, 0.136, 244, 199, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4077, d1g0uR_, 0.8139, 2.96, 0.204, 230, 201, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4078, p5vfrm_, 0.8138, 2.67, 0.146, 240, 199, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4079, p5dsvG_, 0.8137, 2.81, 0.136, 242, 199, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4080, d3mg8R_, 0.8136, 2.76, 0.206, 242, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4081, d3mg7R_, 0.8135, 2.76, 0.206, 242, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4082, d3sdkX_, 0.8134, 2.01, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4083, d3mg6R_, 0.8134, 2.76, 0.206, 242, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4084, p5mp9G_, 0.8133, 2.67, 0.147, 243, 197, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4085, d3sdkJ_, 0.8133, 2.04, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4086, d3mg8X_, 0.8133, 2.01, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4087, p5t0hS_, 0.8132, 2.12, 0.207, 213, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4088, p5t0hP_, 0.8131, 2.14, 0.207, 204, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4089, d3sdiR_, 0.8131, 2.99, 0.204, 229, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4090, d3mg7X_, 0.8131, 2.02, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4091, d3mg7J_, 0.8131, 2.04, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4092, p5mpbBA_, 0.8130, 2.20, 0.184, 218, 196, 
4093, d1g0uD_, 0.8130, 2.97, 0.204, 230, 201, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4094, p5ln36_, 0.8129, 2.28, 0.206, 213, 194, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4095, d3oevJ_, 0.8129, 2.03, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4096, d3mg6X_, 0.8129, 2.02, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4097, p5t0cY_, 0.8128, 2.69, 0.141, 240, 199, 
4098, p5t0cEB_, 0.8128, 2.69, 0.141, 240, 199, 
4099, p6epd5_, 0.8127, 2.22, 0.081, 201, 197, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4100, p5nywM_, 0.8127, 3.07, 0.180, 222, 206, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4101, p5mpcU_, 0.8126, 2.71, 0.147, 243, 197, 
4102, d4jsqX_, 0.8126, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4103, d4jsqJ_, 0.8126, 2.06, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4104, d3sdkR_, 0.8126, 2.91, 0.205, 232, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4105, p5mpaG_, 0.8125, 2.68, 0.147, 243, 197, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4106, d4ltcJ_, 0.8125, 2.06, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4107, d3oeuX_, 0.8125, 2.02, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4108, d3mg8J_, 0.8125, 2.05, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4109, d3mg7D_, 0.8125, 3.03, 0.203, 242, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4110, p5wviKA_, 0.8124, 2.13, 0.174, 217, 195, 
4111, d4intX_, 0.8124, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4112, d4intJ_, 0.8124, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4113, d3mg6J_, 0.8123, 2.06, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4114, d3gpjX_, 0.8123, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4115, p4gk7X_, 0.8122, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4116, p4gk7J_, 0.8122, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4117, d3gpjJ_, 0.8122, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4118, p5nywX_, 0.8121, 3.05, 0.180, 225, 206, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4119, p4v7oUA_, 0.8121, 1.82, 0.198, 199, 187, 
4120, d4fzgJ_, 0.8121, 2.07, 0.228, 198, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4121, d3okjJ_, 0.8121, 2.07, 0.228, 198, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4122, p5nyw1_, 0.8120, 3.06, 0.180, 223, 206, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4123, d4ltcX_, 0.8120, 2.06, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4124, d4jsuX_, 0.8120, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4125, d4jsuJ_, 0.8120, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4126, d4fzgX_, 0.8120, 2.07, 0.228, 198, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4127, d3tddX_, 0.8120, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4128, d3tddJ_, 0.8120, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4129, d3okjX_, 0.8120, 2.08, 0.228, 198, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4130, p5mpag_, 0.8119, 2.72, 0.147, 243, 197, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4131, p4y8pM_, 0.8119, 2.02, 0.182, 214, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4132, p4y8pa_, 0.8119, 2.02, 0.182, 214, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4133, d4inuJ_, 0.8119, 2.08, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4134, d4inrJ_, 0.8119, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4135, d4eu2G_, 0.8119, 2.69, 0.147, 244, 197, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4136, d4cr23_, 0.8119, 2.06, 0.193, 204, 192, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4137, d3oevD_, 0.8119, 3.04, 0.203, 242, 202, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4138, d3bdmJ_, 0.8119, 2.08, 0.228, 198, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4139, p5fmgX_, 0.8118, 1.79, 0.197, 191, 188, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4140, p5fmgJ_, 0.8118, 1.79, 0.197, 191, 188, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4141, p3un4J_, 0.8118, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4142, d3oevX_, 0.8118, 2.04, 0.228, 197, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4143, d3bdmX_, 0.8118, 2.08, 0.228, 198, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4144, d1rypY_, 0.8118, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4145, p5t0jS_, 0.8117, 2.13, 0.207, 213, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4146, p5mp9g_, 0.8117, 2.71, 0.147, 243, 197, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4147, d4q1sX_, 0.8117, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4148, d4lqiX_, 0.8117, 2.08, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4149, d4lqiJ_, 0.8117, 2.08, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4150, d4jt0X_, 0.8117, 2.08, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4151, d4jt0J_, 0.8117, 2.08, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4152, p3un4X_, 0.8117, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4153, d3oeuJ_, 0.8117, 2.05, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4154, d3nzxJ_, 0.8117, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4155, d2f16R_, 0.8117, 2.99, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4156, p4y75M_, 0.8116, 2.03, 0.182, 214, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4157, p4y75a_, 0.8116, 2.03, 0.182, 214, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4158, d3un8X_, 0.8116, 2.08, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4159, d3un8J_, 0.8116, 2.08, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4160, d3nzxX_, 0.8116, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4161, d3nzwX_, 0.8116, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4162, d3nzwJ_, 0.8116, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4163, d3mg0X_, 0.8116, 2.07, 0.228, 198, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4164, d2f16D_, 0.8116, 2.99, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4165, d1z7qE1, 0.8116, 2.98, 0.205, 242, 200, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4166, p5nywB_, 0.8115, 3.08, 0.180, 222, 206, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4167, p5dsvK_, 0.8115, 2.79, 0.136, 244, 198, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4168, d4r02F_, 0.8115, 2.69, 0.147, 243, 197, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4169, d4inrX_, 0.8115, 2.08, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4170, d3wxrY_, 0.8115, 2.07, 0.228, 198, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4171, d3oeuD_, 0.8115, 2.93, 0.205, 242, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4172, d3mg4J_, 0.8115, 2.07, 0.228, 198, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4173, d3mg4R_, 0.8114, 2.91, 0.205, 242, 200, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4174, d3gptX_, 0.8114, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4175, d3gptJ_, 0.8114, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4176, d1rypE_, 0.8114, 3.00, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4177, p5dsvI_, 0.8113, 2.80, 0.136, 244, 198, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4178, p4y77M_, 0.8113, 2.03, 0.182, 214, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4179, d4hrcX_, 0.8113, 2.06, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4180, d3tddR_, 0.8113, 2.99, 0.204, 242, 201, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4181, d3d29J_, 0.8113, 2.08, 0.228, 198, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
4182, d2gplX_, 0.8113, 2.09, 0.228, 198, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4183, d2gplR_, 0.8113, 2.99, 0.204, 242, 201, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4184, d2gplJ_, 0.8113, 2.09, 0.228, 198, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4185, d2gplD_, 0.8113, 2.99, 0.204, 242, 201, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4186, d2fakX_, 0.8113, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4187, d2fakJ_, 0.8113, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4188, d1rypK_, 0.8113, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4189, d4qwgT_, 0.8112, 2.72, 0.147, 243, 197, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4190, d4inuX_, 0.8112, 2.08, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4191, d4hrdX_, 0.8112, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4192, d3tddD_, 0.8112, 2.99, 0.204, 242, 201, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4193, d3nzjJ_, 0.8112, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4194, d3mg0J_, 0.8112, 2.08, 0.228, 198, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4195, d3hyeX_, 0.8112, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4196, d3hyeJ_, 0.8112, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4197, d3d29X_, 0.8112, 2.08, 0.228, 198, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
4198, d2fakR_, 0.8112, 2.99, 0.204, 242, 201, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4199, d1g0uT_, 0.8112, 2.71, 0.147, 242, 197, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4200, d1g0uF_, 0.8112, 2.71, 0.147, 242, 197, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4201, p4v7oU_, 0.8111, 2.67, 0.147, 244, 197, 
4202, p4v7oG_, 0.8111, 2.67, 0.147, 244, 197, 
4203, d4qwgF_, 0.8111, 2.72, 0.147, 243, 197, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4204, d4hrdJ_, 0.8111, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4205, d4fzcJ_, 0.8111, 2.09, 0.228, 198, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4206, p4cr47_, 0.8111, 2.32, 0.182, 220, 198, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4207, d3nzjX_, 0.8111, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4208, d3mg8D_, 0.8111, 2.94, 0.205, 242, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4209, d3l5qX_, 0.8111, 2.67, 0.147, 244, 197,  
4210, d3l5qL_, 0.8111, 2.67, 0.147, 244, 197,  
4211, d2fakD_, 0.8111, 3.00, 0.204, 242, 201, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4212, d2f16X_, 0.8111, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4213, d2f16J_, 0.8111, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4214, p5a5b6_, 0.8110, 2.11, 0.197, 222, 193, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4215, d4qz7T_, 0.8110, 2.70, 0.147, 243, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4216, d4qz7F_, 0.8110, 2.70, 0.147, 243, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4217, d4hnpJ_, 0.8110, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4218, d4fzcX_, 0.8110, 2.09, 0.228, 198, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4219, p4cr36_, 0.8110, 2.11, 0.197, 222, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4220, d3sdiX_, 0.8110, 2.07, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4221, d3gpwX_, 0.8110, 2.09, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4222, p5wviPA_, 0.8109, 2.15, 0.174, 217, 195, 
4223, p5nywQ_, 0.8109, 3.04, 0.180, 227, 206, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4224, p4y8nM_, 0.8109, 2.04, 0.182, 214, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4225, p4v7oCB_, 0.8109, 2.67, 0.147, 244, 197, 
4226, d4r18T_, 0.8109, 2.69, 0.147, 243, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4227, d4r18F_, 0.8109, 2.69, 0.147, 243, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4228, d4q1sJ_, 0.8109, 2.10, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4229, d4hrdF_, 0.8109, 2.71, 0.147, 244, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4230, d3wxrK_, 0.8109, 2.09, 0.228, 197, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4231, d3gpwJ_, 0.8109, 2.09, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4232, d1vsyU_, 0.8109, 2.67, 0.147, 244, 197,  
4233, d1jd2J_, 0.8109, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4234, p5nywZ_, 0.8108, 3.06, 0.180, 225, 206, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4235, d5l69T_, 0.8108, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4236, d5l69F_, 0.8108, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4237, p4v7oOA_, 0.8108, 2.67, 0.147, 244, 197, 
4238, d4qz1T_, 0.8108, 2.71, 0.147, 243, 197, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4239, d4qz1F_, 0.8108, 2.71, 0.147, 243, 197, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4240, d4qlsR_, 0.8108, 2.92, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4241, d4no9T_, 0.8108, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4242, d4no9F_, 0.8108, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4243, d4hnpF_, 0.8108, 2.70, 0.147, 244, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4244, d1z7qS1, 0.8108, 2.90, 0.206, 242, 199, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4245, d1vsyG_, 0.8108, 2.67, 0.147, 244, 197,  
4246, d1rypS_, 0.8108, 2.91, 0.205, 242, 200, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4247, d1jd2Q_, 0.8108, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4248, p4zzgU_, 0.8107, 2.55, 0.148, 244, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4249, d4qlvR_, 0.8107, 2.92, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4250, d4qlvD_, 0.8107, 2.92, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4251, d4qlsD_, 0.8107, 2.92, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4252, d4hnpX_, 0.8107, 2.07, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4253, d4fzgF_, 0.8107, 2.71, 0.147, 244, 197, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4254, d3sdiT_, 0.8107, 2.70, 0.147, 242, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4255, d3gpwR_, 0.8107, 3.00, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4256, d3gpwD_, 0.8107, 3.00, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4257, p5nifE_, 0.8106, 2.94, 0.204, 236, 201, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4258, d5lajF_, 0.8106, 2.70, 0.147, 243, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4259, d5l5tT_, 0.8106, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4260, d5l5tF_, 0.8106, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4261, d5l5jT_, 0.8106, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4262, d5l5jF_, 0.8106, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4263, p4y81T_, 0.8106, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4264, p4y81F_, 0.8106, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4265, d4qw4T_, 0.8106, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH CARFILZOMIB
4266, d4qw4F_, 0.8106, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH CARFILZOMIB
4267, d4qlsF_, 0.8106, 2.69, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4268, d4hrcJ_, 0.8106, 2.08, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4269, d4fzgT_, 0.8106, 2.71, 0.147, 244, 197, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4270, d3shjX_, 0.8106, 2.09, 0.228, 198, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4271, d3shjR_, 0.8106, 3.00, 0.204, 242, 201, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4272, d3shjJ_, 0.8106, 2.09, 0.228, 198, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4273, d3shjD_, 0.8106, 3.00, 0.204, 242, 201, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4274, d3okjD_, 0.8106, 3.00, 0.204, 242, 201, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4275, d3hyeR_, 0.8106, 3.00, 0.204, 242, 201, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4276, d3hyeD_, 0.8106, 3.00, 0.204, 242, 201, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4277, d1g65J_, 0.8106, 2.10, 0.228, 198, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4278, p5nywJ_, 0.8105, 3.06, 0.180, 224, 206, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4279, d5l5yT_, 0.8105, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4280, p4ya9T_, 0.8105, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4281, p4ya9F_, 0.8105, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4282, d4qz4T_, 0.8105, 2.70, 0.147, 243, 197, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4283, d4qz4F_, 0.8105, 2.70, 0.147, 243, 197, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4284, d4qwkT_, 0.8105, 2.72, 0.147, 243, 197, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4285, d4qwkF_, 0.8105, 2.72, 0.147, 243, 197, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4286, d4qwfT_, 0.8105, 2.71, 0.147, 243, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4287, d4qwfF_, 0.8105, 2.71, 0.147, 243, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4288, d4qlsT_, 0.8105, 2.69, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4289, d3sdiF_, 0.8105, 2.60, 0.148, 242, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4290, d3mg4D_, 0.8105, 2.94, 0.205, 242, 200, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4291, d3gptR_, 0.8105, 3.00, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4292, d5l68T_, 0.8104, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4293, d5l68F_, 0.8104, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4294, d5l63T_, 0.8104, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4295, d5l63F_, 0.8104, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4296, d5l61T_, 0.8104, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4297, d5l61F_, 0.8104, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4298, d5l5yF_, 0.8104, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4299, p4y8iT_, 0.8104, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4300, p4y8iF_, 0.8104, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4301, d4qz7R_, 0.8104, 2.93, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4302, d4qz7D_, 0.8104, 2.93, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4303, d4qwxF_, 0.8104, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4304, d4qw6F_, 0.8104, 2.71, 0.147, 243, 197, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4305, d4nnwF_, 0.8104, 2.69, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4306, p4inuR_, 0.8104, 3.02, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4307, d3gptD_, 0.8104, 3.01, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4308, d3e47X_, 0.8104, 2.10, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4309, d3e47J_, 0.8104, 2.10, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4310, d1rypG_, 0.8104, 2.69, 0.147, 244, 197, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4311, p5nifU_, 0.8103, 2.56, 0.148, 244, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4312, d5m2bT_, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4313, d5m2bF_, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4314, d5l6cF_, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4315, d5l64T_, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4316, d5l64F_, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4317, d5l62T_, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4318, d5l62F_, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4319, d5l60T_, 0.8103, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4320, d5l60F_, 0.8103, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4321, d5l5wT_, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4322, d5l5wF_, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4323, d5l5dT_, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4324, d5l5dF_, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4325, d5fgiT_, 0.8103, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4326, d5fgiF_, 0.8103, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4327, p5cghT_, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4328, p5cghF_, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4329, p4y8pT_, 0.8103, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4330, p4y8oT_, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4331, p4y8oF_, 0.8103, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4332, p4y7xT_, 0.8103, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4333, p4y7xF_, 0.8103, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4334, d4r02R_, 0.8103, 2.93, 0.205, 235, 200, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4335, d4qwxT_, 0.8103, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4336, d4qwrF_, 0.8103, 2.72, 0.147, 243, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4337, d4qw6T_, 0.8103, 2.71, 0.147, 243, 197, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4338, d4no6F_, 0.8103, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4339, d4nnwT_, 0.8103, 2.69, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4340, p3un4R_, 0.8103, 3.01, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4341, d3okjR_, 0.8103, 3.04, 0.203, 242, 202, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4342, p3e47R_, 0.8103, 3.00, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4343, p5nywU_, 0.8102, 3.07, 0.180, 224, 206, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4344, p5nywC_, 0.8102, 3.07, 0.180, 225, 206, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4345, d5l6cT_, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4346, d5l66F_, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4347, d5l65F_, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4348, d5l5sT_, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4349, d5l5sF_, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4350, d5l5qT_, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4351, d5l5qF_, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4352, d5l5pT_, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4353, d5l5pF_, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4354, d5l5iT_, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4355, d5l5iF_, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4356, p5gjqm_, 0.8102, 2.84, 0.142, 238, 197, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4357, d5fggT_, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4358, d5fggF_, 0.8102, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4359, d5fgdT_, 0.8102, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4360, d5cz9T_, 0.8102, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4361, d5cz9F_, 0.8102, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4362, d5bouT_, 0.8102, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4363, d5bouF_, 0.8102, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4364, p4ya2D_, 0.8102, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4365, p4y8pF_, 0.8102, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4366, d4rurF_, 0.8102, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4367, d4qwrT_, 0.8102, 2.72, 0.147, 243, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4368, d4qw5T_, 0.8102, 2.71, 0.147, 243, 197, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4369, d4qw5F_, 0.8102, 2.71, 0.147, 243, 197, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4370, d4qw3T_, 0.8102, 2.72, 0.147, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4371, d4qvmT_, 0.8102, 2.71, 0.147, 243, 197, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4372, d4qvmF_, 0.8102, 2.71, 0.147, 243, 197, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4373, d4qlvT_, 0.8102, 2.69, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4374, d4qlvF_, 0.8102, 2.69, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4375, d4no6T_, 0.8102, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4376, p3un4D_, 0.8102, 3.01, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4377, d3nzxR_, 0.8102, 3.00, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4378, d3nzwR_, 0.8102, 2.93, 0.205, 242, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4379, d3mg6D_, 0.8102, 2.98, 0.204, 242, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4380, p3e47D_, 0.8102, 3.00, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4381, d2fnyX_, 0.8102, 2.10, 0.228, 198, 193,  
4382, d2fnyJ_, 0.8102, 2.10, 0.228, 198, 193,  
4383, d1rypU_, 0.8102, 2.59, 0.148, 244, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4384, d5lajT_, 0.8101, 2.69, 0.147, 243, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4385, d5laiT_, 0.8101, 2.71, 0.147, 243, 197, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4386, d5laiF_, 0.8101, 2.71, 0.147, 243, 197, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4387, d5l66T_, 0.8101, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4388, d5l65T_, 0.8101, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4389, d5jhsT_, 0.8101, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4390, d5jhsF_, 0.8101, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4391, p5fghT_, 0.8101, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4392, p5fghF_, 0.8101, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4393, d5fgeT_, 0.8101, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4394, d5fgeF_, 0.8101, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4395, d5fgdF_, 0.8101, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4396, p4ya5T_, 0.8101, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4397, p4ya5F_, 0.8101, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4398, p4ya2R_, 0.8101, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4399, p4y82F_, 0.8101, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4400, p4y6vT_, 0.8101, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4401, p4y6vF_, 0.8101, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4402, d4rurT_, 0.8101, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4403, d4qz6T_, 0.8101, 2.71, 0.147, 243, 197, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4404, d4qz0T_, 0.8101, 2.71, 0.147, 243, 197, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4405, d4qz0F_, 0.8101, 2.71, 0.147, 243, 197, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4406, d4qwsT_, 0.8101, 2.73, 0.147, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4407, d4qwsF_, 0.8101, 2.73, 0.147, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4408, d4qwiT_, 0.8101, 2.72, 0.147, 243, 197, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4409, d4qw7T_, 0.8101, 2.71, 0.147, 243, 197, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4410, d4qw7F_, 0.8101, 2.71, 0.147, 243, 197, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4411, d4qw3F_, 0.8101, 2.72, 0.147, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4412, d4qvwT_, 0.8101, 2.71, 0.147, 243, 197, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4413, d4quxF_, 0.8101, 2.71, 0.147, 243, 197, YCP BETA5-A49T-MUTANT
4414, p4inuD_, 0.8101, 3.02, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4415, d3wxrS_, 0.8101, 2.93, 0.205, 238, 200, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4416, d3sdiJ_, 0.8101, 2.09, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4417, d3nzxD_, 0.8101, 3.01, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4418, d3nzwD_, 0.8101, 2.93, 0.205, 242, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4419, d3bdmC_, 0.8101, 2.95, 0.180, 241, 200, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4420, d2zcyX_, 0.8101, 2.09, 0.228, 198, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4421, d2zcyJ_, 0.8101, 2.09, 0.228, 198, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4422, d1g65X_, 0.8101, 2.10, 0.228, 198, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4423, p5nywG_, 0.8100, 3.10, 0.180, 223, 206, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4424, p5nywD_, 0.8100, 3.07, 0.180, 223, 206, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4425, d5l6bT_, 0.8100, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4426, d5l6bF_, 0.8100, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4427, d5l6aT_, 0.8100, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4428, d5l6aF_, 0.8100, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4429, d5l5vT_, 0.8100, 2.71, 0.147, 243, 197,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4430, d5l5vF_, 0.8100, 2.71, 0.147, 243, 197,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4431, d5l5hT_, 0.8100, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4432, d5l5hF_, 0.8100, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4433, d5cz6F_, 0.8100, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4434, p4ya7T_, 0.8100, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4435, p4y8nT_, 0.8100, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4436, p4y8nF_, 0.8100, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4437, p4y82T_, 0.8100, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4438, p4y80T_, 0.8100, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4439, p4y80F_, 0.8100, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4440, p4x6zU_, 0.8100, 2.61, 0.148, 244, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4441, d4qxjT_, 0.8100, 2.72, 0.147, 243, 197, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4442, d4qxjF_, 0.8100, 2.72, 0.147, 243, 197, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4443, d4qwjF_, 0.8100, 2.73, 0.147, 243, 197, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
4444, d4qwiF_, 0.8100, 2.72, 0.147, 243, 197, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4445, d4qw0T_, 0.8100, 2.72, 0.147, 243, 197, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4446, d4qw0F_, 0.8100, 2.72, 0.147, 243, 197, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4447, d4qvyT_, 0.8100, 2.71, 0.147, 243, 197, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
4448, d4qvyF_, 0.8100, 2.71, 0.147, 243, 197, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
4449, d4qvwF_, 0.8100, 2.71, 0.147, 243, 197, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4450, d4quxT_, 0.8100, 2.71, 0.147, 243, 197, YCP BETA5-A49T-MUTANT
4451, d4qltR_, 0.8100, 2.93, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4452, d4qltD_, 0.8100, 2.93, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4453, d4qlqF_, 0.8100, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4454, d4j70J_, 0.8100, 2.09, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4455, d3bdmQ_, 0.8100, 2.95, 0.180, 241, 200, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4456, d1g65R_, 0.8100, 3.01, 0.204, 242, 201, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4457, d5l67T_, 0.8099, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4458, d5l67F_, 0.8099, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4459, d5l5xT_, 0.8099, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4460, d5d0vT_, 0.8099, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4461, d5d0vF_, 0.8099, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4462, d5cz6T_, 0.8099, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4463, p4y6zT_, 0.8099, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4464, p4y6zF_, 0.8099, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4465, p4y69T_, 0.8099, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4466, p4y69F_, 0.8099, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4467, d4r17R_, 0.8099, 2.93, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4468, d4r17D_, 0.8099, 2.93, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4469, d4qzwF_, 0.8099, 2.72, 0.147, 243, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4470, d4qz5T_, 0.8099, 2.71, 0.147, 243, 197, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4471, d4qz5F_, 0.8099, 2.71, 0.147, 243, 197, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4472, d4qz2T_, 0.8099, 2.72, 0.147, 243, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4473, d4qz2F_, 0.8099, 2.72, 0.147, 243, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4474, d4qwjT_, 0.8099, 2.73, 0.147, 243, 197, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
4475, d4qvnF_, 0.8099, 2.70, 0.147, 243, 197, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4476, d4qlqT_, 0.8099, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4477, p4qbyR_, 0.8099, 2.93, 0.205, 235, 200, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4478, p4qbyD_, 0.8099, 2.93, 0.205, 235, 200, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4479, d4inrR_, 0.8099, 3.02, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4480, d3dy3X_, 0.8099, 2.10, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4481, p5nywL_, 0.8098, 3.08, 0.180, 227, 206, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4482, d5l5xF_, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4483, d5l5uT_, 0.8098, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4484, d5l5uF_, 0.8098, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4485, d5l5fT_, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4486, d5l5fF_, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4487, d5l5eT_, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4488, d5l5eF_, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4489, d5l55R_, 0.8098, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4490, d5l54R_, 0.8098, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4491, d5l54D_, 0.8098, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4492, d5l52R_, 0.8098, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4493, d5l52D_, 0.8098, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4494, d5jhrT_, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4495, d5jhrF_, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4496, p5gjrX_, 0.8098, 2.81, 0.142, 238, 197, 
4497, d5dkiT_, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
4498, d5dkiF_, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
4499, d5d0zT_, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4500, d5d0zF_, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4501, d5cz5T_, 0.8098, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4502, d5cz5F_, 0.8098, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4503, p5cgiT_, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4504, p5cgiR_, 0.8098, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4505, p5cgiF_, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4506, p5cgiD_, 0.8098, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4507, p5cggT_, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4508, p5cggF_, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4509, p4y8tT_, 0.8098, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4510, p4y8tF_, 0.8098, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4511, p4y8sF_, 0.8098, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4512, p4y8qT_, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4513, p4y8qF_, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4514, p4y8kF_, 0.8098, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4515, p4y8jT_, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4516, p4y8jF_, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4517, p4y74T_, 0.8098, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4518, p4y74F_, 0.8098, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4519, p4y6aT_, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4520, p4y6aF_, 0.8098, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4521, d4qzwT_, 0.8098, 2.72, 0.147, 243, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4522, p4qz4R_, 0.8098, 2.93, 0.205, 235, 200, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4523, p4qz4D_, 0.8098, 2.93, 0.205, 235, 200, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4524, p4qz0R_, 0.8098, 2.93, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4525, p4qz0D_, 0.8098, 2.93, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4526, d4qw1T_, 0.8098, 2.71, 0.147, 243, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4527, d4qw1F_, 0.8098, 2.71, 0.147, 243, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4528, d4qvnT_, 0.8098, 2.70, 0.147, 243, 197, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4529, d4qvlT_, 0.8098, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH BORTEZOMIB
4530, d4qvlF_, 0.8098, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH BORTEZOMIB
4531, d4qluF_, 0.8098, 2.68, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4532, d4j70X_, 0.8098, 2.09, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4533, p4fzgR_, 0.8098, 2.94, 0.205, 242, 200, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4534, d3mg8T_, 0.8098, 2.72, 0.147, 237, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4535, d3mg0R_, 0.8098, 2.98, 0.204, 242, 201, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4536, d3dy4J_, 0.8098, 2.10, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4537, d3dy3J_, 0.8098, 2.10, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4538, d2zcyQ_, 0.8098, 3.00, 0.179, 241, 201, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4539, d2zcyC_, 0.8098, 3.00, 0.179, 241, 201, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4540, d5l5aT_, 0.8097, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4541, d5l5aF_, 0.8097, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4542, d5l55D_, 0.8097, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4543, d5fggR_, 0.8097, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4544, d5fggD_, 0.8097, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4545, d5dkjT_, 0.8097, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4546, d5dkjF_, 0.8097, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4547, d5d0xT_, 0.8097, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4548, d5d0xF_, 0.8097, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4549, d5d0sT_, 0.8097, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4550, d5d0sF_, 0.8097, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4551, d5cz8R_, 0.8097, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4552, d5cz8D_, 0.8097, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4553, d5bxnT_, 0.8097, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4554, p4ya2T_, 0.8097, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4555, p4ya2F_, 0.8097, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4556, p4ya0F_, 0.8097, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4557, d4y9yT_, 0.8097, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4558, p4y8sT_, 0.8097, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4559, p4y8kT_, 0.8097, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4560, p4y78T_, 0.8097, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4561, p4y78F_, 0.8097, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4562, p4y77T_, 0.8097, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4563, p4y77F_, 0.8097, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4564, p4y75T_, 0.8097, 2.60, 0.148, 243, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4565, p4y75F_, 0.8097, 2.60, 0.148, 243, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4566, d4r02T_, 0.8097, 2.69, 0.147, 243, 197, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4567, d4qz2R_, 0.8097, 2.94, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4568, d4qw1R_, 0.8097, 2.94, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4569, d4qvqT_, 0.8097, 2.71, 0.147, 243, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4570, d4qvqF_, 0.8097, 2.71, 0.147, 243, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4571, d4qv0T_, 0.8097, 2.71, 0.147, 243, 197, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4572, d4qv0F_, 0.8097, 2.71, 0.147, 243, 197, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4573, d4qluT_, 0.8097, 2.68, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4574, d4no1F_, 0.8097, 2.69, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4575, p4gk7R_, 0.8097, 2.94, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4576, p4gk7D_, 0.8097, 2.94, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4577, p4fzgD_, 0.8097, 2.94, 0.205, 242, 200, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4578, d3mg7F_, 0.8097, 2.70, 0.147, 237, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4579, d3dy4X_, 0.8097, 2.10, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4580, p5nywS_, 0.8096, 3.08, 0.180, 224, 206, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4581, p5nywF_, 0.8096, 3.09, 0.180, 223, 206, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4582, d5lttT_, 0.8096, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4583, d5lttF_, 0.8096, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4584, p5ln3G_, 0.8096, 3.02, 0.134, 242, 201, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4585, d5lajR_, 0.8096, 2.94, 0.205, 235, 200, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4586, d5lajD_, 0.8096, 2.94, 0.205, 235, 200, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4587, d5l6bR_, 0.8096, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4588, d5l6bD_, 0.8096, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4589, d5l5zT_, 0.8096, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4590, d5l5zF_, 0.8096, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4591, d5l55F_, 0.8096, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4592, d5fhsT_, 0.8096, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4593, d5bxlF_, 0.8096, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4594, p4ya3T_, 0.8096, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4595, p4ya3F_, 0.8096, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4596, p4ya0T_, 0.8096, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4597, p4y9zT_, 0.8096, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4598, p4y9zF_, 0.8096, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4599, d4y9yF_, 0.8096, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4600, p4y8uT_, 0.8096, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4601, p4y8uF_, 0.8096, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4602, p4y8sR_, 0.8096, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4603, p4y8sD_, 0.8096, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4604, d4y8rR_, 0.8096, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4605, p4y8gT_, 0.8096, 2.60, 0.148, 243, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4606, p4y8gF_, 0.8096, 2.60, 0.148, 243, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4607, p4y84T_, 0.8096, 2.60, 0.148, 243, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4608, p4y84F_, 0.8096, 2.60, 0.148, 243, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4609, d4r18R_, 0.8096, 2.94, 0.205, 235, 200, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4610, d4r18D_, 0.8096, 2.94, 0.205, 235, 200, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4611, d4qz2D_, 0.8096, 2.94, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4612, d4qwxR_, 0.8096, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4613, d4qwxD_, 0.8096, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4614, d4qwlT_, 0.8096, 2.71, 0.147, 243, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4615, d4qwlR_, 0.8096, 2.93, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4616, d4qwlF_, 0.8096, 2.71, 0.147, 243, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4617, d4qwlD_, 0.8096, 2.93, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4618, d4qw1D_, 0.8096, 2.94, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4619, d4qvvT_, 0.8096, 2.73, 0.147, 243, 197, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4620, d4qvvF_, 0.8096, 2.73, 0.147, 243, 197, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4621, d4no8R_, 0.8096, 2.93, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4622, d4no8D_, 0.8096, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4623, d4no1T_, 0.8096, 2.69, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4624, d4j70R_, 0.8096, 2.93, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4625, d4hrdR_, 0.8096, 2.91, 0.205, 242, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4626, d4hnpT_, 0.8096, 2.71, 0.147, 244, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4627, d4eu2U_, 0.8096, 2.70, 0.147, 244, 197, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4628, d3sdkT_, 0.8096, 2.70, 0.147, 236, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4629, d3oeuT_, 0.8096, 2.71, 0.147, 237, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4630, d3nzjR_, 0.8096, 3.09, 0.203, 242, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4631, d1g65F_, 0.8096, 2.72, 0.147, 244, 197, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4632, d1g65D_, 0.8096, 3.01, 0.204, 242, 201, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4633, d1g0uJ_, 0.8096, 2.12, 0.228, 198, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4634, d5l65R_, 0.8095, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4635, d5l65D_, 0.8095, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4636, d5l5oT_, 0.8095, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4637, d5l5oF_, 0.8095, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4638, d5l55T_, 0.8095, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4639, d5l54T_, 0.8095, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4640, d5l54F_, 0.8095, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4641, d5l52T_, 0.8095, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4642, d5l52F_, 0.8095, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4643, d5fhsF_, 0.8095, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4644, d5fgfT_, 0.8095, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4645, d5fgfF_, 0.8095, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4646, d5cz4T_, 0.8095, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4647, d5cz4F_, 0.8095, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4648, p5cggR_, 0.8095, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4649, p5cggD_, 0.8095, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4650, d5cgfR_, 0.8095, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4651, d5cgfD_, 0.8095, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4652, d5bxlT_, 0.8095, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4653, p4zzgD_, 0.8095, 2.87, 0.176, 241, 199, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4654, d4ya1R_, 0.8095, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4655, d4ya1D_, 0.8095, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4656, p4y9zR_, 0.8095, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4657, p4y9zD_, 0.8095, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4658, d4y8rD_, 0.8095, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4659, p4y7yF_, 0.8095, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4660, d4qz6R_, 0.8095, 2.93, 0.205, 235, 200, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4661, d4qz6F_, 0.8095, 2.70, 0.147, 243, 197, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4662, d4qz6D_, 0.8095, 2.93, 0.205, 235, 200, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4663, d4qz5R_, 0.8095, 2.94, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4664, d4qz5D_, 0.8095, 2.94, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4665, d4qz3T_, 0.8095, 2.70, 0.147, 243, 197, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4666, d4qz3F_, 0.8095, 2.71, 0.147, 243, 197, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4667, p4qw5R_, 0.8095, 2.93, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4668, d4qv5T_, 0.8095, 2.71, 0.147, 243, 197, YCP BETA5-M45I MUTANT
4669, d4qv5F_, 0.8095, 2.71, 0.147, 243, 197, YCP BETA5-M45I MUTANT
4670, d4qv4T_, 0.8095, 2.71, 0.147, 243, 197, YCP BETA5-M45T MUTANT
4671, d4qv4F_, 0.8095, 2.71, 0.147, 243, 197, YCP BETA5-M45T MUTANT
4672, d4inuT_, 0.8095, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4673, d4inuF_, 0.8095, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4674, d4intT_, 0.8095, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4675, d4hrdT_, 0.8095, 2.72, 0.147, 244, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4676, d3nzjF_, 0.8095, 2.71, 0.147, 244, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4677, d3nzjD_, 0.8095, 3.09, 0.203, 242, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4678, d3gpjQ_, 0.8095, 2.96, 0.180, 241, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4679, d3gpjC_, 0.8095, 2.96, 0.180, 241, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4680, d3dy3C_, 0.8095, 2.96, 0.180, 241, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4681, p5t0cLB_, 0.8094, 1.97, 0.241, 205, 191, 
4682, p5t0cFA_, 0.8094, 1.97, 0.241, 205, 191, 
4683, p5nifG_, 0.8094, 2.58, 0.148, 244, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4684, d5laiR_, 0.8094, 2.95, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4685, d5laiD_, 0.8094, 2.95, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4686, d5l5rT_, 0.8094, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4687, d5l5rF_, 0.8094, 2.69, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4688, d5l5eR_, 0.8094, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4689, d5l5eD_, 0.8094, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4690, d5l5dR_, 0.8094, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4691, d5l5dD_, 0.8094, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4692, d5l5bT_, 0.8094, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4693, d5l5bF_, 0.8094, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4694, d5fg7R_, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4695, d5d0zD_, 0.8094, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4696, d5d0wR_, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4697, d5d0wF_, 0.8094, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4698, d5d0wD_, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4699, d5d0vR_, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4700, d5d0vD_, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4701, d5d0tT_, 0.8094, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4702, d5d0tF_, 0.8094, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4703, d5d0sR_, 0.8094, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4704, d5d0sD_, 0.8094, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4705, d5cz9D_, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4706, d5ahjR_, 0.8094, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4707, d5ahjD_, 0.8094, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4708, p4zzgG_, 0.8094, 2.57, 0.148, 244, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4709, p4ya7R_, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4710, p4ya7F_, 0.8094, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4711, p4ya7D_, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4712, d4ya4T_, 0.8094, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4713, d4ya4R_, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4714, d4ya4F_, 0.8094, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4715, d4ya4D_, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4716, d4y9yR_, 0.8094, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4717, d4y9yD_, 0.8094, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4718, d4y8mT_, 0.8094, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4719, d4y8mF_, 0.8094, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4720, p4y8lT_, 0.8094, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4721, p4y8lF_, 0.8094, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4722, p4y7yT_, 0.8094, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4723, p4y70F_, 0.8094, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4724, d4qzxR_, 0.8094, 2.94, 0.205, 235, 200, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4725, d4qz3R_, 0.8094, 2.94, 0.205, 235, 200, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4726, d4qz3D_, 0.8094, 2.94, 0.205, 235, 200, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4727, d4qwuT_, 0.8094, 2.70, 0.147, 243, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4728, d4qwuF_, 0.8094, 2.70, 0.147, 243, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4729, p4qwfR_, 0.8094, 2.94, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4730, p4qwfD_, 0.8094, 2.94, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4731, d4qw6R_, 0.8094, 2.94, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4732, d4qw6D_, 0.8094, 2.94, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4733, p4qw5D_, 0.8094, 2.93, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4734, p4qvwR_, 0.8094, 2.95, 0.205, 235, 200, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4735, p4qvwD_, 0.8094, 2.95, 0.205, 235, 200, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4736, d4qvpT_, 0.8094, 2.71, 0.147, 243, 197, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4737, d4qvpF_, 0.8094, 2.71, 0.147, 243, 197, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4738, d4qvlR_, 0.8094, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH BORTEZOMIB
4739, d4qvlD_, 0.8094, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH BORTEZOMIB
4740, d4qv1T_, 0.8094, 2.70, 0.147, 243, 197, YCP BETA5-M45A MUTANT
4741, d4qv1F_, 0.8094, 2.70, 0.147, 243, 197, YCP BETA5-M45A MUTANT
4742, d4qlqR_, 0.8094, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4743, d4qlqD_, 0.8094, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4744, d4q1sR_, 0.8094, 2.93, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4745, d4nnnT_, 0.8094, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH MG132
4746, d4nnnF_, 0.8094, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH MG132
4747, d4jsuR_, 0.8094, 3.06, 0.203, 242, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4748, d4jsuD_, 0.8094, 3.06, 0.203, 242, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4749, p4gk7F_, 0.8094, 2.71, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4750, d3nzjT_, 0.8094, 2.71, 0.147, 244, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4751, d3mg6F_, 0.8094, 2.71, 0.147, 237, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4752, d3mg4F_, 0.8094, 2.70, 0.147, 244, 197, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4753, d3dy3Q_, 0.8094, 2.96, 0.180, 241, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4754, d3d29T_, 0.8094, 2.69, 0.147, 244, 197, PROTEASOME INHIBITION BY FELLUTAMIDE B
4755, d3d29F_, 0.8094, 2.69, 0.147, 244, 197, PROTEASOME INHIBITION BY FELLUTAMIDE B
4756, d5l68R_, 0.8093, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4757, d5l68D_, 0.8093, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4758, d5l5oR_, 0.8093, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4759, d5l5oD_, 0.8093, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4760, d5l5jR_, 0.8093, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4761, d5l5jD_, 0.8093, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4762, d5l5bR_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4763, d5l5bD_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4764, d5jhsR_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4765, d5jhsD_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4766, d5jhrR_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4767, d5jhrD_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4768, d5fgaR_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4769, d5fgaD_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4770, d5fg9F_, 0.8093, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4771, d5fg7D_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4772, d5d0zR_, 0.8093, 2.93, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4773, d5d0wT_, 0.8093, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4774, d5czaR_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4775, d5czaD_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4776, d5cz9R_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4777, d5cz8F_, 0.8093, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4778, d5bxnR_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4779, d5bxnD_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4780, d5bxlR_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4781, d5bxlD_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4782, d4z1lR_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4783, d4z1lD_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4784, d4ya1T_, 0.8093, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4785, d4ya1F_, 0.8093, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4786, p4y7wT_, 0.8093, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4787, p4y7wF_, 0.8093, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4788, p4y75R_, 0.8093, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4789, p4y70T_, 0.8093, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4790, d4r17T_, 0.8093, 2.69, 0.147, 243, 197, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4791, d4r17F_, 0.8093, 2.69, 0.147, 243, 197, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4792, d4qzzT_, 0.8093, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH OMURALIDE
4793, d4qzzF_, 0.8093, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH OMURALIDE
4794, d4qzxT_, 0.8093, 2.73, 0.147, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4795, d4qzxF_, 0.8093, 2.73, 0.147, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4796, d4qzxD_, 0.8093, 2.94, 0.205, 235, 200, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4797, p4qz1R_, 0.8093, 2.95, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4798, d4qxjR_, 0.8093, 2.94, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4799, d4qxjD_, 0.8093, 2.94, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4800, d4qvpR_, 0.8093, 2.95, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4801, d4qvpD_, 0.8093, 2.95, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4802, d4qv7R_, 0.8093, 2.94, 0.205, 235, 200, YCP BETA5-A50V MUTANT
4803, d4qv7F_, 0.8093, 2.71, 0.147, 243, 197, YCP BETA5-A50V MUTANT
4804, p4qv0R_, 0.8093, 2.94, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4805, p4qv0D_, 0.8093, 2.94, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4806, d4quyT_, 0.8093, 2.70, 0.147, 243, 197, YCP BETA5-A49S-MUTANT
4807, d4quyR_, 0.8093, 2.94, 0.205, 235, 200, YCP BETA5-A49S-MUTANT
4808, d4quyF_, 0.8093, 2.70, 0.147, 243, 197, YCP BETA5-A49S-MUTANT
4809, d4no9R_, 0.8093, 2.93, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4810, d4no9D_, 0.8093, 2.93, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4811, p4jt0R_, 0.8093, 3.06, 0.203, 242, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4812, p4jt0D_, 0.8093, 3.06, 0.203, 242, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4813, d4intR_, 0.8093, 3.06, 0.203, 242, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4814, d4inrD_, 0.8093, 3.07, 0.203, 242, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4815, d3gpjT_, 0.8093, 2.70, 0.147, 244, 197, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4816, d3d29R_, 0.8093, 3.01, 0.204, 242, 201, PROTEASOME INHIBITION BY FELLUTAMIDE B
4817, d3d29D_, 0.8093, 3.01, 0.204, 242, 201, PROTEASOME INHIBITION BY FELLUTAMIDE B
4818, d1g65C_, 0.8093, 3.09, 0.178, 241, 202, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4819, p5nywV_, 0.8092, 3.08, 0.180, 224, 206, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4820, p5mpbJ_, 0.8092, 2.17, 0.192, 204, 193, 
4821, d5l6aR_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4822, d5l6aD_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4823, d5l5uR_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4824, d5l5uD_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4825, d5l5tR_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4826, d5l5tD_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4827, d5l5rR_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4828, d5l5rD_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4829, d5l5iR_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4830, d5l5iD_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4831, d5l5aR_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4832, d5fgfR_, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4833, d5fgfD_, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4834, d5fgaT_, 0.8092, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4835, d5fgaF_, 0.8092, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4836, d5fg9T_, 0.8092, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4837, d5fg9R_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4838, d5fg9D_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4839, d5d0tR_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4840, d5czaF_, 0.8092, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4841, d5cz8T_, 0.8092, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4842, d5cz6R_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4843, d5cz6D_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4844, d5ahjT_, 0.8092, 2.60, 0.148, 243, 196, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4845, d5ahjF_, 0.8092, 2.60, 0.148, 243, 196, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4846, p4y8tR_, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4847, p4y8pR_, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4848, p4y8pD_, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4849, d4y8mR_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4850, d4y8mD_, 0.8092, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4851, p4y8jR_, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4852, p4y8jD_, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4853, p4y8hR_, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4854, p4y8hD_, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4855, p4y84R_, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4856, p4y84D_, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4857, p4y7yR_, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4858, p4y75D_, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4859, p4y70R_, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4860, p4y70D_, 0.8092, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4861, p4x6zS_, 0.8092, 2.87, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4862, p4qzwR_, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4863, p4qzwD_, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4864, p4qz1D_, 0.8092, 2.95, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4865, p4qwuR_, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4866, p4qwuD_, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4867, d4qwiR_, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4868, d4qwiD_, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4869, d4qw7R_, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4870, d4qw7D_, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4871, d4qvyR_, 0.8092, 2.95, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
4872, d4qvyD_, 0.8092, 2.95, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
4873, d4qvnR_, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4874, d4qvnD_, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4875, d4qv9R_, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-C63F MUTANT
4876, d4qv9D_, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-C63F MUTANT
4877, d4qv8T_, 0.8092, 2.71, 0.147, 243, 197, YCP BETA5-C52F MUTANT
4878, d4qv8F_, 0.8092, 2.71, 0.147, 243, 197, YCP BETA5-C52F MUTANT
4879, d4qv7T_, 0.8092, 2.71, 0.147, 243, 197, YCP BETA5-A50V MUTANT
4880, d4qv7D_, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-A50V MUTANT
4881, p4qv3R_, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-M45V MUTANT
4882, p4qv3D_, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-M45V MUTANT
4883, d4quyD_, 0.8092, 2.94, 0.205, 235, 200, YCP BETA5-A49S-MUTANT
4884, d4nnnR_, 0.8092, 2.93, 0.205, 235, 200, YCP IN COMPLEX WITH MG132
4885, d4nnnD_, 0.8092, 2.93, 0.205, 235, 200, YCP IN COMPLEX WITH MG132
4886, d4intD_, 0.8092, 3.07, 0.203, 242, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4887, p4cr43_, 0.8092, 2.09, 0.198, 204, 192, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4888, p3un4T_, 0.8092, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4889, p3un4F_, 0.8092, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4890, p3jcpP_, 0.8092, 2.59, 0.148, 244, 196, 
4891, p3jcoMA_, 0.8092, 3.02, 0.179, 241, 201, 
4892, p3jcoM_, 0.8092, 3.02, 0.179, 241, 201, 
4893, d2zcyR_, 0.8092, 3.01, 0.204, 242, 201, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4894, d2fakT_, 0.8092, 2.72, 0.147, 244, 197, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4895, p6gopD_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4896, p5nywT_, 0.8091, 3.09, 0.180, 224, 206, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4897, p5nifD_, 0.8091, 2.88, 0.176, 241, 199, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4898, d5lttR_, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4899, d5lttD_, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4900, d5l6cR_, 0.8091, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4901, d5l6cD_, 0.8091, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4902, d5l67R_, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4903, d5l67D_, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4904, d5l5pR_, 0.8091, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4905, d5l5pD_, 0.8091, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4906, d5l5fR_, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4907, d5l5fD_, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4908, d5l5aD_, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4909, d5fhsR_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4910, d5fhsD_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4911, d5d0tD_, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4912, d5czaT_, 0.8091, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4913, d5cz7R_, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4914, p5cghR_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4915, p5cghD_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4916, p4ya9R_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4917, p4ya9D_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4918, p4y8tD_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4919, d4y8rT_, 0.8091, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4920, d4y8rF_, 0.8091, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4921, p4y8gR_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4922, p4y8gD_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4923, p4y80R_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4924, p4y80D_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4925, p4y7yD_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4926, p4y7wR_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4927, p4y7wD_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4928, p4y77R_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4929, p4y77D_, 0.8091, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4930, p4y6vR_, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4931, p4y6vD_, 0.8091, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4932, d4r00T_, 0.8091, 2.72, 0.147, 243, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
4933, d4r00F_, 0.8091, 2.72, 0.147, 243, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
4934, d4qw4R_, 0.8091, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH CARFILZOMIB
4935, d4qw4D_, 0.8091, 2.95, 0.205, 235, 200, YCP IN COMPLEX WITH CARFILZOMIB
4936, d4qv5R_, 0.8091, 2.94, 0.205, 235, 200, YCP BETA5-M45I MUTANT
4937, d4qv5D_, 0.8091, 2.94, 0.205, 235, 200, YCP BETA5-M45I MUTANT
4938, d4qv4R_, 0.8091, 2.95, 0.205, 235, 200, YCP BETA5-M45T MUTANT
4939, d4qv4D_, 0.8091, 2.95, 0.205, 235, 200, YCP BETA5-M45T MUTANT
4940, p4quxR_, 0.8091, 2.95, 0.205, 235, 200, YCP BETA5-A49T-MUTANT
4941, p4quxD_, 0.8091, 2.95, 0.205, 235, 200, YCP BETA5-A49T-MUTANT
4942, d4qluR_, 0.8091, 2.93, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4943, d4qluD_, 0.8091, 2.93, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4944, d4qltT_, 0.8091, 2.60, 0.148, 243, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4945, d4qltF_, 0.8091, 2.60, 0.148, 243, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4946, d4q1sF_, 0.8091, 2.71, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4947, p4no6R_, 0.8091, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4948, p4no6D_, 0.8091, 2.94, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4949, d4ltcF_, 0.8091, 2.73, 0.147, 244, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4950, d4jsqR_, 0.8091, 3.10, 0.203, 242, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4951, d4jsqD_, 0.8091, 3.10, 0.203, 242, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4952, d4j70D_, 0.8091, 2.94, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4953, d4eu2E_, 0.8091, 3.02, 0.204, 242, 201, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4954, d3un8F_, 0.8091, 2.71, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4955, d3oeuF_, 0.8091, 2.72, 0.147, 237, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4956, p3jcpPA_, 0.8091, 2.59, 0.148, 244, 196, 
4957, d3gpjR_, 0.8091, 3.01, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4958, d3dy4T_, 0.8091, 2.70, 0.147, 244, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4959, d3dy4F_, 0.8091, 2.70, 0.147, 244, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4960, d3bdmT_, 0.8091, 2.60, 0.148, 244, 196, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4961, d2zcyD_, 0.8091, 3.01, 0.204, 242, 201, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4962, d1g65Q_, 0.8091, 3.09, 0.178, 241, 202, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4963, p6gopR_, 0.8090, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4964, d5m2bR_, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4965, d5m2bD_, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4966, d5l69R_, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4967, d5l69D_, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4968, d5l66R_, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4969, d5l66D_, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4970, d5l61R_, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4971, d5l61D_, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4972, d5l5sR_, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4973, d5l5qR_, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4974, d5l5hR_, 0.8090, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4975, d5l5hD_, 0.8090, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4976, d5fg7T_, 0.8090, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4977, d5fg7F_, 0.8090, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4978, d5dkjR_, 0.8090, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4979, d5dkjD_, 0.8090, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4980, d5d0xR_, 0.8090, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4981, d5d0xD_, 0.8090, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4982, d5cz7D_, 0.8090, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4983, d5cz5R_, 0.8090, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4984, d5cz5D_, 0.8090, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4985, d5cgfF_, 0.8090, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4986, d4z1lT_, 0.8090, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4987, d4z1lF_, 0.8090, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4988, p4y8lR_, 0.8090, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4989, p4y8lD_, 0.8090, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4990, p4y74R_, 0.8090, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4991, p4y74D_, 0.8090, 2.94, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4992, p4x6zG_, 0.8090, 2.62, 0.148, 244, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4993, d4rurR_, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4994, d4rurD_, 0.8090, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4995, d4qzzR_, 0.8090, 2.95, 0.205, 235, 200, YCP IN COMPLEX WITH OMURALIDE
4996, d4qzzD_, 0.8090, 2.95, 0.205, 235, 200, YCP IN COMPLEX WITH OMURALIDE
4997, d4qwrR_, 0.8090, 2.94, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4998, d4qwrD_, 0.8090, 2.94, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4999, d4qwkR_, 0.8090, 2.95, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
5000, d4qwkD_, 0.8090, 2.95, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
